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This thesis is concerned with the application and
development of serum enzyme tests in the diagnosis of myo¬
cardial infarction. Two aspects of the problem have been
selected for detailed study: firstly, the measurement of
the activity of the MB isoenzyme of creatine kinase and,
secondly, the release of mitochondrial enzyme^ in myo¬
cardial infarction. In addition, the biochemical prop¬
erties of the MB isoenzyme have been compared with those
of the MM isoenzyme of creatine kinase in an attempt to
provide the basis of a simple test for the measurement of
serum levels of the MB isoenzyme.
The enzyme tests used in the study were assessed.
While, in most cases, existing laboratory methods were found
to be suitable, a method of quantitating the MB isoenzyme
was developed from a qualitative electrophoretic technique
already available, and a new method for the measurement of
malate dehydrogenase (MI)) activity was developed.
Serum samples were obtained from the following groups:
142 patients with suspected myocardial infarction; 201
patients with disorders, other than myocardial infarction,
known to cause elevation of serum total creatine kinase
activity; and 132 apparently healthy male blood donors.
The last group was used to determine reference ranges for
each of the enzymes under investigation.
Serial determination of the serum activity of the MB
isoenzyme of creatine kinase, total creatine kinase, asp¬
artate aminotransferase'(AST), urea-stable lactate
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dehydrogenase (LD), malate dehydrogenase (md) and alanine
aminotransferase (ALT), were made on all patients with
suspected myocardial infarction.
The MB isoenzyme of creatine kinase was found to
become elevated before any of the other enzymes, abnormal
activities being observed as early as three hours after the
onset of chest pain. Enzyme activity reached a peak after
about 17 hours, significantly earlier than any other enzyme
studied, but activity also returned to normal more rapidly
than the other enzymes.
The MB isoenzyme of creatine kinase appeared to be a
more sensitive index of myocardial infarction, the average
peak activity being over 20 times the upper reference value,
whereas corresponding figures for total creatine kinase
and AST were less than 10 times the upper reference value.
The MB isoenzyme was also found to be more specific
for myocardial damage than total creatine kinase. The
studies on patients not suspected of having had myocardial
infarcts confirmed this greater specificity since, apart
from patients after cardiac operations, the raised serum
total creatine kinase activity was not accompanied by any
elevation of MB isoenzyme activity.
Determination of the activity of glutamate dehydrog¬
enase and the mitochondrial isoenzymes of AST and MD were
made on 68 of the patients with unequivocal myocardial
infarction. The mitochondrial isoenzymes reached their
peak activity later than the corresponding cytoplasmic
"Isoenzymes. Furthermore, although the peak activities
of* mitochondrial AST and MD correlated well with one
another, they did not correlate well with the correspon¬
ding peak activities of" the cytoplasmic isoenzymes. Al¬
though the mitochondrial isoenzymes were less sensitive
indicators of myocardial infarction than the cytoplasmic
enzymes, there was some evidence to suggest that the
activity of the mitochondrial isoenzymes provided a better
index of the severity of the condition, at least insofar
as the incidence of heart failure was concerned. There
was insufficient evidence to determine whether the pattern
of release of mitochondrial isoenzymes differed in important
respects from the cytoplasmic isoenzymes. Elevations in
serum glutamate dehydrogenase activity were inconsistent
and, when present, only small elevations were seen except
in patients who had coincident liver damage.
Partially purified preparations of the MM and MB iso¬
enzymes of creatine kinase were prepared from human heart
tissue, and the physical and biochemical properties of the
two isoenzymes were compared. The MB isoenzyme was more
sensitive to denaturation by heat, 8 mol/l urea and extremes
of pH than the MM isoenzyme. Under certain conditions,
however, the MM isoenzyme was found to be inactivated by
p-hydroxymercuribenzoate more rapidly than the MB isoenzyme.
The two isoenzymes also had different substrate affinities,
the MB isoenzyme having lower values for MgADP and
creatine phosphate. The values of the two isoenzymes
also behaved differently when the pH of the assay medium
was altered. In most of the other properties studied
(type of reaction mechanism, behaviour with inhibitors,
activation by thiols) the two isoenzymes were similar to
one another.
An assessment of some-of the currently available methods
of assay of the MB isoenzyme of creatine kinase in serum
has been carried out. An unsuccessful attempt was made
to develop a method based on the differences in behaviour
of the two isoenzymes with p-hydroxymercuribenzoate. A
simple ion-exchange method, using DEAE Sephadex, was
developed and was compared with polyacrylamide and agarose
gel electrophoretic techniques. While all three methods
were able to give satisfactory results, the ion-exchange
method and a commercial electrophoretic method using agarose
gel were found to be more precise, accurate and convenient
than polyacrylamide gel electrophoresis.
The present studies, in conjunction with those from
other laboratories, confirm that measurement of serum
activities of the MB isoenzyme of creatine kinase is valuable
in the diagnosis of myocardial infarction. It is more
doubtful whether the mitochondrial isoenzymes of AST and MD
have significant advantages over other enzyme tests.
However, knowledge of the factors controlling the release of
enzyme from damaged myocardium is still incomplete and




1-1 Multiple forms of enzymes.
Enzymes are named after and identified by their cata¬
lytic activities. Different proteins with the same cata¬
lytic activity are therefore classified under the same name.
In 1895 Emil Fischer advised that tissue and species origin
should be reported when describing enzymes, thus implying
that there might be tissue and species differences between
enzymes. Although many enzymes and co-enzymes have been
proved to be very similar (if not identical) despite differ¬
ent biological origins, examples of species differences in
enzymes abound in the literature, e.g. aldolase (Warburg
and Christian, 19^3) and pancreatic amylase (Meyer e_t al. ,
19^7)• Comparative studies of such enzymes are valuable
in the investigation of molecular evolution.
In 19^8 Warburg suggested that enzymes catalysing
similar reactions in different tissues might be organ-
specific. This has been found to be true for many enzymes.
Alkaline phosphatases, for example, in bone, intestine and
liver, differ in electrophoretic mobilities, immunological
properties and many other biochemical properties. Other
examples include serum and erythrocyte cholinesterases, and
prostatic and erythrocyte acid phosphatases.
There are also some enzymes which occur within a spec¬
ies in a number of different forms distributed in different
proportions in different tissues. Lactate dehydrogenase
is an example in this category. Wieland and Pfleiderer
(1957) found that most organs had five protein fractions
with lactate dehydrogenase activity. Later Vesell and
Beam (1961 ) showed that the electrophoretically fast moving
forms predominated in human heart tissue while the slow
forms predominated in human liver and skeletal muscle. It
has been suggested that such differences may have biological
significance (Umbarger, 1961). Thus, Cahn e_t al. (1962)
proposed that the slow forms of lactate dehydrogenase, which
are only slightly inhibited by excess lactate, allowed the
accumulation of lactate hence favouring the anaerobic respi¬
ration which may be found in skeletal muscle. The fast
forms, on the other hand, which are more sensitive to inhibi¬
tion by excess lactate are found predominantly in heart tissue
where aerobic respiration is the rule.
The multiple enzyme forms in tissue may be found in the
same or different parts of the cell. All five forms of
lactate dehydrogenase are present in the cytoplasm. On the
other hand, the two different forms of aspartate aminotrans¬
ferase (Boyd, 1961), malate dehydrogenase (Wieland ejt al. ,
1959) and ^-glycerophosphate dehydrogenase are separated
from each other, one in the cytoplasm and the other in the
mitochondria. Since it is likely that substrate concentra¬
tions and metabolic activities in cytoplasm and mitochondria
are different, it is hardly surprising that the different
isoenzymes present in these two sites might have different
kinetic and physical properties.
Markert and Miller (1959) were the first to use the
term "isozyme" to describe different proteins with similar
catalytic properties. The precise definition of the term
is difficult as many enzymes have broad and overlapping
substrate specificities. Different forms of enzymes may
arise from genetically independent proteins (e.g. aspartate
aminotransferase isoenzymes) or from heteropolymers of two
or more polypeptide chains under separate gerftic control
(e.g. lactate dehydrogenase). Apart from these genetic
causes, multiple enzyme forms may arise from:
1. proteins being conjugated to different groups (e.g.
phosphorylases a and b);
2. proteins being derived from one parent polypeptide
chain (e.g. family of chymotrypsins from chymotryp-
sinogen);
3- polymerisation of a single subunit (e.g. glutamate
dehydrogenase);
conformational changes in protein molecules (all
allosteric modifications of enzymes);
5. artifacts arising from the preparation and separa¬
tion of the enzyme.
In 1964, the Standing Committee on enzymes of the Inter¬
national Union of Biochemistry stated that the term, iso¬
enzyme or isozyme, should only be applied to different enzy¬
matic forms within a species arising from genetically det¬
ermined differences in the primary structure.
I
The study of isoenzymes within and among tissues has
an important application in clinical medicine. It has been
found that isoenzyme patterns not only vary with species and
tissues, but also with age and in pathological conditions.
Schapira e_t al. (1968) pointed out that there was a general
tendency for isoenzymes to revert to their foetal pattern
in cancerous and atrophic tissues. This might be taken as
an expression of tissue de-differentiation at molecular
level. It is possible that, more can be discovered about
both the progress and the molecular aetiology of some dis¬
eases by studying the isoenzyme patterns of the affected
tissues. Moreover, during tissue necrosis enzymes are
released into the circulation and become detectable in the
body fluids.
By measuring the activity of the released enzymes more
ft
information about the nature of the disease can be obtained.
The value of such enzyme determinations may be greatly in¬
creased by isoenzyme studies which help to demonstrate the
tissue of origin of the enzyme so that the site as well as
the extent of the disease can be more accurately assessed.
The work described in this thesis is concerned with these
clinical applications of isoenzyme measurements.
The release of the isoenzymes of creatine kinase, asp¬
artate aminotransferase and malate dehydrogenase from damaged
human myocardium has been studied with a view to determining
their clinical value in their determination in serum.
1-2 Isoenzymes of creatine kinase •
(ATP: creatine phosphotransferase EC 2.7.3-2.)
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1-2-1 Discovery of creatine kinase and its isoenzymes.
Creatine kinase catalyses the reversible phosphoryla¬
tion of creatine by adenosine triphosphate in the presence
of Mg^+ion.
Creatine + MgATP^- '—k Creatine phosphate^- + MgADP- + H+
The discovery of the enzyme came as a result of the
interest in inorganic phosphates in muscle. In 1927 Fiske
and Subbarow found that much of the inorganic phosphate in
muscle filtrates arose from acid hydrolysis of an organic
phosphate. They considered that their organic compound
contained equimolar amounts of creatine and phosphate.
Lohmann in 1928 found that a considerable part of the organic
phosphate was linked to adenylic acid and was relatively
stable to acid. A few years later Lohmann ( 1 93^+) was able
to demonstrate the presence of an enzyme catalysing the
transfer of a phosphate group from creatine phosphate to
adenylic acid forming "adenyl pyrophosphate". The reverse
reaction, the transfer of phosphate from ATP to creatine,
was soon shown by Needham and Van Heyningen (1935)- Lehmann
(1935, 1936) considered the reaction to consist of two stages
1. Creatine + ATP ADP + Creatine phosphate
2. ADP + Creatine AMP + Creatine phosphate
However, Banga in 19^3 reported that the partially purified
muscle extract was unable to catalyse reaction 2 after the
57°/° ethanol precipitation stage. She concluded that the two
reactions were catalysed by different enzymes. The situation
was clarified by Chappell and Perry (1953) who showed that
muscle extract in the absence of adenylate kinase was unable
to catalyse reaction 2. Adenylate kinase catalyses the
reac tion
2ADP ATP + AMP
Reaction 2 was, therefore, the combined effect of the crea¬
tine and adenylate kinases.
Although most of the pioneering work on creatine kinase
was done with muscle extracts, the enzyme is also present in
high concentration in the brain. Narayanaswami (1952) and
later Wood (1963) showed that the brain enzyme had different
electrophoretic mobilities and substrate affinities from the
muscle enzyme. Electrophoretic studies in vertebrates (Deul
and van Bremen '\()6k, Rosalki, 1965) showed that cytoplasmic
creatine kinase occurred in three distinct forms - one with
high anodal mobility found mainly in brain tissue, one with
low anodal mobility present in muscle and a third one with
intermediate mobility mainly present as a minor component
in heart extracts. Dawson e_t al. (1965) confirmed that the
form with intermediate mobility was a hybrid of the electro-
phoretically fast and slow isoenzymes. They subjected a
mixture of purified fast and slow forms to dissociation with
6.5tnol/l guanidine hydrochloride. After reactivation by
dialysis, electrophoresis showed the presence of the hybrid
between the two parent forms. The three band pattern sugg¬
ested that the enzyme existed as a dimer. According to their
main tissue of origin the three forms were named the muscle
type (MM), the brain type (BB) and the hybrid (MB).
All these isoenzymes have been shown to occur in the
cjrtoplasm. However, other forms of creatine kinase with
properties different from the soluble isoenzymes have also
been found. Jacobs e_t al. (196^) demonstrated creatine
kinase activity in purified mitochondria from skeletal mus¬
cle, cardiac muscle and brain. Ottaway (1967) purified
creatine kinase from the myofibrillar fraction of ox heart
muscle. Keto and Doherty (1968) crystallised creatine
kinase from a non-mitochondrial particulate fraction of a
pig heart extract. The sarcoplasmic reticulum of rabbit
skeletal muscle has also been reported to contain creatine
kinase (Baskin and Deamer, 1970) representing 1 °/o of the total
tissue enzyme, but no properties have been.found to disting¬
uish it from the MM cytoplasmic isoenzyme. To date relati¬
vely little is known about these.particulate enzymes. The
present work is only concerned with the cytoplasmic forms.
1-2-2 Comparative aspects of the cytoplasmic isoenzymes.
Like lactate dehydrogenase isoenzymes, the isoenzyme
patterns of creatine kinase change during both ontogeny and
phylogeny.
Of the thirteen species studied by Eppenberger e_t al.
(1970)j the isoenzyme pattern in the myocardium was found to
be the most variable of all tissues. In man, the myocardium
contained a major band of the MM isoenzyme and a weak band
of the MB isoenzyme. In rabbit, only the MM isoenzyme was
found. In rat all three isoenzymes were present, with the
MM isoenzyme as the major band. In chicken heart tissue
the BB isoenzyme predominated with a weak band of the MB
isoenzyme. Some avian species had two brain-type isoenzymes
which, upon hybridisation with the muscle enzyme, gave two
hybrid bands. By hybridisation and optical rotary disper¬
sion studies, it has been shown that the brain isoenzyme is
structurally less organised than the muscle enzyme and can
therefore give rise to slightly different molecular forms.
Hybridisation of the BB and MM isoenzymes is not confined
within a species. Interspecies MB isoenzyme hybrids have
been formed from mixtures of cat, human and chicken tissue
extracts (Dawson ejt al. , 1967). Indeed, hybridisation bet¬
ween the BB isoenzyme of rabbit and the dirtier arginine kinase
of sea cucumber has been demonstrated (Watts ejt al. , 1972).
These examples show the close structural phylogenetic rel¬
ationship of phosphagen kinases among species. This is made
more evident by protein structure studies.
The MM isoenzymes of different species are more similar
in their primary, secondary and tertiary structures than are
the MM and BB isoenzymes within a single species (Gosselin-
Rey and Gerday, 1970). In ox, rabbit and chicken the BB
isoenzymes are all known to contain significantly fewer basic
amino acids, and more cysteine and aromatic amino acids than
the MM isoenzymes (Noltmann e_t al. , 1962). The presence of
fewer basic amino acids explains the greater anodal electro-
phoretic mobility of the BB form at pH values above neutral¬
ity. The hybrid MB isoenzyme has an amino acid composition
intermediate between its parent forms (Eppenberger e_t aT. ,
1967)• Antisera raised against the MM isoenzyme will not
cross-react with the BB isoenzyme and viee versa, but will
react with the same isoenzymes from other species (Bulcke
and Sherwin, 1969). Sedimentation and other studies have
confirmed that the isoenzymes consist of two freely dissoci¬
able subunits, each consisting of a single polypeptide chain
having no disulphide bridges (Yue ejfc al. , 1967). The sub-
units are cigar-shaped and lie side by side. It is believed
that all three isoenzymes have this shape, which is strongly
retained among phosphagen kinases throughout evolution.
The changes of isoenzyme pattern with ontogeny have been
studied by Eppenberger e_t aT. (1964). They demonstrated in
»
rat and chicken embryos that the brain-type isoenzyme (BB)
appeared first in heart, skeletal muscle and brain tissues.
In brain the BB isoenzyme remained the only type of creatine
kinase throughout development. In heart and skeletal muscle
the BB isoenzyme was gradually replaced by the MB isoenzyme
which was in turn replaced by the MM type. These transitions
correlated with morphological and physiological changes.
Eppenberger aT. (1964) divided this development into four
stages:
1. The myoblast stage when the BB was the only iso¬
enzyme present. The MB isoenzyme began to appear
when myocells were formed.
2. The myotube stage when the cells showed fibrilla¬
tion and cross-striation. The MB isoenzyme was
the predominant creatine kinase at this stage.
3. The myofibril stage, characterised by a rapid rise
of actomyosin and creatine kinase activity. The
„ BB isoenzyme then disappeared with the myotubes
and the MM isoenzyme became more and more pre¬
dominant .
k. The final stage was marked by further increase of
creatine kinase, actomyosin and creatine phosphate.
By this stage the MB isoenzyme had been completely
replaced by the MM isoenzyme. In mature myocar¬
dium, however, the MB isoenzyme still remained in
significant concentration. This may be attributed
to the morphological differences between skeletal
muscle and myocardium. Although the myocardium
contains contractile proteins similar to those of
adult skeletal muscle, many of its structural prop¬
erties resemble more those of the embryonal muscle
of the myotube stage when both the MM and MB iso¬
enzymes are present.
Reversion to the foetal-stage isoenzyme pattern has also
been observed in various forms of muscular dystrophy. The
exact mechanism of this reversion is still not clear.
1-2-3 Physiology of creatine kinase isoenzymes in human
myocardium .
Energy liberation, conservation and utilisation are
three important phases in the metabolism of normal myocar¬
dium. The cardiac muscle takes up from blood energy-
containing compounds which include fatty acids, pyruvate,
lactate, acetoacetate and glucose. The energy liberated
from the catabolism of these substances is largely stored
in the form of "high-energy" phosphate compounds whose
breakdown provides energy for the contractile mechanism of
the muscle cell for the performance of mechanical work.
The heart is well adapted for continuous aerobic work since
it is 3 - ^ times more vascular and has 10 - 20 times more
blood-flow per unit weight of tissue than has skeletal mus¬
cle (Olson and Schwartz, 1 95"• ) • It is rich in myoglobin
and has a very high concentration of mitochondria.
Myocardial creatine kinase is mainly concerned with
energy storage. The enzyme maintains a transphosphorylation
equilibrium between ATP and creatine phospfiate which together
constitute 90°/o of the "energy-rich" phosphate bonds in card¬
iac muscle (Furchgott and Lee, 1'961). At pH 7^0 the free
energy made available by hydrolysis of creatine phosphate is
about 63OO j/mol greater than that of ATP, thus the equilib¬
rium favours the formation of ATP. ATP is the major energy
source for muscle contraction while creatine phosphate acts
as an energy reserve. Any ATP used up is rapidly repleni¬
shed by creatine phosphate through the action of creatine
kinase. Interference with oxidative metabolism has been
found to result in a decrease in creatine phosphate concent¬
ration, ATP levels being more slowly affected (Furchgott and
Lee, 1961). The free energy of hydrolysis of creatine phos¬
phate cannot be made directly available to the contractile
element, actomyosin. Nevertheless, it has been found that,
in the absence of any added nucleotide and in the presence
of creatine phosphate, the unpolymerised globular form of
actin (G-actin), when complexed with ADP, can function as
substrate for creatine kinase and form a single molecular
complex with the enzyme (Yagi and Noda, i960). In vivo,
ADP bound to actin may, therfore, be directly phosphorylated
to ATP during each contractile cycle.
The physiological significance of the presence of diff¬
erent creatine kinase isoenzymes in the myocardium is still
not clear. It is not certain if the cytoplasmic MM and MB
isoenzymes serve different functions, or if the MB isoenzyme
is no more than an embryonic vestige. The latter interpret¬
ation seems more likely as the MB isoenzyme is absent in the
»
myocardium of many other species.
Attempts have been made to assign a different function
to the mitochondrial creatine kinase. This isoenzyme has
been found to react only with extra-mitochondrial adenine
nucleotides. Since it is capable of regenerating ADP from
extra-mitochondrial ATP in the presence of creatine, it has
been suggested that it might help to regulate mitochondrial
respiration in response to the requirements of muscle contr¬
action (Bessman and Fonyo, 1966).
1-3 The isoenzymes of aspartate aminotransferase (L-aspart-
ate: 2-oxoglutarate aminotransferase EC 2.6.1.1).
Aspartate aminotransferase is the most abundant of the
numerous aminotransferases in human tissues. Occurring in
most major human tissues, especially in heart, liver and
skeletal muscle, it catalyses the reaction
-"2-oxoglutarate + AspartateGlutamate + Oxaloacetate
in the presence of pyridoxal phosphate as co-enzyme. The
enzyme occupies a central role in both anabolism and cata-
bolism of amino acids and serves as a link between amino
acid and carbohydrate metabolism. At physiological pH the
reaction equilibrium favours the formations of glutamate and
oxaloac etate.
The enzyme has at least two fractions separable by elec¬
trophoresis, as first reported by Green ejt al. (19^5)« The
cationic fraction has been shown to originate from the mito¬
chondria and the anodic fraction from the cell cytosol (Hird
and Rowsell, 1950; Boyd, 1961). The two isoenzymes differ
greatly in many biochemical properties:
1. They have different amino acid compositions, although
their molecular weights are similar (Martinez-
Carrion e_t al. , 1 967) •
2. Antisera raised against one isoenzyme do not cross-
react with the other (Nisselbaum and Bodansky, 196^).
3. They have different kinetic parameters. For exam¬
ple, the mitochondrial isoenzyme has a lower Mich-
aelis constant (Km) for aspartate, whereas the cyto¬
plasmic form has a lower Km for 2-oxoglutarate.
k. The mitochondrial isoenzyme is stable in acid pH
5-7 while the cytoplasmic isoenzyme is not.
5. The cytoplasmic isoenzyme is appreciably more stable
to heat (Wada and Morino, 196^).
There is evidence which suggests that the two isoenzymes
are not homogeneous. Three separate bands in the cytoplasmic
isoenzyme and two in the mitochondrial isoenzyme have been
reported in human sera using starch gel electrophoresis
(Block ejt aT. , 196^t). It is not certain whether the occur¬
rence of* two isoenzymes and their sub-forms has any biologi¬
cal significance.
1-k Isoenzymes of malate dehydrogenase (L-malate: NAD
oxidoreductase EC 1.1.1.37)*
Malate dehydrogenase catalyses the reaction
Malate + NAD . Oxaloacetate + NADH
»
The enzyme catalyses one of the stages in the aerobic
oxidation of carbohydrates via the tricarboxylic acid cycle.
At physiological pH the equilibrium favours the formation of
malate. Like aspartate aminotransferase it is heterogen¬
eous, occurring in cytoplasmic and mitochondrial forms, each
of which is further separable by electrophoresis into 5 or 6
sub-bands of identical catalytic activity (Thorne jsjfc al. ,
1963). The exact nature of these sub-forms is unknown.
At pH 6.2 the soluble (cytoplasmic) isoenzyme migrates
towards the anode and the mitochondrial isoenzyme towards
the cathode during electrophoresis on starch gel. The iso¬
enzymes have different substrate affinities and turnover
rates. Both forms are strongly inhibited by excess sub¬
strate, the mitochondrial form by oxaloacetate and the cyto¬
plasmic form by malate. It is thought that these charact¬
eristics may prevent the reduction of oxaloacetate in mito¬
chondria and the oxidation of malate in the cytoplasm.
Based on this, different roles have been assigned to the two
forms of enzyme (Kaplan, 1961). The cytoplasmic isoenzyme
couples NADH oxidation with the reduction of oxaloacetate to
malate. The malate thereby produced enters the mitochondria,
where it is oxidised by the mitochondrial isoenzyme in the
presence of the mitochondrial bound NAD. The oxaloacetate
regenerated may then be released into the cytoplasm enabling
the cycle to continue. In this way the two isoenzymes help
regulate the NAD/NADH ratio within the mitochondria.'
1-5 Isoenzymes in the diagnosis of mycardial infarction.
1-5-1 Biochemical changes in myocardial infarction.
Ischaemia produced by coronary occlusion disturbs myo¬
cardial metabolism by interfering with energy production.
Most of our biochemical knowledge about myocardial ischaemia
comes from animal experiments. It has been shown that
following complete ligation of the coronary arteries there
is a rapid decline in the ATP, creatine phosphate and gly¬
cogen content of myocardial cells. Simultaneously there is
a rise in lactate and ^-glycerophosphate concentration indica¬
ting a shift to anaerobic metabolism. As the oxygen tension
in the myocardium falls, the oxidation-reduction systems shift
towards a more reduced state. The NADH/NAD system is one
of the systems involved. As a result, the concentration of
NADH rises and the lactate/pyruvate system, having a redox
potential slightly higher than that of NADH/NAD, is the next
to be reduced in the presence of lactate dehydrogenase.
Pyruvate + NADH ' Lactate + NAD
In the presence of anoxia this allows other metabolic sys¬
tems needing NAD to continue to function. If the anoxia is
not rectified, the whole energy production system will soon
be severely impaired. Consequently, the muscle cell can no
longer maintain the ionic gradients across the cell membrane.
Cell permeability rises, and various intracellular substances
including enzymes leak from the cell. This may happen be¬
fore the metabolic processes are irreversibly damaged. The
contractile fibril, actomyosin, fails to dissociate to rev¬
erse muscular contraction. Abnormal cross'-linkages are
formed between different filaments. At this stage cell
necrosis sets in.
A series of glycolytic and oxidative enzymes has been
studied in myocardial infarction (Gudb jarnason ejt aT . , 1967)-
It was found that following infarction there was a rapid
decline in mitochondrial enzyme activity in the infarcted
tissue, with the lowest level in the centre of the infarct.
The glycolytic enzymes also decreased significantly in act¬
ivity, for example, aldolase, lactate dehydrogenase and glyc-
eraldehyde phosphate dehydrogenase decreased to 1 k°/o, 21$ and
37°/o of their original activity respectively. In contrast,
the activities of the hexose-monophosphate-shunt enzymes rose
in experimental myocardial infarction. Glueose-6-phosphate
dehydrogenase and 6-phosphogluconate dehydrogenase rose jh-
fold and 10-fold respectively in the affected heart tissue.
This enhanced hexose-monophosphate shunt activity implies
the adaptive synthesis of ribose and ribonucleic acids in
the presence of injury.
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1-5-2 Enzymes in the diagnosis of myocardial infarction.
With the common occurrence of this disease, its diag¬
nosis and prognosis have become a major subject of interest
to cardiologists. The current diagnostic methods based on
clinical assessment and the electrocardiogram are not alto¬
gether satisfactory for the following reasons (Coodley, 1970)i
1 . 25°/o to 30% of myocardial infarcts are not diagnosed
ante mortem.
2. Clinical diagnosis and angiographic studies do not
correlate in 23-30% of patients.
3. Electrocardiographic findings (ECG) may not be
helpful if:
a. Prior left bundle branch block is present.
b. Old changes exist that may obscure the current
ECG pattern.
c. The infarct is intramural, since intramural
infarcts may not change the ECG pattern.
d. The infarct is diaphrametic, since diaphram-
etic infarcts are often missed in the ECG.
In 195^ LaDue, Wroblewski and Karmen were the first to report
a rise of aspartate aminotransferase activity in the sera of
patients after myocardial infarction; the amount and duration
of the elevation roughly correlated with the size of infarct.
Since then, lactate dehydrogenase, creatine kinase, malate
dehydrogenase and a variety of other enzymes have all been
reported to be present in increased amounts in serum after
infarction, and have been used as routine diagnostic tests
fQ.r myocardial infarction.. However, these tests are not as
satisfactory as originally hoped.
The inherent problem is the lack of tissue specificity
of the enzymes, since they are also released in a number of
other disease states. For example, aspartate aminotrans¬
ferase, though rich in heart muscle, occurs in all tissues
of the body. Besides myocardial infarction, it is released
into the circulation in hepato-biliary diseases, severe
tachycardia, pulmonary embolism, intravascular haemolysis,
muscle injury, acute pancreatitis and extensive surgical
operations. The same is true for lactate dehydrogenase -
its activity in serum is raised in hepatic, malignant, haem-
atological, muscular and renal diseases as well as myocardial
infarction. Moreover, normal results of lactate dehydrog¬
enase have been reported in a number of proven cases of myo¬
cardial infarction (Freeman e_t aT. , 1959) • Even creatine
kinase, which was first thought to be more specific to myo¬
cardial infarction than any other enzyme, has also been found
raised in the serum in muscular dystrophy, neurological and
psychiatric disorders, pulmonary and endocrine diseases as
well as in a number of physiological states. This lack of
specificity means that false positive results are frequent
if these enzymes are used uncritically in diagnosing myocard¬
ial infarction.
1-5-3 Use of isoenzymes.
Various attempts have been made to improve the speci¬
ficity of serum enzyme tests. The application of lactate
dehydrogenase isoenzyme patterns in tissue to diagnostic
medicine has had considerable success. The distribution of
the five isoenzymes was studied in several human tissues and
listed as follows:
Lactate Dehydrogenase Activity Obtained by
Starch Block Electrophoresis
°/o Total Activity in Each Peak
Tissue LD1 LD2 LD3 LD4 LD5
Heart 73 24 3 0 0
Liver 4 8 27 24 37
Skeletal muscle 0 0 5 17 78
Kidney 42 45 11 2 0
Red blood cells 43 44 1 2 1 0
White blood cells 12 49 33 6 0
(After Bodansky, 19&7)
From the table it is clear that the isoenzyme pattern of
lactate dehydrogenase differs in human tissues. Wroblewski
and Gregory (1961) suggested that the measurement of indivi¬
dual isoenzyme components might serve to differentiate var¬
ious disease processes and that, by measuring differentially
the fast-moving lactate dehydrogenase isoenzymes, false
positive diagnoses of myocardial infarction would be very
much reduced. However, such studies do not offer complete
tissue specificity. The isoenzymes are also released in
viral myocarditis, active rheumatic carditis and a number of
noil-cardiac conditions including megaloblastic and haemolytic
anaemia and progressive muscular dystrophy.
The study of lactate dehydrogenase isoenzymes has
given impetus to the investigation of other isoenzymes in
the hope of further improving the tissue specificity and
sensitivity of the tests. Several studies of the mito¬
chondrial isoenzyme of aspartate aminotransferase have been
reported. Preliminary studies have shown that the isoenzyme
is raised in the sera of patients with myocardial infarction
(Fleisher e_t aT . , I96O; Boyde and Latner, 1962). Boyde
(1968a) found that the raised serum activities of the mito¬
chondrial isoenzyme returned to normal at a slower rate than
total enzyme activity. In eight cases the isoenzyme activity
was found raised when the total serum aspartate aminotrans¬
ferase activity was still normal and hence the author con¬
cluded that the mitochondrial isoenzyme might be a more sen¬
sitive indicator of myocardial infarction than total enzyme
activity. However, reports by other investigators (Fleisher
and Wakim, 1963; Massarat and Lang, 1965) did not agree with
the findings of Boyde. Much of the evidence gathered so far
is conflicting.
The application of creatine kinase to diagnostic medicine
came almost a decade later than lactate dehydrogenase and
aspartate aminotransferase. When it became clear that total
creatine kinase activity was not as specific to myocardial
infarction as first expected, mainly due to its release from
skeletal muscle in a number of physiological and pathological
conditions, efforts were directed towards the use of isoenzy¬
mes. The MM isoenzymes in heart and skeletal muscle have
been compared, and found to be very similar in all the bio¬
chemical properties studied (Smith, 1970)5 and hence of no
value in the selective diagnosis of myocardial infarction.
On the other hand, it was shown that the MB isoenzyme was
released into the circulation in myocardial infarction (Van
der Veen and Willebrands, 1966; Menache e_t al_. , 1968).
Biochemical data and clinical experience about the potential
value of the MB isoenzyme in diagnosis were lacking when the
present project started in 1972.
1-6 Objectives of the present study.
As discussed in the previous subsection, the data about
the clinical use of mitochondrial isoenzymes and the MB iso¬
enzyme of creatine kinase are few and confusing. It has
been the overall objective of the present investigation to
study the release of these isoenzymes following myocardial
infarction and to see if this knowledge would form the basis
of an improved clinical test for the diagnosis of myocardial
infarction.
It was hoped that the study of the MB isoenzyme would
improve the specificity and sensitivity of creatine kinase
measurement in clinical laboratories. Also by comparing
the release of mitochondrial enzymes (as represented by the
isoenzymes of aspartate aminotransferase and malate dehydro¬
genase, and glutamate dehydrogenase) with those of cyto¬
plasmic origin (lactate dehydrogenase, isoenzymes of aspar¬
tate aminotransferase and malate dehydrogenase) it was hoped
that more insight might be gained into the potential value
of mitochondrial enzymes in indicating tissue damage in
myocardial infarction.
It has also been the aim of the present work to study
the biochemical properties of the MB isoenzyme of human
creatine kinase and to compare them with the more abundant
MM isoenzyme. The MB isoenzyme has been neglected in many
biochemical studies of the creatine kinase isoenzymes. It
is usually regarded as having properties intermediate between
its parent forms. The present investigation may both help
to fill part of this gap and form a basis for a differential
assay of the MB isoenzyme.
The study is divided into three parts. The first deals
»
with the methods of measuring several enzymes in serum. The
second part is concerned with studies of the release of the
enzymes into serum in patients with suspected myocardial
infarction. The third part is a comparative study of the
cytoplasmic isoenzymes of creatine kinase, their enzymatic
properties and their differential determination.
SECTION 2
ENZYME ACTIVITY ASSAY IN SERUM AND TISSUE EXTRACTS
Ixi this section the principles and difficulties of
methods of measuring creatine kinase, aspartate aminotrans¬
ferase, malate dehydrogenase and other enzymes investigated
in the present study are discussed.
2-1 Nature of enzyme activity 'determinations.
The activity of an enzyme is determined by the catalytic
state and by the concentration of the enzyme. By using the
same amount of enzyme and varying the experimental conditions,
enzyme activity measurements provide useful information about
the reaction mechanism and the enzyme active site(s). On
the other hand, by keeping the "assay conditions constant,
enzyme activity measures the amount of enzyme in the reaction
mixture. With few exceptions, activity determinations are
the only means of detecting enzymes, and hence become the
main concern of the clinical biochemist who is, in general,
primarily only interested in enzyme concentration. There¬
fore, enzyme activity measurements are important for both
pure and applied studies of enzymes.
2-1-1 Theoretical considerations.
Enzyme activity is expressed as the velocity of the
reaction it catalyses. The conventional method of follow¬
ing the reaction velocity is to measure the disappearance of
substrate, or the appearance of products, as a function of
time. The velocity at any particular time is obtained by
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drawing a tangent to the concentration-time curve (Fig. 2-1a).
The initial velocity (i.e. velocity at the beginning of the
reaction) should be used for enzyme activity measurement in
order to avoid any complications that may arise during the
reaction, such as the effects of the reverse reaction,
build-up of inhibitory products, exhaustion of substrates
and the possible inactivation of enzymes at the pH and
temperature of the reaction.
In most cases the initial velocity of an enzyme reaction
is directly proportional to the amount of enzyme present.
This relationship forms the basis of nearly all methods of
determination of enzyme concentration. However, Dixon and
Webb (196^) have listed a number of practical situations
when this rule does not hold:-
1. The capacity of the assay is exceeded.
2. Co-factors needed for the reaction in the assay
solution are exhausted owing to the presence of
an excessive amount of enzyme.
3. The presence of toxic impurities in the reagents.
The presence of a reversible inhibitor or activator
in the enzyme preparation.
These possibilities should, therefore, be eliminated first
before the initial velocity is taken as a measure of enzyme
coneentration.
In a chemical reaction the relation between the reaction






The Velocity of Reactions Catalysed by Enzymes
Initial [Substrate]
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where v = initial velocity;
o '
S = substrate concentration;
k = a constant;
n = order of the reaction with respect
to S.
In an enzyme reaction, vq is first order with respect to S
at low concentrations of S, but becomes zero order when S
increases and saturates all the enzyme molecules. At still
high concentrations of S, inhibition (or, less frequently,
activation) may occur (Fig. 2-1b). From an analytical
point of view it is always advisable to measure enzyme act¬
ivity in the presence of an excess of substrate (Zone B
Fig. 2-1 b), firstly to ensure that there is no significant
fall of substrate concentration during the time of assay,
and secondly to minimise instrumental error in delivering
substrate, as the reaction velocity is not sensitive to
minor variations of substrate concentration in this zone.
However, if Zone B is narrow, the fall in substrate concen¬
tration may cause a change from zero order to first order
reaction conditions within the period of measurement. The
activity so obtained is then no longer a true estimation of
enzyme concentration.
2-1-2 Methods.
In general, two classes of methods are used to measure
enzyme activity. In sampling methods, portions of reaction
mixture are taken out at intervals during incubation and
,
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analysed separately to give a number of points representing
the progress of the reaction. If the reaction is assumed
to be linear, only two points are needed. In continuous
methods, the reaction is followed continuously in the reac¬
tion vessel. Of the two methods the continuous method is
usually to be preferred whenever practicable as it gives a
more reliable and accurate estimation of the initial velocity.
The principal measuring techniques involved are:-
1. Spectrophotometry. Many reaction substrates and
products absorb light in the UV and visible region.
Using a suitable spectrophotometer, the absorbance
can be monitored and the rate of appearance or
dissappearance of the light-absorbing material can
be calculated quantitatively.
At
2. Florimetry. The fluorescence of substrate or
product or their derivatives is measured. It is
in most cases many times more sensitive than the
spectrophotometric technique.
3. pH titration for reactions involving H+ production
or consumption. The change of pH as the reaction
proceeds may be monitored or alternatively the pH
may be kept constant by continuous titration.
Miscellaneous. In addition to the above, there
are other more specialised methods meeting the
special requirements of certain types of enzyme
reactions. Examples are manometric methods for
gaseous reaction components, polarimetric methods
for changes of optical rotation, and platinum elec¬




At present, the spectrophotometric techniques are most
commonly used, mainly as a result of the work of Warburg and
Christian (193S) on the coenzymes NAD and NADP. Many of the
reactions follow the oxidation/reduction of NADH/NAD by
monitoring absorbance at 3^0nm where NADH and NADPH have an
absorption maximum not shown by the corresponding oxidised
form of the nucleotide. Not only can oxido-reduction reac¬
tions be followed at 3^0nm, but also other reactions which
are able to be coupled to reactions involving NADH or NADPH,
e.g. creatine kinase and aspartate aminotransferase.




S v Pl > P2
S = substrate for E
x
E^ = the enzyme whose activity is to be measured
P^ = product of Ex
Ec = coupling enzyme which acts on P^
P2 = product of Ec whose formation involves the
NADH/NAD or NADPH/NADP systems
v = reaction rate from S to P„
x 1
v = reaction rate from P„ to P_
c 1 2
When the reaction catalysed by Ex is started, P^ begins to
form. As P^ accumulates, v__ begins to rise in the presence
of E until a steady state, v = v , is reached. As the
c c x
measured activity is v , it is important that the steady
"State be reached as soon- as possible since the shorter this
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lag phase, the more reliable is the estimation of the initial
activity of E^. The velocity (vc) of" the secondary reaction
is maximal when E has a low Michaelis constant for the
c
substrate (K ), so that large amounts of P„ are not re-v
mc 1
quired to "drive" the reaction, and when is present in
high concentration, i.e. when E /K is large. Therefore,
c mc
the larger ratio, E E , the faster is v increasing
c / x c
K K
mc mx
from zero to the value of v . To achieve this, an amount
x '
of E many times in excess of E is needed and a coupling
C X
enzyme with a low K should be preferred if possible. The
same principle applies to systems with more than one coupled
reac tion:
E E E
x c 1 c2
S * Pl >P2 VP3
If care is taken to ensure that the ratios E/K of E . and'
m c 1
Ec2 are many times larger than that of E^, the lag phase can
be short and a linear reaction course can be obtained. How¬
ever, in using highly active purified coupling enzymes, there
is the inherent danger of any essential cofactors in the
assay system being exhausted by these enzymes, and of intro¬
ducing undesirable materials as impurities (such as substr¬
ates or enzymes) giving rise to side reactions. So, in
selecting a coupled-system assay, one has to balance the
advantages against these disadvantages.
2 -1-3 Sources of error.
Recent advances in techniques of enzyme measurements
- 29 -
*
have improved the precision, accuracy and sensitivity of
enzyme assay methods, but the variables affecting enzyme
catalysis are still not fully under control. While it is
relatively easy to control substrate concentration, pH,
temperature, ionic strength and nature of the buffer, other
variables are more difficult to control. These include:-
1. denaturation of enzyme on the surfaces of the
reaction vessel and delivering pipettes,
2. inactivation around liquid-air interfaces,
3. presence of traces of toxic or activating substances,
k. presence of interfering enzymes .in the reaction
mixture,
5. possible dissociation of enzyme into inactive
proteins on dilution,
6. changes of enzyme properties due to ageing,
7. conditions of storing enzyme solutions,
8. human and instrumental errors involved in the
assay.
For these reasons it is very difficult to prepare a satis¬
factory reference enzyme material to standardise techniques
of enzyme measurements. Instead, efforts have been directed
towards obtaining reliable reference methods of analysis;
this should eliminate many intra-laboratory and some inter-
laboratory sources of errors. When enzyme activity is shared
by a number of proteins, it is unlikely that the assay con¬
ditions are optimal for all the enzyme proteins concerned.
The activity measurement may then present a biased picture
of the various contributions of the isoenzymes unless the




2-1-4 Units of enzyme activity.
Differences in the units used to express the results
of determinations of enzyme activity have caused much con¬
fusion. The units of activity were often arbitrarily
defined by the originators of the assay methods and even by
different workers using the same procedures. The Report
of the Commission on Enzymes (1961) of the International
Union of Biochemistry attempted to clarify the situation by
recommending a standard enzyme unit, the international unit
(lU). Oneunit of activity of any enzyme is defined as
"that amount which will catalyse the transformation of 1
micromole of substrate per minute, or where more than 1
bond of each substrate molecule is attacked, 1 mipro-equiv-
alent of the group concerned per minute, under defined con¬
ditions". Since the unit does not define the temperature
of the reaction nor the variables of the reaction mixture,
the degree of uniformity brought about by the proposal has
been limited. It is very likely that different values in
international units will be obtained when the same amount
of enzyme is measured by two different procedures even if
temperature differences are corrected for. This is due to
the fact that the two procedures are probably measuring
different facets of enzyme activity.
Recently, another enzyme unit has been proposed as the
basic unit of enzyme activity. This is the Katal, which is
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mo1/sec of substrate transformed. Throughout the present
work, however, all enzyme activities are express in
XU/litre at 37°C, unless stated otherwise.
2-2 Enzyme measurements in human serum.
A substantial part of the present study is concerned
with enzyme assays in serum. Serum is usually preferred
to plasma in most enzyme assays. One advantage is that
there is no delayed clot formation in serum such as often
»
occurs in stored plasma samples. Also, no anticoagulants,
which may be toxic to one or more enzymes, are present in
serum. However, it should be noted that platelet enzymes
are released into serum as a result of coagulation. Bec¬
ause of the nature and composition of serum, special factors
additional to those mentioned in the last sub-section have to
be considered in the design of experiments for measuring
enzyme activity in this medium:
1. The buffering properties of serum. Serum is a
strong buffer acting over a fairly wide pH range. Xt con¬
tains bicarbonate, phosphate, amphoteric amino acids and
proteinate ions. If added in appreciable quantities, it
can alter the pH of the assay mixture. As the buffer
properties of serum change greatly with pathological states,
no accurate estimation of its effect on the pH of the reac¬
tion mixture can be made. The choice of a buffer of app¬
ropriate strength, therefore, becomes a matter of great
importanc e.
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2. Presence of enzyme substrates in serum. Serum
contains an appreciable quantity of metabolites such as
lactate, pyruvate and other ketoacids, etc. They are the
substrates of a number of enzymes, and their presence in the
reaction mixture may give a high, but variable blank activity.
To eliminate this effect, the serum sample should be pre-
incubated with the reaction mixture for a period long enough
to exhaust all the endogenous substrates before the enzyme
reaction proper is started with an exogenous substrate. It
should also be ensured that no exogenous co-enzymes or
substrates in the reaction mixture are decreased to a sub-
optimal level as a result of taking part in the endogenous
substrate reaction, e.g. the consumption of NADH by lactate
dehydrogenase and pyruvate in serum in the assay of alanine
aminotransferase.
3. Presence of specific and non-specific enzyme
inhibitors. The inhibitors in serum may include
2+ 2+
heavy metal ions such as Cu and Hg , organic acids, in¬
organic anions, and protein macromolecules (antienzymes).
Their concentrations may vary between individuals and with
differing physiological and pathological states. The in¬
hibitors may occur naturally or be of exogenous origin,
e.g. drugs.
4. Presence of proteinases in serum. These proteo¬
lytic enzymes may hydrolyse enzyme proteins in serum.
This constitutes one of the possible causes of the fall of
serum enzyme activity on storage. To prevent this, act¬
ivity should be measured as soon as possible but if storage
^.Is necessary, the serum samples should be refrigerated or
frozen.
5. Presence of bacteria in serum. The bacteria may
be present endogenously in serum in certain pathological
states or, more commonly, they may be introduced into the
samples during collection and storage. The bacteria have
their own patterns of enzyme activity and they may excrete
or secrete toxins. Besides synthesising and secreting
enzymes which may catalyse reactions similar to serum
enzymes, bacteria may also cause breakdown of serum enzymes
and consumption of substrates and co-factors. The effects
of bacterial contamination are such that .any enzyme activity
data obtained from contaminated samples are meaningless.
6. Haemolysis and lysis of white blood cells and
platelets. Since both erythrocytes and leucocytes
are richly endowed with enzymes, their lysis will greatly
distort the enzyme concentration arri distribution pattern in
serum. The lysis of these blood cells may occur in vivo
in some pathological states or, more commonly, in vitro due
to mis-handling of the blood samples.
7. Venous stasis occurring during sample collection
causes an artefactual rise in the apparent concentration of
all serum proteins, including enzymes.
8. High protein concentration in serum. This may
exert a protective effect on many enzymes, but whether this
is of any practical importance in serum enzyme assays is not
clear.
In addition to the above general considerations, each
enzyme is also subject to the influence of a set of factors
- 3h -
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of* its own. For instance, individual enzymes may react
differently to storage conditions, exposure to light and
nature of the diluents, etc. (Thomson, 1962).
2-3 Enzyme assay techniques.
In the present study only creatine kinase activity has
been measured in both serum and tissue extracts. All other
enzymes studied have been assayed only in serum.
The chemicals used were chiefly obtained from B.D.H.
(Poole), Sigma (London) and Boehringer (Lewes). They
»
were of the highest grades commercially available. Glass
distilled water was used in all assays. The pH of the
buffer solutions was adjusted to the desired value at the
temperature of assay (37°C) with a Radiometer Titrator
TTT1, using NaOH or HC1 solutions.
With the exception of a few kinetic studies all the
continuous monitoring of enzyme reactions was carried out
on an LKB 8600 automatic reaction rate analyser. All the
colorimetric measurements were performed with a Unicam
SP1800 spectrophotometer.
In all enzyme reactions involving the NADH/NAD system
the nucleotides were prepared fresh. This was to avoid the
development of a dehydrogenase inhibitor shown to occur in
the p -NADH solution (Fawcett e_t al. , 1 961 ) . The exact
nature of this inhibitor is unknown. Its effect is great¬
est on enzymes using NADH as direct substrate, but smaller
in coupling enzyme systems where both NADH and the coupling
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dehydrogenases are present in excess (Klotzsch and Klotzsch,
1969).
2-3-1 Creatine Kinase.
There are at present at least seven different methods
of measuring creatine kinase activity. These include
colorimetric,fluorimetric, spectrophotometric and contin¬
uous pH titration techniques. Both forward and reverse
reactions may be used. These methods are summarised in
Fig. 2-2. Of these methods, the only satisfactory contin¬
uous monitoring methods are the two coupled-enzyme spectro¬
photometric methods, since the titrimetric method is not
sensitive enough. These, together with two colorimetric
methods, were chosen to measure the forward and backward
reactions of the enzyme. The formation of MgADP and crea¬
tine phosphate from MgATP and creatine was arbitrarily de¬
fined as the forward reaction.
It should be noted here that all these four methods,
especially the spectrophotometric methods, would be invali¬
dated if the enzyme ATPase was present in the medium.
ATPase catalyses the reaction:
ATP ADP + Phosphate
ATPase therefore interferes with any methods that base
the determination of creatine kinase activity on measurement
of ATP, ADP or inorganic phosphate. This is more of a
problem with tissue preparations than with serum, as ATPase
is seldom present in detectable quantities in human serum.
Figure 2-2
Methods of Measuring Creatine Kinase Activity
1. Oliver (1955); Rosalki (1967)
2. Conn and Anido (1966)
3. Hughes (1962)
4. Nuttall and Wedin (1966)
5. Tanzer and Gilvarg (1959)
6. Kuby (1954); Okinawa et al. (1964)
7. Cho et al. (1960)
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2-3-1-1 Continuous-monitoring method: backward reaction
(Oliver, 195^; Rosalki, 1967)-
Principle . This measures the rate of ATP formation in the
backward reaction by two coupled enzyme reactions.
MgADP + Creatine phosphate ? MgATP + Creatine
HK
MgATP + Glucose' ^ * Glucose-6-phosphate + MgADP
G-6-PD
Glucose-6-phosphate + NADP ± 6-phosphogluconate +
NADPH + H+
When the substrate glucose, coenzyme NADP and coupling
enzymes, hexokinase (HK) and glucose-6-phosphate dehydrogen¬
ase (G-6-PD) are present in excess, the increase in absorb-
ance of NADPH at 3^0rm is directly proportional to the rate
of ATP production, which in turn is proportional to creatine
kinase activity.
Reagents. Both manually prepared reagents and a commercial
automatic analysis kit (Boehringer, Lewes) were used for this
method. The working reagents in the analysis kit and manu¬


























Creatine phosphate 10 mmol/l 35 mmol/l
Total assay volume 1 ml 1.1 ml
* reagent concentrations and assay conditions were varied
in certain instances to suit the experiment.
Thiols were added in order to activate and stabilise
the activity of creatine kinase (Section 5)- As myokinase
cannot be excluded from serum samples, AMP was added to in¬
hibit this enzyme (Rosalki, 1967); at the concentration
used, AMP was only slightly inhibitory to creatine kinase.
As the manual procedure contained no AMP, it was used only
for studying the kinetic properties of creatine kinase in
purified tissue preparations where myokinase was shown to
be absent.
Procedure. 25 /Ul of serum sample was pre-incubated with
1.0 ml assay solution for 15 min at 37°C before the reaction
was started with Solution 2. The reaction rate at 3^0 nm
was followed for 2 min.
Assessment of method. A short lag phase ranging from 0.5
to 1.0 min was observed whether the creatine kinase was
measured in serum or in a; purified preparation. This is
^Manually prepared Analysis Kit
20 mmol/l 20 mmol/l
0.6 mmol/l 0.6 mmol/l
1.5 IU/ml(25°C) 1.5 IU/ml (25°C)




characteristic of coupled enzyme reactions. As already
mentioned, the duration of this lag phase is related to the
amount of coupling enzymes added. The activity of creatine
kinase in the assay mixture (volume 1 ml) was seldom over
30 mlU at 37°C, and the activity of the coupling enzymes
was at least 3000 IU/l (namely 100 times higher). The lag
phase of this method is much shorter than the method prop-
. osed by Rosalki (1967) in which creatine kinase activity
was measured at 30°C using the "Calsul" reagent kit from
Calbiochem Ltd.; this took as long as 6 min to achieve
maximum velocity.
Using human heart tissue preparations (Section 5)> it
was found that the method gave a linear relationship with
enzyme concentration (Fig. 2-3).
The precision of the method, expressed as standard
deviations (S.D.) was obtained by repeated analysis of sera
from patients. The S.D. was calculated by the formula
d^/(n - l") where n = total number of observa¬
tions
d = difference between the
duplicates
The standard deviations and coefficients of variation at
different levels of creatine kinase activity are listed in
Table 2-1. It is seen that at low creatine kinase activity,
the precision is poorer.
The commercially available Solution 1 was stated by
the manufacturers to be stable for 3 days after reconstit-
ution. In general, this was confirmed by experiments in
Figure 2-3




Precisions of Some Methods Measuring Creatine Kinase Activity
Levels of
Activity
*Rosalki (1967) Tanzer & Gilvarg
(1959)
Hughes (1962)
x IU/1 52 65 60
S.D.(n) 6.4 (14) 6.3(36) 15.2 (50)
c. V. 12 % 9.7 % 25 %
x IU/1 152 167 180
S. D.(n) 7.9(14) 7.6 (46) 23.3 (56)
C.V. 5.2 % 4.5 % 12.9 %
x IU/1 555 460 412
S.D.(n) 27.8 (14) 21.3 (28) 39 (18)
C.V. 5 % 4.6 % 9.5%
x IUA 3360 - -
S. D. (n) 134.7 (13) - -
C.V. 4 %
x = mean activity
S. D. = standard deviation
C. V. = coefficient of variation
n = number of data obtained
*
= in form of a reagent kit
Serum samples were used for the Rosalki method while purified enzyme
solutions were used for the other methods.
Details of analysis were described in the text.
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which sera from patients were analysed on successive days
(F ig. 2-10) but there were occasions, especially with high
activity specimens, where freshly constituted reagents gave
rise to higher activities. Presumably these changes were
related to partial inactivation of the coupling enzymes or
oxidation of reduced glutathione. In the present investi¬
gation, Solution 1 has been discarded if not used within 2k
hours of reconstitution.
2-3-1-2 Continuous-monitoring method - forward reaction
(Tanzer and Gilvarg, 1959)-
Principle . This measures the rate of ADP production in the
forward reaction. The ADP formed is coupled to the forma¬
tion of NAD monitored by a decrease in absorbance at 3^0 nm
as follows:
MgATP + Creatine Creatine phosphate + MgADP + H+
PK
MgADP + Phospho-enol-pyruvate - MgATP + Pyruvat e
LD
Pyruvat e + NADH Lactate + NAD
PK pyruvate kinase
LD lactate dehydrogenase
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Procedure♦ 0.85-0.875 ml of Solution 1 was pipetted into a
cuvette and pre-incubated for 15 niin at 37°C. The reaction
was started with 0.1 ml Solution 2. The reaction was
followed for 2-3 min by observing the change of absorbance
at 3^0 nm.
Assessment of method. A lag phase of 1.0 - 1.5 min was
observed. The linear velocity obtained after the lag phase
was taken as a close approximation of the real initial
velocity.
Using tissue preparations, it was found that the act¬
ivity was linearly related to enzyme concentration only up
to a limit, beyond this the curves flattened. This, however,
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was not observed in the method of Rosalki (1967) presum¬
ably because there a much more dilute enzyme preparation
was used. The amount of enzyme and hence activity used in
the present method was therefore limited to the linear
region of the graph (Fig. 2-4).
The precision of the method was calculated as in method
1 (Table 2-1).
2-3-1-3 Colorimetrie-method: backward reaction
(Hughes, 1962).
This is a colorimetric assay measuring the formation
of creatine during the backward direction. The creatine
reacts with diacetyl and ^-naphthol to form a red colour
complex in an alkaline medium:
MgADP + Creatine phosphate ' Creatine + MgATP
Creatine + Diacetyl + ?<-naphthol »■ Red complex
The red complex absorbs maximally at 520 nm.
Reagents . The substrate concentrations in the assay solu¬
tion (with some modifications in certain experiments) were
as follows:
Solution 1 Final concentration
Tris/HCl pH 7.0 50 mmol/l




The Method of Tanzer and Gilvarg (1959): Correlation between




O MM isoenzyme with original extract diluted 7.5 times.
A MB isoenzyme with original extract diluted 6.0 times.
- k2 -
Solution 2
Creatine phosphate 10 tnmol/l
Enzyme solution 50 jul
(suitably diluted)
Total assay volume 0.5 ml
Colour-developing solutions:
a. 30 mmol/l £-hydroxymercuribenzoate
b. 60 g/1 Ba(OH)g
c. 50 g/1 ZnSO^
»
d. 16 g/l <K-naphthol, freshly made up in 1.5 mol/l NaOH
and 1.2 mol/l Na^CO^
e. Diacetyl, 1:2000 dilution in water made up freshly
Procedure• The reaction mixture (Solution 1) was pre-
incubated in a water bath for 15 min at 37°C to achieve
thermal equilibrium. The reaction was started with Sol¬
ution 2 and allowed to proceed for 15 min. It was stopped
by the addition of 0.5 ml of Solution a. The mixture was
then deproteinised by introducing 0.5 ml of Solutions b
and c in that order. The precipitate was centrifuged and
1.0 ml of the supernatant was transferred to a fresh tube
to which were added 2.5 ml Solution d, 0.5 ml Solution e
and 6 ml of water in that order. The tubes were shaken
between additions. They were put in a 37°C water bath for
1 hour, after which the colour in each tube was read at
520 nm against a blank omitting the enzyme solution, and
converted to enzyme activity by reading off from a standard
curve (Fig. 2-5 ) . - ...
Figure 2-5
a. The Kuby Method (1954) : Standard Curve for the Absorbance of
Inorganic Phosphate
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b. The Hughes Method (1962): Standard Curve for the Absorbance of
Creatine




The protein precipitation step was omitted when
purified enzyme preparations were used.
There was at least one blank in each batch, omitting
the enzyme or introducing it after Solution a.
Assessment of method. This method is essentially a 2-point
assay method. There 'is no check that the reaction is linear.
However, if no more than 20°/o of the substrate is consumed
in the course of the reaction, only minor variations (largely
arising from variations in the use of substrate concentra¬
tions) should be encouVered, and it was not considered
ft
necessary to follow the course of each reaction by with¬
drawing samples at timed intervals from the reaction mix¬
ture. This, in practical terms, means that if the enzyme
concentration used is not higher than those shown in Fig.
2-6a, in a 15 min incubation period, the measured velocity
should be a good approximation to initial velocity (Fig.
2-6b). The precision of this method was assessed at
different levels of enzyme activity (Table 2-1).
Apart from the possible danger of non-linearity of the
reaction, the creatine colour development may also be a
source of error in this method as it is sensitive to minor
variations in the experimental conditions. A long incuba¬
tion period (1 hour at 37°C) for the colour development is
needed to minimise this effect (Hughes, 1962). Moreover,
the creatine colour development is inhibited by thiols
which are essential to ensure full activation of creatine
kinase. Therefore, thiols must be removed before colour
development, and this is done by adding jo-hydroxy-mercuri-
Figure 2-6













The original Isoenzyme (MM) preparation was diluted 200 fold. Enzyme
activity was measured after 15 min incubation period at 37 C. Linear
relationship between enzyme activity and enzyme concentration was
observed within the sample volume range 0 - 150 jul.
Figure 2-6
b. The Hughes Method : Time Course of the Reaction of Creatine
Kinase (MM Isoenzyme)
Incubation Period min
The original enzyme preparation was diluted 200 fold :
o 25 jul □ 50 ^ul • 100 jul A 175 jal
kk
benzoate which also serves to stop the enzyme reaction.
Also, absorbance measurements should be made soon after the
colour has been developed, since the colour fades over a
period of a few hours.
2-3 -1-^ Colorimetric method: forward reaction
(Kuby, 195^; Okinawa ejt ad., 196^).
Principle . This method measures the amount of creatine
phosphate formed from the forward reaction. The creatine
»
phosphate is hydrolysed with acid and the amount of inorganic
phosphate liberated is determined with the classical ammonium
molybdate reaction. The blue colour complex formed has a
maximum absorption at 700 nm.
MgATP + Creatine , ' MgADP + Creatine phosphate
acid hydrolysis
Creatine phosphate Inorganic phosphate
ammonium molybdate
Inorganic phosphate ■* Blue chromogen
Reagents Unless stated otherwise, the reagent concentrat¬
ions were as follows:












Enzyme solution 50 /Jl
Total assay volume 1.0 ml
Colour developing solutions:
a. 20g/l ascorbic acid and 100 g/l trichloroacetic acid
b. 10g/l ammonium molybdate in water
c. 20g/l sodium citrate + 20g/l sodium arsenite in 20g/l
acetic acid.
Procedure• The reaction was started by adding 0.2 ml
Solution 2 to 0.75 ml Solution 1 after the solutions had
been equilibrated at 37°C with the enzyme solution. The
reaction was allowed to proceed for 15 min, at the end of
which it was stopped by adding 1.5 ml of Solution a.
After standing for 30 min at room temperature (25°C), 0.5 m
Solution b was added followed by 1.0 ml Solution c. The
mixture was thoroughly shaken between each addition. The
blue colour took about 15 min to develop (Baginski et_ al. ,
1967). The colour was read and converted to enzyme act¬
ivity units with a standard graph (Fig. 2-5 ).
Blanks were prepared for each concentration of the
adenine nucleotide substrate as it contained traces of
inorganic phosphate and was slightly (1-3^) hydrolysed
during the complete hydrolysis of creatine phosphate.
Assessment of method . Being a 2-point assay this method ha
the same limitations as Method 3. Therefore, the time-
course of the reaction was followed with an active enzyme
sample (Fig. 2-7a). From these results an incubation
period of 15 min was considered suitable for the concentra¬
tion of enzyme used in this study. The inorganic phosphat
Figure 2-7
The Kuby Method (1954)
a. Time Course of the Reaction of Creatine Kinase
Incubaticm Period mi n
The two isoenzyme preparations were each diluted 10 fold,
using 50 /al for the MM isoenzyme assay and 75 ^il for the
MB.
b. Correlation between Enzyme Activity and Enzyme Concentration
500
40 60 80 100
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measured after hydrolysis was found to be proportional to
enzyme concentration (Fig. 2-7b).
Not enough data were available for the assessment of
precision of the method. The limited number of data, how¬
ever, did suggest that it was of the same magnitude as the
colorimetric assay of Hughes (1962).
The major drawback of this technique is the presence of
inorganic phosphate in the blank. This reduces the sensit¬
ivity of the assay and also necessitates accurate blank
correction. In the original method of Fiske and Subbarow
(1925) there were additional blank problems caused by the
continuing slow hydrolysis of organic phosphates occurring
after the addition of ammonium molybdate, the liberated
phosphates contributing to the final colour developed. In
the present study this problem has been overcome by adding
arsenite to exhaust all the excess ammonium molybdate after
the ammonium molybdate had complexed with inorganic phosph¬
ate (Baginski e_t a_l. , 1967). Any subsequent formation of
inorganic phosphate arising from the hydrolysis of labile
organic phosphates would no longer contribute to the colour
development.
2-3-1-5 Selection of a method for measuring serum creatine
kinase activity .
A method had to be chosen that was suitable for
measuring the activity of a large number of serum samples
in' the clinical study (Sec.tion ^). Relevant considerations
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included the requirement that the method should preferably
be simple and convenient.
From Table 2-1 it is evident that the spectrophoto-
oietric assays are more precise than the colorimetric tech¬
niques at all levels of enzyme activity. They are more
sensitive, and less laborious to perform. Using the LKB
8600 automatic analyser, they require much less time for
analysis than the corresponding colorimetric assays.
Both spectrophotometric methods show the same order of
precision, but the method of Rosalki (1967) is more sensitive
than the method of Tanzer and Gilvarg (1959)• The differ¬
ence in sensitivity is probably attributable to inherent
kinetic differences between the backward and forward reac¬
tions. The magnitude of this difference was determined by
comparing, for the same amount of enzyme, the maximum vel¬
ocities of both forward and backward reactions using the
two spectrophotometric methods of assay that have been
studied. With purified isoenzyme preparations, ratios
(V backward at pH 7-0/V forward at pH 9*0) of 10.3max max
and 3.6 were obtained for the MM and MB isoenzymes respect¬
ively. These values suggested large differences in the
turnover rates of the isoenzymes (especially the MM iso¬
enzyme) between forward and backward reactions when assayed
in the conditions described above.
The method of Rosalki, which measures the backward
direction was, for the above reasons, considered to be the
most suitable of the methods studied here for measuring
serum creatine kinase activity. For convenience, the
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Boehringer analysis kit was used exclusively for this
purpose. The other methods were reserved for the kinetic
studies of the creatine kinase isoenzymes (Section 5)-
2-3-1-6 Effect of dilution on serum creatine kinase
ac tivity .
Although a linear relationship was obtained between
activity and enzyme concentration using purified enzyme
solutions, this was not the case when serum samples were
used (Compare Figs. 2-3 and 2-8). Elevation of activity
was observed on diluting serum samples. The exact nature
of this activation effect is still unsettled. Craig ejt al . ,
(1967) reported a progressive increase of activity when
serum samples from patients with various pathological con¬
ditions were diluted. The dilution effect was observed
irrespective of the direction of the reaction or the methods
used for measuring enzyme activity. The extent of activa¬
tion varied with the nature of diluents. The authors
recommended the use of heat-inactivated serum as diluent as
it gave the least activation among the diluents studied.
On the basis of the progressive nature of the activation
that occurred on dilution of samples, they argued against
the presence of an inhibitor in serum.
To investigate more fully the effect of diluting serum
upon the results of enzyme activity measurements serum samples
were chosen from 8 different patients with myocardial in¬
farction, covering a wide range of creatine kinase activity.
Figure 2-8
Effect of Dilution with Water on the Activity of Serum Creatine
Kinase
1-8 Serum samples
The sera were diluted with distilled water in varying prop¬
ortions, and creatine kinase activities measured (Fig. 2-8).
In contrast to the findings in the above reports, creatine
kinase was found to be activated to a relatively small
extent, an increase of 1.1 to 1.3 times on a 25-fold dilu¬
tion, with the exception of Sample 3 in which the activity
increased 1.6 times when diluted 12-fold. In those samples
showing the most activation (Samples 3 and 6) the rise in
activity occurred almost entirely in the initial (up to
about 1:5) dilutions with further dilution having little
effect. This might be explained by the presence of a
"serum inhibitor" the effects of which were removed almost
completely by dilution. The rest of the samples showed
only a small increase in activity which was linear with
dilution in the range studied. So, while some samples did
suggest the existence of a serum inhibitor, others did not
support the presence of such inhibitors in serum.
The effect of dialysis was studied with a batch of 70
serum samples from patients with myocardial infarction.
The specimens were dialysed against 5 mmol/l Tris/HCl buffer
pH 8.0 for 2h hours with 3 changes of buffer. Figure 2-9
shows the relationship between activities before and after
dialysis. The majority of the samples (i.e. below the ^5°
line) indicated some loss of activity, probably due to the
effect of slight dilution occurring during dialysis. There
were a few that showed activation, but in no case was the
activation greater than 20 per cent. The many-fold increase
and decrease in activity after dialysis reported by Snehalatha
Figure 2-9
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et al., (1973) was not observed here. The data from these
dialysis experiments thus give no support for the hypo¬
thesis that a dialysable serum inhibitor or activator exists
From these two experiments and the reports in the lit¬
erature mentioned above it is likely that the effect of
diluting serum upon creatine kinase activity not only
varies with disease states, but also between individuals.
The nature of this effect of dilution is likely to be com¬
plex and cannot be explained by any simple theory.
2-3-1-7 Other factors affecting serum creatine kinase
ac tivity.
Thiol groups . In the present work 2 common thiols, reduced
glutathione and j5-mercaptoethanol, were used to activate
the enzyme. In the absence of thiol groups the enzyme
activity is sensitive to minor changes of assay conditions
and rapidly becomes inactivated in serum. Although the
exact mechanism of this thiol activation is not certain,
the thiol is thought to act by keeping the thiol groups of
the enzyme essential to activity in reduced form, and by
protecting them from any thiol-blocking reagents.
Storage conditions■ These affect the stability of serum
creatine kinase. Thomson (1962) suggested storage at ^°C
in darkness instead of deep-freezing, as he found that
decrease in activity at ^°C was less marked. He also
reported a loss of activity of up to 25°/o when serum samples
were exposed to daylight...-
The stability of creatine kinase activity in serum
from patients with proven myocardial infarction was studied.
The samples were stored at ^°C in darkness as recommended.
In all samples studied, no significant change of activity
was observed over a period of 3 weeks (Fig 2-10). The
minor fluctuations in activity can be explained by the lack
of precision of the method used.
2-3-2 Aspartate aminotransferase in serum.
The enzyme catalyses the reaction
Aspartate + 2-oxoglutarate ;—" Oxaloacetate + Glutamate
Various methods have been used to measure the activity of
this enzyme in the past. The following is a brief summary
of some of these techniques:
Chromatographic assay (Awapara and Seale, 1952). This
measures the formation of the product, glutamate, by quan¬
titative paper chromatography. The glutamate is eluted
from the paper and forms a coloured complex with ninhydrin.
Manometric method (Krebs, 1950). The amount of amino acids
changed or produced can be measured by using specific amino
acid decarboxylases.
Colorimetric methods. The oxaloacetate formed is converted
to pyruvate in the presence of aniline citrate. The pyruv¬
ate then reacts with dinitrophenyl hydrazine to form
pyruvate-dinitophenyl hydrazone which is extracted with
toluene. The colour intensity is taken as a measure of
enzyme activity (Tonhazy e_t aT. , 1950). This method has
3500r 3300 3100 1800 1600







































been simplified by Reitman and Frankel (1956). Another
colorimetric method has been described by Babson e_t ad. ,
(1962), in which the oxaloacetate formed is coupled with a
stable diazonium salt. The. resulting colour is proportional
to the amount of oxaloacetate present and can be measured
at 500-550 nm.
Spectrophotome trie methods. The high UV absorption of
oxaloacetate at 280 nm can be used to follow the transamina¬
tion reaction (Cammarata and Cohen, 1951)» but the instab¬
ility of oxaloacetate, the relatively low aminotransferase
activity in serum, and the high protein concentration in
serum make this method unsatisfactory. Another spectro¬
photometry method developed by Karmen (1955) is widely
used. This isa coupled enzyme technique:-
2-oxoglutarate + L-aspartate, - L-glutamate + Oxaloacetate
MD
Oxaloacetate + NADH + H * L-malate + NAD
The decrease in absorption of NADH at 3^0 nm is a measure
of the aminotransferase activity provided malate dehydrog¬
enase (MD) and co-enzyme NADH are in excess.
The chromatographic and manometric methods are obsol¬
ete, and the colorimetric methods are gradually being
superseded by the more precise, more convenient and faster
UV kinetic assay in serum activity determinations. In the
present study all serum aspartate aminotransferase activities
were measured by the method of Karmen (1955) as modified by























0.85 ml volumes of Solution 1 were pipetted into
cuvettes and pre-incubated with serum samples at 37°C for
about 15 min. The reaction was started by adding 0.05 ml
Solution 2. The absorbance change at 3^+0 nm was followed
for 1 min.
Assessment of method.
The enzyme requires pyridoxal phosphate as co-enzyme.
So far it has been standard laboratory practice to assume
that the co-enzyme is present in sufficient quantities in
the serum and that no extra amount of the co-enzyme is
needed in the assay medium. However, Hamfelt (1966) con¬
sidered that pyridoxal phosphate should be added to the
serum of elderly patients, chronic alcoholics, and patients
with thyrotoxicosis or intermittent porphyria. Rej e_t al .
(1973) recommended the use of 25 ^imol/l pyridoxal phosphate
in the assay solution, and reported that this gave an
average increase of 16°/o in the enzyme activity.
Side-reactions occur in the assay solution before the
reaction is started by the addition of 2-oxoglutarate, as
serum contains an appreciable quantity of 2-oxoglutarate.
There might therefore be a danger that the concentration of
NADH could become sub-optimal as a result of these endogen¬
ous reactions. The amount of NADH added for use in the
assay was, however, sufficient to offset these reactions in
nearly all cases.
If the coupling enzyme is introduced as an ammonium
sulphate suspension, the ammonium ion may react with 2-
oxoglutarate in the presence of glutamate dehydrogenase,
which is present in serum in some pathological states:
NH^+ + 2-oxoglutarate + NADH Glutamate + NAD + H^O
In most cases a pre-incubation period at 37°C for 15
min is long enough for the completion of these side reactions.
The between-batch precision of the method in the range up
to 50 IU/l was 1.8 IU/l.
2-3-3 NAD - dependent malate dehydrogenase •
The enzyme catalysis the reaction
Malate + NAD - Oxaloacetate + NADH
Many early methods used oxaloacetate as substrate and
followed the reaction from right to left because the pos-
ition of the equilibrium at pH "[ .k is favourable in this
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direction (Siegel and Bing, 1956). The main technical
difficulty in measuring activity in this direction is the
instability of oxaloacetate, which decomposes to pyruvate
in aqueous solution. Because lactate dehydrogenase act¬
ivity in serum is usually many times more active than mal-
ate dehydrogenase, this newly formed pyruvate would con¬
tribute significantly to the measured reaction velocity.
To overcome this difficulty the oxaloacetate can be produced
enzymatically by inclusion of purified aspartate aminotrans¬
ferase and L-aspartate in the assay solution. The reaction
is then started by adding an excess of 2-o3coglutarate.
Alternatively, the reaction can be measured in the opposite
direction using as starting substrate malate, which is
more stable than oxaloactate. In the present study a

















Procedure. O.85 ml volumes of Solution 1 were pipetted
into cuvettes and pre-incubated with serum samples at room
temperature for 1 hour followed by 15 min at 37°C. The
reaction was started by adding 50 >ul L-malate solution.
The increase in absorbance at 3^0 nm was followed for 1
min.
Assessment of method
Choice of Buffer. Among the different buffers studied,
triethanolamine, 2-amino-2-hydroxy-methyl 1:3 propandiol,
tris/HCl, glycine/NaOH, borate, diethanolamine and diethyl-
barbiturate, diethanolamine gave the highest activity.
With this buffer the optimal pH at 37°C was found to be in
the region of 9.2. Serum activity of malate dehydrogenase
was little affected by the strength of the buffer in the
range 10 to 900 mmol/l. 100 mmol/l was adopted as the
working buffer concentration.
Substrate concentrations. The substrate affinities for
malate and NAD were investigated with five randomly chosen
active serum samples. They all showed that malate at high
concentration was inhibitory. No such inhibition was
observed for NAD (Fig. 2-11a and b). Working concentra¬
tions of 25 mmol/l and 3 mmol/l were chosen for malate and
NAD respectively. Magnesium ions were found to activate
the serum enzyme slightly (0-8^), but the extent of activa¬
tion was not thought to be large enough to warrant its
inclusion in the reaction mixture.
Owing to the presence of endogenous lactate and lactate
dehydrogenase in serum, the addition of NAD to the mixture
led to its spontaneous reduction. This side-reaction had
to be allowed to proceed until all lactate was exhausted.
A "standing period of one hour at room temperature before the
Figure 2-11
Assay of Malate Dehydrogenase in Serum:
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reaction was started with malate was found to be sufficient.
This technique gave activity data proportional to
enzyme concentration, as shown in Fig. 2-11c. Its precis¬
ion, obtained by duplicate analysis of serum samples, is
listed in Table 2-2. The correlation between this technique
and that of Siegel and Bing (1956) is shown in Fig. 2-11d.
2—3 — ^ Assay of miscellaneous enzymes.
In the course of the study activities of some other
enzymes in serum were also measured. They were the anodal
isoenzymes of lactate dehydrogenase, alanine aminotrans¬
ferase and glutamate dehydrogenase.
Urea-stable lactate dehydrogenase .
Lactate dehydrogenase activity is measured in the pres¬
ence of urea, which inhibits the activity of the isoenzymes
of lactate dehydrogenase to a varying extent.
Pyruvate + NADH . Lactate + NAD
This measures principally the anodal isoenzymes of
lactate dehydrogenase and is used as a test in the diagnosis
of myocardial infarction.
The method of Brydon and Smith (1973) was used.
Solution 1 Final Concentration
/3-NADH 0.18 mmol/1
Urea 1.8 mmol/l
Phosphate buffer pH 7^5 100 mmol/l
Figure 2-11
Assay of Malate Dehydrogenase in Serum;
c. Correlation between Enzyme Activity and Enzyme Concentration
0 25 50 75 100 125 150
Serum Volume ( jj\ )
Figure 2-11
Assay of Malate Dehydrogenase Activity in Serum:
Correlation between the Present Technique and that of Siegel and
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Table 2-2
Precision of the Malate Dehydrogenase Assay Using
Malate as Substrate
Range IU/l Mean IU/l S.D. IU/l ' C.V.
0-30 (23) 18 3.0 16.6$
30 - 100(11) 44 4.0 9.1$
100 - 750 (6) 287 6.6 2.3$
( ) = number of! pairs of data
S.D. = standard deviation











The reaction rate was monitored at 3^0 nm on an LKB 8600
reaction rate analyser for 1 min for each sample. The
between-batch precision of the method was 20 IU/l in the
range up to 500 IU/l.
Alanine aminotransferase (Karmen, 1955; Henry et al., i960)
•
The activity was measured by a coupled enzyme reaction.
Alanine + 2-oxoglutarate ;—* Glutamate + Pyruvate
LD
Pyruvate + NADH ;= Lactate + NAD
When lactate dehydrogenase (LD) and NADH are present in
excess, the decrease in absorbance of NADH at 3^0 nm is in





















The reaction rate was measured for 1 min at 3^0 nm
after a pre-incubation period of 15 tnin at 37°C. The
between-batch precision in the range up to 50IU/1 was
2 IU/1.
Glutamate dehydrogenase (Ellis and Goldberg, 1972).
NH^+ + 2-oxoglutarate + NADH ;=±Glutamate + NAD + H^O
The assay solution contained:





buffer pH J .h 50 mmol/l
Solution 2
Ammonium sulphate 50 mmol/l
(starting substrate)
Serum 200
Total -assay volume 1 .0 ml
The reaction was followed at 3^0 nm at 37°C for 2 min.
Ammonium sulphate was used to start the reaction in prefer¬
ence to 2-oxoglutarate, as originally described by Ellis
and Goldberg (1972), b ecause the endogenous L-aspartate
would react with 2-oxoglutarate in the presence of serum
aspartate aminotransferase. Although L-aspartate is
present in only very small amounts in serum, if 2-oxo¬
glutarate was to be used as starting substrate, this reaction
would add to the measured reaction velocity.
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2-k Quality control.
In view of the large number of serum enzyme samples
that had to be measured over a long period (about 10 months),
rigorous quality control of the assay methods was needed.
The performance cf all determinations in duplicate was not
considered practicable as it would not only have doubled
the time and expense of all enzyme assays, but the very
-pressure of repetitive work could have become a major factor
itself contributing to unsatisfactory quality of results.
The repeat analysis of a limited number of serum samples
that had already been determined in the previous batch was,
however, routinely employed. The use of such repeat
specimens from patients had the advantage over the use of
pooled serum controls that the specimens from patients had
been stored for much shorter periods and hence had had less
time in which to deteriorate. This method of quality
control was used to monitor the short-term day-to-day
precision of the assay methods. It was of less value in
assuring the long-term stability of a method. For this a
freeze-dried commercially available enzyme control material,
Precipath E (Boehringer Corporation, Lewes), was used
routinely.
SECTION 3
THE RELEASE OF CYTOPLASMIC AND MITOCHONDRIAL
ENZYMES IN ACUTE MYOCARDIAL INFARCTION
This section and the next describe the enzyme findings
in a group of patients admitted to the Coronary Care Unit
of the Royal Infirmary, Edinburgh, with suspected myocardial
infarction. In the present section the principles under¬
lying the release of enzymes after cell injury are discussed.
The patterns of release of certain mitochondrial enzymes,
namely glutamate dehydrogenase (GLDH) and the mitochondrial
isoenzymes of aspartate aminotransferase (mAST) and malate
dehydrogenase (mMD), have been studied and compared with
those of the cytoplasmic isoenzymes of aspartate aminotrans¬
ferase (cAST) and malate dehydrogenase (cMl)) .
3-1 Theoretical considerations
3-1-1 Plasma enzymes in health.
Many enzymes have been detected in blood plasma.
They can in general be classified into two groups, those
that have metabolic functions in plasma and those that do
not. The first group includes all those enzymes involved
in blood coagulation, fibrinolysis and the complement
system. The second group includes a diversity of enzymes
which are either secreted by cells or released into the
circulation as a result of the normal "wear and tear" of
the body tissue.
In healthy individuals the activities of most enzymes
in plasma stay more or les,s constant, indicating that the
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rates of release into and removal from plasma are equal.
However, some variation in these "normal" levels may occur
among individuals due to the influence of a number of factors,
including:-
1. Race and other genetic factors (Rucknagel and Neel, 1961).
2. Social Class. For example, it has been found that
there is a correlation between social class and plasma
alkaline phosphatase activity (Goldberg and Winfield, 197^)-
3. Physiological State. The reports of Wilding et_ al .
(1972) and Goldberg and Winfield (197^+) showed that many
"normal" enzyme levels are affected by the'age, weight and
sex of the individual. The state of physical fitness and
exercise may also have an effect on the plasma activity of
AST, creatine kinase (CK), lactate dehydrogenase (LD) and
MD (Nuttall and Jones, 1968; Halonen and Konttinen, 1962).
Normal muscular activity may produce high levels in some
young ("enzyme-labile") subjects (Griffiths, 1966). Nut¬
ritional and psychic states are also a determining factor.
k. Miscellaneous Factors. Climate, occupation, living
standard and even season of the year may, to a smaller
extent, affect plasma enzyme activities (Richterich, 1968).
The handling of blood specimens before enzyme assay
may affect the activity measured. For example, it has been
reported that the chilling of samples of clotted blood may
cause an irreversible efflux of enzymes from erythrocytes
without producing haemolysis (Sweetin and Thomson, 1973)•
Most of the available evidence indicates that the range
of. variation in plasma enzyme activity in the same individual
is less than the range of variation seen between individuals,
even if the population is homogeneous with regard to age,
sex and race. Although theoretically desirable to use an
individual as his own source of reference data, this is
usually impracticable. Therefore, it is customary to
evaluate the results of plasma enzyme tests in relation to
reference values obtained from the healthy population,
matched if possible for age, sex and any other factor known
to be important in determining plasma activity in health.
The reference range of values obtained from such a popula¬
tion often approximate either to a normal distribution or
to a log-normal distribution. In either case, it is poss¬
ible using appropriate parametric methods to evaluate a
range, between the 2.5 percentile and the 97-5 percentile,
which will include 95°/° of the results obtained from a healthy
population. Alternatively, if it is not wished to make any
'
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assumptions about the distribution of the results, non-
parametric methods may be used (Reed ejt aT . , 1971)* Unless
stated otherwise, reference ranges derived in this study
will be based on 95°fo confidence limits obtained by the
appropriate parametric method.
3-1-2 The release of enzymes into the circulation in disease.
In healthy individuals only minor fluctuations of plasma
enzyme levels are seen in most cases. In disease states,
however, there may be a significant change in the activity
of plasma enzymes. With a few exceptions, where the
activity of certain plasma enzymes is decreased (e.g. dec¬
reased cholinesterase in liver disease, and decreased alk¬
aline phosphatase in hypophosphatasia), the majority of
diseases where plasma enzymes are of value in diagnosis
involve an increase in plasma enzyme activity. This
increase may be due to a change in the permeabiltiy of cell
membranes in the affected tissue or to cell necrosis as
result of infection, trauma or anoxia. To a smaller
extent, the rise in plasma enzyme activity may also be
caused by impaired excretion of the enzyme due to obstruction
of excretory pathways (e.g. raised plasma amylase in pancrea¬
tic duct obstruction).
Zierler (1958) studied the permeabiltiy of muscle cells
to aldolase and concluded that aldolase efflux was increased
by a high external K+ concentration, anoxia or deficiency of
glucose. He suggested that cel1-membrane depolarisation
might contribute to the release of enzymes. Dreyfus ejt al .
(1958) studied the mechanism of release of aldolase in
progressive muscular dystrophy, and considered that increase
in cell permeability was caused by anoxia, shortened life¬
span of the muscle cell and the general reaction of the whole
body to stress. Thomson e_t al. (i960) also studied the
release of enzymes in muscular dystrophy and concluded that
the primary cause for the release was a change of cell memb¬
rane permeabiltiy, not cell necrosis, as they argued that
fewer enzymes were released in neurogenic muscular atrophy
in which there is more extensive muscular damage than in
muscular dystrophy. The release of hormones can also have
a profound effect on the release of enzymes. For example,
adrenocorticotropic hormone and cortisone increase plasma
aldolase activity by 200-1000^ in the rat and the rabbit
(Schapira, 195^)•
Henley e_t ad. (1958) compared the release of AST and
ALT (alanine aminotransferase) in liver slices and found
that alkaline pH favoured the release of ALT while its
substrate alanine promoted its retention, thus suggesting
that the presence of substrate in cells might affect the
release of its enzyme. Innerfield (i960) stated that water
and electrolyte changes in the inflamed tissue caused
efflux of proteolytic enzymes. Recent work on human
leukocytes and rat lymphocytes (Wilkinson and Robinson,
197^) suggested that the integrity of the cell membrane was
related to the concentration of ATP in the cell. The pres¬
ence of phospholipases A and C in inflammatory fluids might
also play a part in liberating intracellular enzymes (Rob¬
inson and Wilkinson, 1973). The release of these intra¬
cellular enzymes is, among other things, determined by their
shape and molecular weight. In principle, the smaller the
molecular weight, the more likely the enzyme is to diffuse
out of the cell (Schmidt and Schmidt, 1967). In addition
to the molecular weight, the intracellular location and the
binding properties of the enzyme molecule to substrates and
cell membranes are important.
The release of enzymes from heart tissue in myocardial
infarction is believed to be due to ischaemia. Human
heart tissue is rich in many enzymes especially MD, LD,
glyceraldehyde-3-phosphate dehydrogenase, AST, L-glycerol-
3-phosphate dehydrogenase, CK, aldolase and isocitrate
dehydrogenase in decreasing order of abundance (Schmidt and
Schmidt, 1960b). In the infarcted area of heart tissue
there is a rapid decline in most glycolytic and oxidative
enzymes (Gudbjarnason ejfc al., 1967)- The enzymes lost are
believed to be released from the cell, and a portion of thes
enzymes enters the circulation. Most enzymes found to be
depleted in the infarcted myocardium can be shown to exhibit
raised activity in the blood plasma with the notable except¬
ion of isocitrate dehydrogenase. The failure to detect a
rise of isocitrate dehydrogenase in plasma has been attrib-
/
uted to the rapid clearance rate of the enzyme from plasma
(Strandjord e_t aT. , 1959) > and to the thermal instability
of the enzyme (Campbell and Moss, 1962).
The mechanisms controlling release of enzymes from
cells are still incompletely understood. It is, however,
fairly certain that cell necrosis is not the only cause for
the release of enzymes in myocardial infarction. Reversibl
changes in membrane permeability without cell death, inc¬
reased intracellular enzyme synthesis in the injured cell,
and the release from non muscle-cells around the infarcted
area (as a result of change of cellular composition due to
damage) may all contribute significantly to the increase in
plasma enzyme activity.
3-1-3 Fate of the released enzymes.
Little is known about this subject. At one time it
was thought that biliary excretion might play a major role
in the removal of enzymes from plasma (Armstrong e_t aA . ,
193^)• Later work, however, showed that this was not so
for many enzymes. Hepatectomy had little effect on the
clearance of plasma aminotransferases (Cleeve, 1962).
- Work on aspartate aminotransferase (Dunn ejt aA . , 1958) and
aldolase (Sibley, 1958) also showed that biliary excretion
played little or no part in the clearance of these enzymes.
The renal excretion of plasma enzymes has been invest¬
igated for many years. Rosalki and Wilkinson (1959)
reported that, except for some digestive enzymes, most
plasma enzymes of use in diagnosis were detected only in
traces in urine. Subsequently, Kemp and Laursen (i960),
Amador ejt aA. (1965) and Appert et aA. (1968) showed that
renal excretion could not account for the clearance of
lactate dehydrogenase, alkaline phosphatase, aspartate
aminotransferase, alanine aminotransferase or amylase from
plasma, except in renal damage. Removal via the saliva
(Cornish and Posen, 1968) and the gastrointestinal tract
(Fleisher and Wakim, 1968) were also shown to be unimportant
routes of elimination.
Fleisher and Wakim (1963a; 1963b) and Wakim and
Fleisher (1963a; 1963b) showed that the reticuloendothelial
system was a major site for the clearance of aspartate
aminotransferase isoenzymes, alanine aminotransferase and
lactate dehydrogenase from.- plasma. They showed that
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blockage of the reticuloendothelial system by zymogen
caused a decrease in the clearance rate of injected enzymes.
However, the clearance of alkaline phosphatase remained
unchanged when the reticuloendothelial system was blocked
(Mahy and Rowson, 1965).
Posen (1970) suggested that at least three mechanisms
were involved in the clearance of plasma enzymes:
1. Rapid binding of the enzymes at sites near the intra¬
vascular compartment. This mechanism seems able to be
saturated and applies especially to denatured protein.
%
2. A mixing phase which is mainly a dilution effect bet¬
ween intra- and extra-vascular compartments.
3. Irreversible denaturation by exo- and endopeptidases
and by non-enzymic mechanisms.
Other removal mechanisms may also exist. For example,
it is possible that enzyme inhibitors may be produced in
plasma in response to high plasma enzyme levels in certain
cases (Wilkinson, 1962). There is also the possibility
that the plasma enzymes might be incorporated into a variety
of cells. Indeed, uptake of enzymes by cells has been
observed (Warburg e_t aT., 195^)*
The clearance rate of most plasma enzymes can be
divided into at least two phases, an initial rapid and a
subsequent slow phase. The rapid phase is due mainly to
the equilibration of the enzyme between the intra- and
extravascular spaces; and the slow phase represents the
inactivation or denaturation of the circulating enzyme.
Fleisher and Wakim (1963a), suggested a three compartment
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model to describe the decay in activity of plasma enzymes.
The compartments are the plasma space, the lymph space and







The clearance rate of a plasma enzyme can be approximated
by a mathematical expression:
. ~ t ~ ?\,t ht .A = a^e + a^e 1 + a^e i + A oo
where A = activity of the plasma enzyme at time t.
A^ = activity of the plasma enzyme at steady state.
a^_^= arbitrary constants.
*1-3= inactivation constants of the plasma enzyme in
compartments 1-3.
Values of >. may be obtained by plotting log (A - Aoo )
against time.
3-1Origin of plasma enzymes - organ specificity and
In most
enzyme pattern,
disease states, many enzymes are released into
the circulation, but not all of them are suitable for
diagnostic purposes. The rise in activity of the enzyme
in plasma must be high enough to permit a sharp distinction
between normal plasma activity and activity in the patholo¬
gical state under consideration. It is also important
that the enzyme should be easily related to its tissue of
origin to indicate the site of damage. For routine diagno¬
stic measurements, which are likely to be requested frequently,
it is highly desirable that the technique of measurement
should be simple to perform.
Organs and tissues, depending on their functions, have
different enzyme compositions. The differences may be
qualitative, but in most cases they are only quantitative.
One way of tracing the origin of raised plasma enzymes is
to study the relative activities of several plasma enzymes.
As most tissues have a fairly distinct enzyme composition,
if a definable enzyme pattern is found in plasma, this sugg¬
ests that a particular tissue is involved in the disease.
Such an approach is, nevertheless, liable to misinterpreta¬
tion as a result of pattern distortion after the enzymes
have entered the circulation. The causes for such distor¬
tion may be different rates of release, diffusion and clear¬
ance of the enzymes, changes in cellular composition, and
changes in intracellular enzyme pattern of the tissue due to
damage. The enzyme pattern may also be distorted by the
release of various enzymes from more than one tissue of the
body.
Another method of determining the origin of plasma
enzymes is the measurement of isoenzyme activities in
plasma. The present section is concerned with the release
of subcellular-specific isoenzymes, a comparative study on
the liberation of cytoplasmic (cAST and cMD) and mitochond¬
rial (mAST, mMD and GLDH) enzymes from the damaged myocar¬
dium in patients. The use of isoenzymes in the diagnosis
of myocardial infarction has been discussed in Section 1,
and Section k deals with the release pattern and tissue
specificity of the MM and MB isoenzymes of creatine kinase.
•
3-1-5 Release of mitochondrial enzymes in myocardial
infarc tion.
Soon after the discovery of the diagnostic value of
plasma AST in myocardial infarction by LaDue £jt ad. (195^) »
the clinical value of many other plasma enzymes was in¬
vestigated. Consequently, LD and later CK were found to
be useful in the diagnosis of the disease. The clinical
value of MD in myocardial infarction has also been establi¬
shed although the test is seldom used; Yakulis and co¬
workers (1962) reported, however, that there was no change
in the isoenzyme pattern of MD in the sera of patients after
myocardial infarction and suggested that such studies had
little value in diagnosis. Glutamate dehydrogenase has
not been found to be of value in the diagnosis of acute
myocardial infarction, but, has proved a useful index of
damage in certain types of liver disorders (see below); it
is possible that a similar use for the test could be devel¬
oped in patients with myocardial infarction.
Subcellular fractionation studies have shown that tnAST,
mMD and GLDH are all located in the inner membranee matrix
fraction of the mitochondrion (Addink e_t ad., 1972; Lardy
and Ferguson, 1969). The order of abundance of AST, MD
t k /
and GLDH in human heart tissue is MD (1 x 10 units/g
protein) > AST (1 x 10"^ units/g protein) > GLDH (20 units/g
protein) (Schmidt and Schmidt, i960). Between ^40 and 68°/o
of the total AST is mitochondrial (Bodansky e_t ad., 1968).
The corresponding percentage for MD in human heart is less
well documented and is generally believed to be between ^0
and 60°/o.
The release of mMD, mAST and GLDH in liver disease
has been studied by many investigators (Schmidt ejt ad. ,
1967a; Gabrielli and Orfanos, 1968). Schmidt e_t ad.
(1967a) suggested that the varying behaviour of the mito¬
chondrial enzymes GLDH, mAST and mMD might offer a precise
indication of the extent and type of mitochondrial damage
in liver disease. Equivalent studies, mainly on mAST, in
myocardial infarction have not yielded conclusive results.
Several investigators (Fleisher e_t ad., I96O; Boyde and
Latner, 1962) reported the occurrence of mAST in the serum
of patients with myocardial infarction. Later, Massarat
and Lang (1965) studied 10 patients with the disease and
found that mAST was detectable on the first day of the
infarct; they concluded that the release of mAST was mainly
a phenomenon characteristic of the first 2k hours. Boyde
(1968a) reported that mAST returned to normal at a slower
rate than the total serum activity and suggested that the
enzyme was released gradually from the cell. He further
observed (1968b) that mAST activity was found to be raised
even when the total serum activity had returned to normal,
and thus regarded mAST as a more sensitive index of myo¬
cardial infarction than total AST. Murros e_t aT. (1973)
examined the serum mAST in 2k patients with recent myocar¬
dial infarcts. They also suggested that mAST was gradually
released from the damaged myocardium but, in contrast to the
report of Massarat and Lang (1965)? they were able to detect
mAST in serum for longer than the first day after the
infarc t.
In recent years considerable effort has been spent on
attempts at improving the specificity of enzyme tests as
well as on searching for an accurate index for the severity
of the infarct. Although none of the mitochondrial enzymes
mentioned here is "heart-specific", it is possible that by
virtue of their subcellular location they could indicate
more accurately than cytoplasmic enzymes the extent of cell
necrosis and hence infarct size.
3-2 Clinical material and methods of assay.
3-2-1 Clinical material.
The clinical study was carried out in the period
September 1973 - July 197^ on patients in the Royal
Infirmary of Edinburgh. The patients studied consisted
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of 3 groups:
Group 1 Patients with suspected myocardial infarction
admitted to the Coronary Care Unit (C.C.U.). There were
altogether 1^2 patients, selected on a random basis (one in
three) on admission to the unit. Three patients died
before sufficient data had been obtained and hence were
discarded from the study. The remaining 139 patients
(109 males; 30 females) were divided into k classes accord¬
ing to ECG and clinical findings, the enzyme activity res¬
ults not being considered in making the classification:-
Class 1 "Proven" myocardial infarction.
The clinical symptoms and ECG findings of 68 patients
fulfilled the criteria for "very probable myocardial in¬
farction" (WHO 1959).
Class 2 Possible myocardial infarction.
The ECG of 17 patients showed less distinct diagnostic
abnormalities, but the patients were nevertheless consid¬
ered by the doctors concerned to have had myocardial
infarcts on the basis of the clinical findings.
Class 3 Myocardial ischaemia.
39 patients had probable cardiac pain accompanied by
ECG findings which were either normal or showed only trans¬
ient changes.
Class ^ Non-infarction.
There were 15 patients in whom the diagnosis of
ischaemic heart disease was considered unlikely.
Group 2 Patients without myocardial infarction, but with
disorders known to cause raised serum CK activity.
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Class 1 170 patients who had undergone non-cardiac
surgical operations varying from cystoscopy to
major abdominal surgery.
Class 2 36 patients who had undergone cardiac bypass
operations mainly for valve replacement.
Class 3 9 patients on haemodialysis for acute renal
failure.
Class h k patients with Grades III and IV coma due to
barbiturate poisoning.
Class 5 A "miscellaneous" group comprising 1 patient
with hypothermia and 1 patient with the "Munchausen
Syndrome".
Group 3 Control group.
132 apparently healthy male blood donors, aged between
30 - 65 years, served as a control group for determining
the reference values for the activity of some enzymes in
serum.
Only the 68 patients with proven myocardial infarction
(Group 1 : Class 1) were involved in the study of the mito¬
chondrial and cytoplasmic enzymes to be described in this
section. The other groups were studied in the investigation
of the MM and MB isoenzymes of CK described in the next
sec tion.
3-2-2 Enzyme analysis.
For Group 1 patients, blood samples were collected on
admission to the Coronary Care Unit and subsequently at
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intervals of 6 hours for the first 2k hours and thereafter
at about 12 hourly intervals until discharged from the
C.C.U. - usually between 60 - 72 hours after admission.
For Groups 2 and 3 patients, with the exception of
the bypass patients where 2-3 serial samples were obtained
from each patient, only single samples of blood were taken.
The blood samples were allowed to clot and serum was
separated within 2 hours of sample collection. Enzyme
tests were performed as soon as possible, mostly within 2k
hours of receiving the sample; all tests were performed
within 3 days. The serum samples were stored at 4°C in
the dark. All visibly haemolysed samples were rejected.
The following enzyme assays were performed:-
1. Total creatine kinase activity by the method of Rosalki
(1967) using reagents supplied by Boehringer Ltd.
(Lewes, England).
2. Total aspartate aminotransferase, using a modification
(Smith ejt al. , 1970) of the method of Henry e_t al .
(1960).
3. Alanine aminotransferase (ALT) using a modification
(Smith e_t aT. , 1970) of the method of Henry e_t al.
(i960). The purpose of the inclusion of this enzyme
was to indicate possible liver involvement during the
course of the disease.
4. NAD-dependent malate dehydrogenase. A method using
malate as substrate was developed for this purpose
(Section 2-3-3).
5. Urea-stable lactate dehydrogenase (USLD) using the method
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of Brydon and Smith (1973).
6. Glutamate dehydrogenase using the method of Ellis and
Goldberg (1972).
The evaluation of all these methods has already been des¬
cribed in Section 2.
Isoenzymes of AST, MD and CK were measured by methods
to be described separately (Section 3-2-3 and Section k-2).
3-2-3 Determination of the isoenzymes of AST and MD.
A simple chromatographic technique based on the method
of Schmidt e_t aT. (1967b) was used. It separates simultan¬
eously the mitochondrial isoenzymes of both AST and MD
from their cytoplasmic components.
Reagents.
1. Potassium phosphate buffer 8 mmol/l pH 7.0.
2. DEAE Sephadex A50 (Pharmacia, Uppsala, Sweden)
pre-equilibrated in phosphate buffer.
3. Visking dialysis tubing (8/32).
Proc edure.
The serum samples were dialysed overnight in Visking
tubing against phosphate buffer. The pre-equilibrated
Sephadex was packed into small columns (0.8 cm in diameter)
to a height of about 10 cm. 1-2 ml of the dialysed serum
was introduced into the column followed by elution with
phosphate buffer. The eluates were collected in 5 fractions
of about 3 ml each in a LKB UltroRac fraction collector
(No. 7000). The activity of mAST and tnMD in each fraction
was assayed using 0.7 ml of eluate in place of the usual
0.1 ml to increase sensitivity. The effect of dialysis
on activity was corrected for by multiplying the total
activity of all the fractions by the ratio:
Activity of the original sample/Activity of the dialysed sample.
In nearly all the samples studied, very little change of
activity was observed on dialysis for either AST or MD,
apart from a slight decrease attributable to the small
increase in volume occurring as a result of dialysis. The
activity of the cytoplasmic isoenzyme was* obtained by sub¬
tracting the activity of the mitochondrial form from the
total activity.
Assessment of the method.
For this purpose partially purified extracts of mAST,
cAST, mMD and cMD were prepared from human heart. They
were shown to be free from contamination with their other
isoenzyme by electrophoresis in 7°/° polyacrylamide gel.
Various amounts of the four isoenzymes were added to
inactive serum and then dialysed overnight. The dialysed
samples were applied to the column which was then eluted
first with the 8 mmol/l phosphate buffer followed by 0.2
mol/l potassium phosphate buffer pH 7*0 containing 0.2
mol/l NaCl, shown to be capable of eluting the cytoplasmic
isoenzymes (Schmidt e_t al. , 1967b).
The recovery of the mitochondrial and cytoplasmic
isoenzymes is shown in Table 3-1• The precision of the
Tables 3-1
Recovery of Isoenzymes from Column Eluates


































* For mitochondrial isoenzymes the recovery percentages refered to the
first eluate (eluted with 8 mmol/1 phosphate buffer pH 7.0); for cyto¬
plasmic isoenzymes the recovery percentages refered to those of the
second eluate (eluted by 0.2 mol/1 phosphate buffer pH 7.0 + 0.2




method, calculated from duplicate analysis of samples, is
listed in Table 3-2. Since almost all mAST was recovered
in the first eluate (Table 3-1), it seems unlikely that the
binding of mAST to c^-macroglobulin in serum (Boyde and
Prime, 1968) was significant in the dialysed sera under the
present experimental conditions.
3-3 Results.
3-3-1 Determination of reference ranges.
The reference ranges for the activity of AST, MD, CK,
USLD, ALT and GLDH in serum were determined from the 132
male blood donors, while those for mAST and mMD were obt¬
ained from a group of 68 people (55 male and 13 female).
The distribution of these data was checked by plotting the
cumulative frequency against enzyme activity on probability
paper. It was found that AST, CK, USLD and ALT data had
a log-normal distribution while MD, mAST, mMD and GLDH data
fitted neither a normal nor a log-normal distribution (Fig.
3-1a and b). Their distributions were all skewed to the
right. The reference ranges of these enzymes are listed
in Table 3-3•
The reference range for GLDH was found to be higher
than that reported by Ellis and Goldberg (197^)> 0-4 IU/l,
using the same assay method. As there are sex differences
in the reference values of some enzymes, the following upper
Table 3-2
Repeatability of the Column Method
mAST IU/1 mMD IU/1
144 140 44 45 60 66 20 18
124 104 36 39 50 52 16 15
106 107 26 26 30 33 10 12
99 103 20 27 30 32 2 5
90 94 18 19 25 30 0 1
86 80 14 15 20 24 0 1
58 61 2 3 -
S.D. = 4 IU/1 (C.V. =7.7%) S.D. = 2 IU/1 (C.V. = 10%)
The standard deviation (S.D.) was calculated from the formula
n-1) where d = difference between duplicates
ji = total number of observations
The coefficient of variation (C.V.) was obtained from S.D. / mean value.
 
Figure 3-1
Distribution of Serum Enzyme Activities in Healthy Individuals
b.
A significant portion of the sample showed no detectable activity of
mMD, mAST and GLDH; the assay methods (see text) used for these
enzymes were not sensitive enough to detect activity between 0-1
IU/1.
Table 3-3
Reference Raiges for Serum Enzymes
Enzymes No. of Mean IU/1 S.D. IU/1 Reference Range
data IU/1
CK 131 102 45 40 - 200
AST (Total) 99 20.2 4.9 10 - 30
USLD 98 203 49 100 - 300
MD(Total) 124 15 8 5 - 36
Alt 99 19.2 7.8 10 - 35
mAST 64 2 1.3 0 - 4
mMD 65 1.5 1.0 0 - 4
gldh 58 4.0 2.3 0 - 7
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reference limits for women were assumed based on previous
studies in our laboratory as well as those in the litera¬
ture (e.g. Goldberg and Winfield, 197^+) s AST and ALT 25
IU/1 , CK 150 XU/1 .
3-3-2 Release of cytoplasmic and mitochondrial
enzymes into the circulation.
For each enzyme, the peak activity was the highest activity
observed in the enzyme profile; the peak time was the time
between the onset of symptoms and the time when the peak
♦
activity was observed.
Figure 3-2 shows the variation of serum enzyme activity
with time in a typical patient; Table 3-A shows the average
peak time of mMD, mAST, cMD and cAST in serum after infarc¬
tion. The peak times for each of the four enzymes all
approximated to a normal distribution about their respective
means. Paired Student's "t" test analysis shows that the
two mitochondrial enzymes (mAST and mMD) reached peak values
of activity in serum significantly later than their cyto¬
plasmic isoenzymes. There is no significant difference
between the average times for peak activity of mAST and mMD,
whereas cMD reached its peak of activity significantly earl¬
ier than cAST.
The release of mAST, mMD, cMD, cAST and GLDH was foll¬
owed for up to 130 hours after the onset of pain in some
cases. The period was divided into 12 intervals, and the
average activity of each of the serum enzymes and the percentage
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Table 3-4
Average Peak-time of the Isoenzymes of AST and MP
in Serum after Myocardial Infarction
mMD mAST cMD cAST
No. of




(hr) 41.1 39.0 17.9 26.4
S.D. (hr) -14.0 12.0 7.5 8.3
Significance of the Difference between Average Peak-times
of the Enzymes (by Paired Student's "t" test)
mMD:mAST mMD:cMD mASTccAST cAST:cMD
Pairs of
Data 50 51 52 55
"t" 1.4 9.9 8.1 9.7
Probability
(P) 0.1 >P> 0.05 P«0.0005 P« 0.0005 P« 0.0005
abnormal enzyme results in each interval was noted (Table
3-5)* It can be seen that mAST and mMD became abnormal
considerably later than their cytoplasmic isoenzymes.
The serum activity of GLDH did not rise to a distinct
peak value in most patients studied. The average GLDH
activity remained normal throughout the 130 hour period,
although individual patients sometimes showed small rises.
3-3-3 Rate of clearance of enzymes from serum.
The rate of decay of enzyme activity was measured for
each of the enzymes after the enzyme activity had reached
its peak. Many of these clearance curves were found to
show two components, an initial fast phase and a subsequent
slow phase. The apparent overall half-life (Tjl) of the
2
serum enzymes was obtained by tracing the enzyme profile
to half-peak activity level for each patient; cMD was
cleared fastest (Tjl = 19-3 hours) while mAST was the slowest
2
(Tjl = 36.6 hours). The mean apparent Tjl values were all
2 2
significantly different from each other with the exception
of mAST and mMD. The mitochondrial isoenzymes were cleared
significantly more slowly than their cytoplasmic components
(Table 3-6).
3-3-k Abnormal peak activity of cytoplasmic and
mitochondrial enzymes.
The peak activities,of cAST, mAST, cMD, mMD and GLDH
Table 3-5
The Release of Cytoplasmic and Mitochondrial Enzymes in Patients
with Proven Myocardial Infarction
Time after Mean Value
Pain (hr)
cAST IU/1 cMD IU/1 mAST IU/1 mMD IU/1 GLDH IU/1
0 - 6 32(63) *35% 42(63) 37% 1.8(55) 55% 1.4(55) 4% 4.2(54) 1%
6 - 12 99(59) 95% 102(59) 93% 3.0(58) 22% 2.4(59) 15% 4.0(48) 8%
12 - 18 180(49) 100% 147(49) 98% 5.7(51)49% .3.7(51)24% 3.0(40) 5%
18 - 24 204(48) 100% 125(48) 98% 8.2(47) 72% 4.9(47) 47% 3.8(36) 3%
24 - 30 228(32) 100% 106(32) 91% 14.7(29) 86% 9.2(30) 67 % 4.3(27) 7%
30 - 36 212(31) 100% 82(31) 77% 16.5(31) 90% 10 . 3(30) 67 % 4.6(25) 16%
36 - 42 193(31) 94% 63(31) 77% 15.4(23) 96% 10.0(24) 79% 4.1(22) 14%
42 - 48 171(26) 100% 52(27) 67% 16.0(24) 92% 11.8(24) 75% 6.1(15) 27%
48 - 54 131(18) 100% 54(17) 65% 14.2(22)100% 9.5(22) 68% 4.4(21) 10%
54 - 66 112(29) 100% 39(29) 55% 14.5(38) 89% 9.2(33) 67 % 5.7(35) 20%
66 - 80 74(34) 97% 33(33) 24% 12.7(30) 80% 9.7(30) 73% 6.4(25) 32%
80 - 130 47(28) 79% 30(28) 18% 5.7(27) 49% 4.0(27) 35% 6.7(17) 22%
* = percentages of abnormal results
() = number of data
Table 3-6
Rates of Decay of the Released Enzymes (Apparent Tj^ Values)
——— 2
mAST cAST mMD cMD
No. of
Patients 31 49 28 49
Mean T j_
(hr) 2 36.6 30.5 32.8 19.3
'S.P. 12.4 7.4 16.7 6.8
Significance of the Difference between the Mean Tj^ Values of
the Enzymes (using the Student's paired "t" test) 2
mASTimMD mAST:cAST mMD:cMD cASTicMD
No. of
Pairs of
Data 26 28 25 46
"t" 1.16 3.27 3.69 10.16
Probability






were compared with the respective values for the upper
limit of the reference range. Cytoplasmic AST, cMD and
mAST had raised peak activities in all patients studied,
93°/o of the patients had abnormal peak mMD activities but
only about kO°/o had abnormal peak GLDH activity. The
highest rises in activity observed in the present study
were cAST - 19 times, mAST - 14 times, cMD - 13 times, mMD
-11 times and GLDH - 9-5 times their respective upper
reference values.
The peak values of cAST, mAST, cMD, mMD and total CK
»
were then compared with each other. A regression analysis
was done on each comparison (Table 3-7)• It was found
that the activities of the mitochondrial enzymes correlated
well with each other (r = 0.9)> and so did the cytoplasmic
enzymes (r = 0.88) (Fig. 3-3a and b). However, the correl¬
ation between cytoplasmic and mitochondrial enzymes was
poorer (r ranging from 0.59 to 0.75)•
3-3-5 Correlation of cytoplasmic and mitochondrial
enzymes with degrees of heart failure.
The patients with myocardial infarcts, in whom suffic¬
ient data were available, were placed into four clinical
grades depending on the presence and extent of heart
failure; none, mild, moderate and severe. Table 3-8 shows
that in general there is a relationship between the severity
of heart failure and the magnitude of the peak value of
activity, for all four enzymes. The mitochondrial enzymes
Table 3-7
Correlations between the Peak Values of Serum Enzymes
mAST:mMD mAST:cAST mMD:cMD cAST:cMD mMD:CK mAST:CK
Sample
Size 60 pairs 61 pairs 62 pairs 66 pairs 58 pairs 57 pairs
r 0.9 0.75 0.59 0.88 0.70 0.72
r = coefficient of correlation
a.
Figure 3-3
Correlation between the Peak Activities of Mitochondrial MD and
AST in Serum after Myocardial Infarction
i/ni aww
Figure 3-3
b. Correlation between the Peak Activities of Cytoplasmic MP and
AST in Serum after Myocardial Infarction
Table 3-8
Correlation between the Release of Enzymes and Different
Degrees of Post-infarct Heart Failure










































* = Significance of the difference between mean activities of various
groups with respect to "None" ; values of P were obtained by the
Student's "t" test.
.,<7/*
seemed to show a better correlation than the cytoplasmic,
since patients with "severe" heart failure showed average
mitochondrial AST and MD peak activities that were 2.1 times
those from patients with no heart failure; the correspon¬
ding figure for cytoplasmic AST and MD was 1.^ times.
3-k Discussion.
Mitochondrial enzymes and cell necrosis. The first manif¬
estation of cell injury due to ischaemia (or any other
cause) is cell swelling as a result of disturbance in the
sodium pump and ATP production in the cell (Ginn e_t aT. ,
1968). The permeability of the cell membrane changes and
it is conceivable that at this stage certain cytoplasmic
enzymes could be released from the cell, especially those
with small molecular weight. So far the change in the cell
is completely reversible, with no apparent functional damage.
If, however, the injury continues, derangement of the intra¬
cellular organelles occurs. At this point the mitochondria
begin to swell, assuming bizarre shapes and sizes, followed
by rupturing of their membranes. It is presumably during
this phase that the mitochondrial enzymes are released.
With this irreversible damage to the cell's respiratory app¬
aratus, death of the cell almost certainly ensues.
The present serum enzyme findings seem to be compatible
with this sequence of events. The release of cAST and cMD
was significantly earlier than the corresponding release of
mAST and mMD (Table 3-k). This is in agreement with the
hypothesis that the cytoplasmic enzymes begin to "leak"
during the initial reversible phase of cell injury. This
hypothesis seems to be further supported by the fact that
the release of the cytoplasmic enzymes correlated poorly
with the release of the mitochondrial ones (Table 3-7) >
a result to be expected if only cytoplasmic enzymes were
released in the early stage of injury. However, more
conclusive evidence is necessary for validation of this
hypothesis.
It is likely that the majority of the mitochondrial
enzymes - mAST, mMD and GLDH, leak out of* the cell during
the rupturing stage rather than the swelling stage of the
mitochondria, since these enzymes (being in the inner mem¬
brane matrix) have to pass through both the inner and outer
membranes of the organelle. If this is true, these mito¬
chondrial enzymes will offer a much better indication of
cell death (and hence infarct size) than the cytoplasmic en¬
zymes in cases where there is a large area of affected tiss¬
ue surrounding a small necrotic centre. The present semi¬
quantitative analysis (Table 3-8) on heart failure seems to
support this view. A rigorous quantitative validation of
this suggestion in the present study would have been difficu
as the mitochondrial enzymes (mAST and mMD) took a long time
(more than 100 hours after the infarct) to return to normal,
by which time patients had already been discharged from the
Coronary Unit. Therefore, peak activity values had to be
used in place of the total area under the graph of enzyme
activity against time which would have been a more accurate
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index of the total amount of enzyme released. Moreover,
there were very few deaths in the present study, and the
physical assessment of the infarct size at autopsy was
therefore not feasible. Instead, a clinical phenomenon
(heart failure) related to the infarct size had to be used,
but the degree of heart failure is also influenced by many
factors other than infarct size.
Another major disadvantage in using mAST or mMD to
assess cell death in myocardial infarction is the fact
that these enzymes, though specific to mitochondria, are
not specific to myocardium; they may derive from other
organs, especially the liver. Failure to recognise this
may lead to gross overestimation of the degree of myocardial
damage.
GLDH was slightly raised in many of the patients
studied and normal in the rest. This is perhaps related
to its high molecular weight (1 000 000) and its presence
in only small quantities in the myocardium. However, a
very high value (350 IU/1 ) was observed in 1 patient who
also had high values of mAST (1^0 IU/1 ) and mMD (56 IU/1 ) .'
This patient was later shown not to have had a myocardial
infarct but to be suffering from liver disease.
Clearance of the enzymes from serum. The measurement of
Tjl values for the clearance rates of enzymes from serum in
2
patients can only be approximate. The apparent Tjl value
2
obtained is a composite of the mode of release of the enzyme,
mixing between body fluids and the multiphasic clearance of
the enzyme. The data from the present study show that the
apparent half-lives of mAST and tnMD in serum after myocardial
infarction are similar (36.6 and 32.8 hours respectively)
and tend to be longer than the corresponding half-lives for
cAST and cMD (30*5 and 19-3 hours respectively) (Table 3-6).
Animal experiments, in which known amounts of enzyme were
injected, suggested a much shorter half-life for mAST (0.5
-1.0 hours) (Fleisher e_t aT. , 1963) and for cAST (8 - 12
hours) (Fleisher e_t aT . , 1963; Schmidt e_t aT . , 1967a),
whereas those for mMD (about 28 hours) and cMD (about ~\k
hours) (Schmidt e_t a_l . , 1967a) were of the same order as
those found for the human enzymes in this* study.
If the data from these animal experiments are applic¬
able to humans, then the most likely explanation for the
long apparent half-1ives of mAST and cAST in human serum
after myocardial infarction would be that the enzymes cont¬
inued to be released for several days after the episode.
Furthermore, it would be necessary to postulate that the
pattern of release of mMD and cMD was dissimilar from that of
the AST isoenzymes, with most of the mMD and cMD being rel¬
eased as single discharges after infarction. The report
of Murros ert aT. (1973) on the release of mAST agrees with
this hypothesis. However, it seems unlikely that mMD and
mAST should have different manners of release since they
are located in similar sites in the mitochondrion. It is
thus doubtful whether the extrapolation of reults from animal
experiments to humans is entirely justified, although mAST
in different species has been found to be very similar
(Gehring e_t aT . , 1975)> and injection experiments on a single
patient (Dawson, et al . , 1969) gave Tj_ values of similar
2
magnitude (for cMD and total AST) as in the animal experi¬
ments described above. Further experiments appear to be
needed before valid conclusions can be drawn from these
studies.
The mitochondrial and cytoplasmic enzymes as indicators of
myocardial infarction. In all the 68 patients with proven
myocardial infarction cAST, cMD and mAST were raised, while
93°/° had raised mMD and about 40°/o had raised GLDH. The
maximum peak heights (relative to the upper limit of the
reference range) were higher for the cytoplasmic than the
mitochondrial enzymes. Also they began to show their max¬
imum frequency of abnormal results (about 12 hours after the
onset of pain) earlier than the mitochondrial (2^4 - 30 hours
after the onset of pain) (Table 3-5)- In terms of sensiti¬
vity and the early detection of the infarction, it seems
that the mitochondrial enzymes are less suitable than the
cytoplasmic. Although mAST had a longer apparent half-
life than cAST, the finding of Boyde (1968b) that mAST
remained raised when total AST activity had returned to normal
was not evident in the present study.
Of the two cytoplasmic enzymes, cAST is superior to cMD
as a diagnostic aid in myocardial infarction. The released
cAST stays in the blood longer and rises to a higher value.
Comparison of the two mitochondrial enzymes shows that mAST
is better than mMD in supporting the diagnosis of infarction,
since mAST rises to a higher value and is detectable in a
higher percentage of patients with the disease.
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Patterns of release of mitochondrial enzymes in myocardial
infarction compared with those in liver disease .
Mitochondrial AST, mMD and GLDH are present in many tissues
and are known to be released in a number of pathological
conditions other than myocardial infarction e.g. liver
disease. It is interesting to compare the release of these
enzymes in myocardial infarction with their release in liver
disease, using data from the reports of Schmidt e_t al . (196J&) ,
and Gabrieli and Orfanos (1968):-
1. The ratio mMD/cMD in serum is higher in hepatitis (mMD
being 25 - 35^ of the total MD activity) than in myo¬
cardial infarction (mMD less than 20°/o of the total
enzyme activity).
2. The ratio mAST/cAST in serum is higher in myocardial
infarction (mAST about 1 k°/o of the total enzyme activity)
than in liver disease (mAST about 8°/o of the total).
3. Proportionately more GLDH is released in liver disease
than in myocardial infarction, although the comparison
here is not strictly valid as two different methods
of assay were used. The few GLDH assays on patients
with liver disease in the present study, however, agree
with this view.
k. The rise in activity of mAST, mMD and GLDH in serum is
slower in liver disease than in myocardial infarction,
probably due to the different nature of cellular damage
involved.
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Conelusion. In a group of 68 patients with proven myo¬
cardial infarction, the mitochondrial isoenzymes of AST
and MD were found to be released into the blood later and to
have a longer apparent half-life than the corresponding
cytoplasmic isoenzymes. Their peak activities did not
correlate well with those of the cytoplasmic enzymes.
This is presumably due to the additional release of the
cytoplasmic enzymes during the reversible swelling of the
cell prior to permanent damage. In terms of sensitivity
and early detection of the disease, the cytoplasmic iso-
enzymes are superior to the mitochondrial. The only diag¬
nostic value of the mitochondrial isoenzymes studied seems
to be their greater specificity for indicating cell





THE RELEASE OF CREATINE KINASE ISOENZYMES
IN MYOCARDIAL INFARCTION
4-1 Introdue t ion.
This Section is particularly concerned with a compara¬
tive study of the release of the MM and MB isoenzymes of
creatine kinase in patients with suspected myocardial in¬
farction. It compares the results of these studies with
other enzymes (AST, USLD and ALT) that are frequently inv¬
estigated in patients with this condition.
Creatine kinase was first shown to be of diagnostic
value in muscular dystrophy by Ebashi e_t al. (1959). In
the following year, Dreyfus ejt aT. (1960a) detected the
enzyme in normal serum and further observed (1960b) that
CK activity may be elevated up to 10-25 times the upper
limit of the "normal range" in patients with myocardial
infarction. Since then the diagnostic value of CK in myo¬
cardial infarction has been confirmed by many investigators
(Hughes, 1962; Konttinen and Holonen, 1963; Smith, 1964;
Duma and Siegel, 1965).
There have been many studies on the specificity of this
enzyme, at one time thought to be specific to muscular
damage, but further work revealed that serum CK activity
was raised in a number of diseases with no apparent muscular
involvement. Creatine kinase has been found in the thyroid
gland (Graig and Smith, 1966) and the lung (Perkoff, 1968),
and it is released into the blood in pneumonia and pulmonary
embolism as well as in hypothyroidism (Graig and Ross, 1963).
Serum CK activity is also occasionally raised in patients
with cerebral infarcts (Hess e_t aT., 1964), cerebrovascular
accidents (Kalbag e_t aT . , 1966) and psychotic disorders
(Meltzer, 1968). Even when muscular injury is present, the
release of CK has been found to be by no means confined to
myocardial infarction and muscular dystrophy. Plasma enzyme
activity may be raised in normal individuals after strenuous
exercise (Griffiths, 1966). It may also be elevated follow¬
ing accidental and surgical trauma (Eshchar and Zimmerman,
1967)? administration of drugs by muscular injection (Melt¬
zer £jt ad., 1970) and various forms of cardiac disease -
myocardial trauma, acute rheumatic carditis, paroxysmal
tachycardia and pericarditis (King and Zapf, 1972).
»
The use of isoenzymes in improving the diagnostic spec¬
ificity of CK for myocardial infarction has only been studied
relatively recently. The minor component, the MB isoenzyme,
is mainly present in appreciable quantity (about 30°/°) in human
heart tissue (Eppenberger e_t ad., 1970; Dawson and Fine,
1967). The potential value of this relatively heart-specific
isoenzyme has not yet been fully evaluated although a prel¬
iminary report about its release in myocardial infarction
was published nine years ago by Van der Veen and Willebrands
(1966), who stated that the MB isoenzyme was present in
serum in muscular dystrophy. More recently, a number of
reports have suggested that the MB isoenzyme might be a better
test for myocardial infarction than total serum CK activity
(Konttinen and Somer, 1972; Roe e_t ad. , 1972; Smith, 1972).
The following study attempts to assess the diagnostic
potential of the MB isoenzyme in patients with myocardial
infarction and to compare its pattern of release, its
clearance from the blood and its diagnostic specificity
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with those of the more abundant MM isoenzyme.
h-2 Materials and methods.
The classification cf patients and the collection of
serum samples have been described in Section 3-2. The
assay of total CK activity and its isoenzymes was performed
in all three groups of patients.
The MM and MB isoenzymes were assayed after separation
by electrophoresis on polyacrylamide gel,, using a technique
based on the method of Smith (1972). Some modifications
were made to optimise the method for quantitative measure¬
ments. The isoenzyme activity was demonstrated on the gel
by staining via two coupled enzyme reactions:
CK
ADP + Creatine phosphate ^ ATP + Creatine
hexokinase
ATP + Glucose * ADP + Glucose-6-phosphate
Glucose-6-phosphate
Glucose-6-phosphate + NADP ~ 7 7 *
dehydrogenase
NADPH + 6-phospho-gluconate
NADPH + Phenazine methosulphate + Nitroblue tetrazolium
^Purple formazan
Reagents and apparatus.
1 . 7°/o polyacrylamide gel slab (containing 5°/° bisacrylamide
was prepared fresh in a glass plate compartment
(20 x 8 x 0.2 cm).
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Buffer in electrophoretic tanks and in gel: 0.08 mol/l
tris-EDTA-borate pH 8.^.
Electrode tanks . Both anode (25 x 10 x 7 cm) and
cathode (25 x 7 x 7 cm) tanks were made of perspex
with a single platinum wire running along the length
of the tank. The upper cathode tank was divided along
its length into two compartments: the larger (5 cm
wide) contained the platinum electrode and was sep¬
arated from the smaller (1.5 cm wide) by a perspex
sheet containing, near its lower border, three holes
(0.7 cm in diameter) plugged with cotton wool. A slit
(20 x 0.8 cm) for the insertion of the polyacrylamide
electrophoresis cell was cut in the bottom of the
smaller compartment of the cell (Fig. ^-1). The cell
was then temporarily sealed into position by a flexible
sealing compound (Bostik Ltd., Leicester, England).
Sample compartment spacers. Soft rubber tubing
2.5 mm in outer diameter and 1 cm long.
Staining solution:
Reagents Final concentration
Creatine phosphate 35 mmol/l
ADP 2 mmo1/1
AMP 20 mmol/l
Magnesium acetate 10 mmol/l
Glucose 20 mmol/l
NADP 1 mmol/l
Nitro-blue tetrazolium (NBT) 30 mg in 15 ml
Phenazine methosulphate (PMS) 1 mg in 15 ml
Figure 4-1
Design of the Apparatus for Electrophoresis of Creatine Kinase




All were dissolved in 0.1 mol/l tris-acetate buffer
pH 7 .0 in a total volume of 15 ml. The solution of
reagents without NBT and PMS ( which were added fresh)
was stored at-20°C.
Proc edure.
Temporary sample compartments were made on the gel by
placing the sample spacers 0.5 cm apart. The electroph¬
oresis cell was inserted into the bottom slit of the upper
cathode compartment as described. The lower anode tank was
filled with the tris-EDTA-borate buffer and the electrophor-
»
esis cell, with attached cathode, placed in the tank.
100 ml of the same buffer, to which 50IU hexokinase and 10
IU glucose-6-phosphate dehydrogenase had been added, was
placed in the smaller cathode compartment, and the larger
compartment filled to the same depth with buffer containing
no added enzyme.
The coupling enzymes were introduced into the gel by a
45 - 60 min preliminary run at 400 volts. The current was
switched off and 0.5 ml 30^ bovine albumin and a further
50 IU hexokinase and 10 IU glucose-6-phosphate dehydrogenase
added to a smaller cathode compartment. A 10 ^j.1 sample
(Fig. 4-2) , diluted if necessary in kO°/o sucrose to an activity
of 200 IU/1, was applied to the gel and 5 pi of bromophenol
blue added to one of the compartments to act as a marker.
Electrophoresis was stopped when the complex of bromophenol
blue with albumin had migrated 4-5 cm. The gel was taken
out and immersed in 1 mmol/l /5-mercaptoethanol for 20 min,
followed by 0.1 mmol/l tris acetate pH 7^0 for the same
Figure 4-2























The total peak area was obtained by staining the gel with a substrate
solution for the activity of creatine kinase isoenzymes followed by
scanning with a densitometer as described in the text. The serum
sample volume applied was found to be linear with the total peak area
so obtained within the range 0 - 10 _yul. Hence 10 yul was chosen as
the standard sample volume.
- 95 -
*
period. It was then incubated at 37°C with 15 tnl staining
solution for 70 min (Fig. 4-3). After staining, the gel
was rinsed with 5°f° acetic acid and immediately scanned on
a Vitatron TLD 100 "flying spot" densitometer (Fisons
Scientific Apparatus, Loughborough, England) using the
instrument in the "transmission mode" with a 560 nm filter
in position. Immediate scanning was desirable to avoid
adverse effects due to slight fading of the bands (Fig. 4-4).
The percentage of MB isoenzyme in the sample was cal¬
culated by measuring the areas under the MM and MB isoenzyme
peaks. The MB isoenzyme activity was then calculated from,
the formula:-
(Area under MB peak/Area under MM + MB peaks) x
total CK activity
The MM isoenzyme activity was obtained by subtracting
the MB isoenzyme activity from the tota.l . For each gel
electrophoresis, a control strip was cut off the gel and
stained for activity of the coupling enzymes, hexokinase
and glucose-6-phosphate dehydrogenase, to ensure their even
distribution through the gel (Fig. 4-5).
The assessment and validation of this method is
considered separately, in Section 6.
Results.
Figure 4-3
Relationship between Stained Peak Area and Serum Sample Activity
with Different Incubation Period at 37 C
AO
• A OA
i 40 min ' 50 min I 60 min I 70 min
• A
From graph it can be seen that the sensitivity of the polyacrylamide gel
method increases with increasing incubation time. In the range of
incubation periods investigated, the 70 min incubation was the most
satisfactory. With this incubation period the maximum serum sample
activity should not exceed 200 IU/1 if the enzyme activity is to be linearly
related to peak area. All active serum samples in the present study
were therefore diluted accordingly.
Figure 4-4
Effect of Storage in 5% Acetic Acid on the Intensity of the
Stained CK Bands in 7% Polyacrylamide Gei
Total CK activity:
n 90 IU/1; A 230 IU/1; o 145IU/1; • 344
In the range of serum CK activities studied, a slight fading of the bands
(with a resultant decrease in the MB% of the total peak area) was evident
in the first 65 hours of storage.
Figure 4-5





The control strip was stained for the couplying enzyme activities in
substrate solution containg ATP (1 mmol/1), Magnesium acetate (10
mmol/1), Glucose (20 mmol/1), NADP (1 mmol/1), NBT (2 g/1) and
PMS (0.7 g/1) in a total volume of 10 ml.
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4-3-1 Reference ranges for the MB and MM isoenzymes.
No MB isoenzyme band was detected on the gel in any of
the 132 blood donors. Although the elctrophoretic method
is able to demonstrate activity as low as 5IU/1 in diluted
tissue extracts, it cannot detect with certainty any acti¬
vity below 10 IU/1 in serum due to lack of sensitivity and
precision. Therefore, 10 IU/1 was assumed to be the upper
limit of the reference range of the MB isoenzyme. This could
well be an overestimate in view of the following data pub¬
lished recently by other workers. Henry e_t aT. (1975)>
*
using batch adsorption on glass beads, reported the refer¬
ence serum MB isoenzyme activity to be 1.6 IU/1 (S.D. = 0.28);
Nealon and Henderson (1975)> who applied concentrated plasma
to an ion-exchange column, found a reference range of 1.6 -
7.0 U/1; Yasmineh and Hanson (1975) obtained a value of
0.8 U/1 (S.D. = 0 .5) using stepwise elution chromatography.
The reference range of the MM isoenzyme was assumed to
be that of the total CK as the other component, the MB iso¬
enzyme, occurs only in very small quantities. This means
that the upper limit for the reference activity of the MM
isoenzyme is 150 IU/1 for females and 200 IU/1 for males
(Section 3-3-1).
4-3-2 The pattern of release of the MM and MB isoenzymes
after myocardial infarction.
Only those enzyme data obtained from the 68 patients
-^-sJith proven myocardial infarction (Group 1 - Class 1) were
used for the analysis. In all those patients from whom
sufficient data were obtained, the magnitude of the peak
activity of the isoenzymes, the peak time and the time need¬
ed for activity to fall to half the peak value (apparent Tj_)
2
were noted. The enzyme profile of ClOSS 1 patients is shown
in Fig. k-6.
The maximum serum activity of the MB and MM isoenzymes,
AST and USLD is listed in Table k-'\. The mean rise of MB
isoenzyme activity (22.2 times the upper reference value)
was much greater than that of the MM isoenzyme, total CK,
»
total AST or USLD.
The incidence of abnormal serum levels of the MM and
MB isoenzymes, total CK, AST and USLD at timed intervals
after the onset of infarction is listed in Table k-2 and
shown in Fig. 4-7- The MB isoenzyme had the highest fre¬
quency of abnormal results in the period up to 18 hours.
In the period 19-36 hours all the enzymes had similar fre¬
quencies of abnormal results. From the 37th hour onwards
the frequency of abnormal serum MB isoenzyme activity began
to fall rapidly. As might be expected the frequency of
abnormal results for the MM isoenzyme activity was similar
to that of total CK activity.
The individual values for the peak activity of the MB
isoenzyme did not correlate well with the corresponding
values for the MM isoenzyme of CK or with total AST activities
from the same patient. On the other hand, the peak activities
of the MM isoenzyme of CK and total AST correlated well with
ehch other (Table ^4-3)-' The proportion of the MB isoenzyme
Figure 4-6
Mean Serum Enzyme Activities in Group 1 - Class 1 Patients

























Time since onset of chest pain (h)
Table 4-1
Maximum Enzyme Activity Results in Patients
with Myocardial Infarction
Enzyme Mean Range IU/1 x Upper Reference Range
IU/1 Mean Range
Total CK 1720 300-3200 8.6 1.5-16
MM Isoenzyme 1650 240-3000 8.2 1.2-15
MB Isoenzyme 220 28-700 22.2 2.8-70
Total AST 250 39-600 00 • •CO 1.3-20
USLD 1710 360-420 5.7 1.2-14
Figure 4-7
Incidence of Some Abnormal Serum Enzyme Levels after
Myocardial Infarction in Group 1 Patients
Table 4-2
Incidence of Abnormal Serum Enzyme Activities at Varying
Intervals since Onset of Symptoms of Myocardial Infarction
Intervals since
Infarction (hr) % Abnormal Results
CK (MM) CK (MB) CK(Total) AST USLD
0 - 6 25 58 28 32 18
7 - 12 90 98 93 95 78
13 - 18 98 100 98 98 96
19 - 24 94 96 94 94 96
25 - 36 97 94 97
%
97 98
37 - 48 98 66 98 98 100
49 - 72 83 41 85 95 100
Table 4-3
Correlation between Peak Activities of Serum Enzymes
MBLAST MB:MM AST:MM
r 0.60 0.45 0.90
No. of
Pairs of
Data 58 58 57
r = coefficient of correlation
to total CK activity in the specimen showing peak activity
of the MB isoenzyme was also very variable, ranging from
h°[o - 30°[o (Table 4-4). A review of the clinical symptoms
of the patients showed that the percentage of the MB iso¬
enzyme contributing to the total activity of CK did not seem
to be related to the age cr sex of the patient, to the site
of the infarct nor to any history of previous infarcts or
angina.
It was found that the MM and MB isoenzymes of CK reached
peak values at different times and were cleared from the
circulation at different rates. In 58 patients with proven
myocardial infarction in whom sufficient data were available,
the average time for reaching peak activity of the MM iso¬
enzyme in serum was 24 hours after onset of clinical symp¬
toms; in contrast, the corresponding figure for the MB
isoenzyme was 17 hours. Similarly, the MB isoenzyme was
cleared much more rapidly from the circulation than the MM
isoenzyme, having an apparent Tj_ value of 12.8 hours compared
2
(Tabte4-5)
with 28.5 hours for the MM isoenzyme. Like those of the
AST and MD isoenzymes, most decay curves of both MM and MB
isoenzymes of CK consisted of two components, an initial
rapid and a subsequent slow phase.
As in Section 3j the patients were grouped according
to their different degrees of post-infarct heart failure
(none, mild, moderate and severe) with their respective
serum MM and MB isoenzyme peak activities (Table 4-6).
There whs a significant rise in average activity of the MM
isoenzyme between the "none" and the "severe" groups.
*
Table 4-4
Variability of MB Isoenzyme Percentage at MB Isoenzyme Peak
% MB Isoenzyme at
MB Isoenzyme Peak
No. of Patients Mean Total CK at
MB Isoenzyme Peak
(IU/1)
Not Detectable 0 -
0 - 4 1 -
5 - 9 12 1020
10 - 14 9 1080
15 - 19 17 940
20 - 24 13 827
25 - 29 6 1051
30 + 10 1024
Table 4-5
Peak-time and Half-life of the MM and MB Isoenzymes in Serum
MM Isoenzyme MB Isoenzyme
Mean S. D. Mean S. D.
Peak-time (hr) 24 (58) 7.3 17 (58) 4.5
Apparent
Half-life (hr) 28.5 (57) 9.5 12.8 (57) 4.3
( ) = number of data from which peak-times and half-lives were calculated.
The significance of the difference between MM and MB isoenzymes in i) mean
peak-time and ii) mean apparent half-life has been found to be P< 0.0005 in
each case by the Student's paired "t" test.
Table 4-6
Correlation between Peak Activity Values of CK Isoenzymes with
Different Grades of Post-infarct Heart Failure in Patients with
Proven Myocardial Infarction
None Mild Moderate Severe
No. of Patients 29 9 11 8
Mean Peak
Activity IU/1 (S.D.)
MM Isoenzyme 1420 (779) 1850 (670) 1760 (736) 2260 (627)
MB Isoenzyme 196 (85) 300(106) 320 (118) 290 (90)
*MM Isoenzyme - 0.10> P >
0.05
0/15 > P >
0.10
0.05 > P >
0.025
*MB Isoenzyme - 0.05 > P >
0.025
P = 0.01 P = 0.025
* = sigificance of difference between mean values with respect to "None"
as calculated from the Student's "t" test.
However, no significant rise was detected in the "mild"
and "moderate" groups for this isoenzyme. For the MB
isoenzyme there was a distinct rise in activity from pat¬
ients without heart failure to those with heart failure.
The average activities in the "mild", "moderate" and "severe
groups, however, were not significantly different from each
other.
b-3~3 The diagnostic specificity of the MB isoenzyme of
creatine kinase in myocardial infarction.
The results of the studies of the pattern of release of
the MB isoenzyme have shown that it becomes abnormal earlier
reaches a peak value earlier and returns to normal earlier
than the MM isoenzyme of CK or any of the other enzymes
studied. It also rises to higher maximum values in terms
of its upper reference limit than any of the other enzymes
investigated (Table ^t-1 ) . These properties of the MB
isoenzyme have prompted further study of its diagnostic
specificity for myocardial infarction.
Group 1 Patients with suspected myocardial infarction
admitted to the Coronary Care Unit (see Section 3-2-1).
Class 1: Patients with "proven" myocardial infarction.
In all 68 patients the serum activities of the MB and
MM isoenzymes of CK, AST and USLD were raised. The details
of the.rise have been described above.
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Class 2: Patients with possible myocardial infarction.
Twelve of the 17 patients had raised activities of the MB
isoenzyme as well as raised activities of the MM isoenzyme,
AST and USLD. The overall pattern of elevation in these
patients both in terms of their relative activities and the
time course of elevation was highly suggestive of myocardial
infarction. Consequently, there was little doubt that
these patients had, indeed, had myocardial infarcts.
Two other patients had raised values for the MB iso¬
enzyme only, all other enzymes activities being within
their reference ranges. One of these patients developed
an unequivocal ECG pattern of infarction ^ days after admiss¬
ion, the other also developed highly suggestive sequential
ECG changes. It was very probable that these 2 patients
had also had small myocardial infarcts.
A further 2 patients in whom no enzyme rose above its
reference range had had two previous infarcts rendering
their ECG findings difficult to interpret at the time of
admission. Although diagnosed as probably having had
infarcts, more detailed evaluation of the clinical data by
several cardiologists led to the conclusion that it was
impossible to give a firm opinion as to whether recent
infarction had occurred.
The remaining patient, whose only raised serum enzymes
were the aminotransferases (peak values - AST: 180 IU/1;
ALT: 196 IU/1), had had angina for a week. Although her
ECG pattern was suggestive of myocardial infarction, it was
_.*,difficult to date the occurrence of the infarct. The
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infarct may therefore have occurred some days before admis¬
sion; this would explain the absence of raised MB isoenzyme
activity as well as other enzymes.
Class 3 '• Patients with myocardial ischaemia.
Ten of the 39 patients in this group showed elevations
characteristic of myocardial infarction with all the enzymes
studied. In another 19 patients the serum enzymes were
normal. In the remaining 10 patients some enzymes were
elevated: k had a rise of only AST, 1 had raised AST and
USLD, 3 had a raised activity of the MM isoenzyme of CK, 1
had raised activity of the MB isoenzyme of CK, and 1 had a
rise in all enzymes except the MB isoenzyme. From their
clinical symptoms and ECG findings these changes were attri¬
buted to causes other than myocardial infarction (Table ^-7).
Class k: Patients having non-cardiac disorders. Out of
these 15 patients, 10 had normal results for serum enzyme
activity measurements. In the remaining 5j one or more of
the enzyme results were abnormal. They were grouped together
with others in Table ^+-7 as being caused by disorders other
than myocardial infarction.
In summary, in this group of 139 patients admitted to
the Coronary Care Unit, 92 were thought to have had myo¬
cardial infarction (namely 68 from Class 1 , 1^+ from Class 2
and 10 from Class 3) of whom 90 showed elevation in the
activities in serum of all the cytoplasmic enzymes that
were studied. The remaining 2 only had an increase in the
MB isoenzyme of CK.
In the 47 patients not thought to have had a myocardial
Table 4-7
Abnormal Enzyme Results in Patients with Chest Pain due
to Causes Other Than Myocardial Infarction







fibrillation 45 260 50 420






Unexplained (myositis ?) N 664 68 320
Following Dental Extraction N 460 N N
Unexplained (3 cases) N 300 (av) N N
Stokes Adams Attack N 300 N 350
AST Mainly Affected
Unexplained* N N 420 N
Heart Failure* N N 230 340
Alcohol Excess* N N 100 N
Heart Failure* N N 90 630
Unexplained* N N 69 N
Unexplained* N N 46 N
Unexplained (5 cases) N N 60 (av) N
USLD Mainly Affected
Haemolysis N 490 80 3700
Heart Failure N N 34 520
Unexplained (2 cases) N N N 500 (aa
* These patients all showed increased serum alanine aminotransferase
activity.
N = within the reference range; av = average value.
infarction, 17 had at least one of the enzymes with raised
activity in serum. This group is important in the study of
the diagnostic specificity of the serum enzymes concerned.
In these 17 patients, only 3 had raised MB isoenzyme act¬
ivity that was not attributable to myocardial infarction.
Two of these patients can have their findings explained by
other myocardial disorders - tachycardia and pericarditis.
The remaining patient, a man of 32 with a history of alco¬
holism, presented with chest pain which clinically did not
seem to be of cardiac type; the MB isoenzyme (28 IU/1) was
the only abnormal enzyme finding and the "ECG was normal.
Six patients had raised total CK activity in serum that
was not caused by myocardial infarction. One of these
patients (260 IU/1) had a marked tachycardia, and had an
elevation of the MB isoenzyme (^5 IU/1). Of the remaining
5 patients, one (^60 IU/1) had recently had a dental extrac¬
tion and another (300 IU/1) had had a Stokes-Adams attack,
a condition previously shown to be associated with a rise
in CK activity in serum (Smith, 1967)> but no reason could
be found for the other three. In all these 5 cases the MB
isoenzyme was undetectable, showing its better diagnostic
specificity than the MM isoenzyme or the total CK.
AST seems to be the least specific of all the enzymes
studied here. There were altogether 11 patients with ele¬
vations not due to myocardial infarction. If AST results
are considered in combination with ALT results, however, the
diagnostic specficity improves appreciably: six of these
11 patients had a concurrent rise of ALT suggesting the
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presence of hepatocellular damage, and two of the 6 had been
drinking heavily prior to admission. The remaining 5
patients (peak values of AST: 76, 47, 68, 69, 42 IU/1)
belonged to the unexplained category.
There were 4 patients with raised USLD activities not
attributable to myocardial infarction. One was probably
at least partly due to haemolysis (3700 IU/1), one due to
heart failure (520 XU/1) and 2 were unexplained (340, 630
IU/1) (Table 4-7).
Group 2 Patients without myocardial infarction (Table 4-8).
Class 1: Postoperative cardiac bypass pdtients. An average
of three serum samples were taken from the patients at about
12 hourly intervals within the'first 2 days after operation.
Most of these patients had received valve-replacements with
periods on bypass usually between 2 and 4 hours. All the
36 patients had raised serum total CK activity, with values
ranging from 240-2300 IU/1. Of these, 24 had no detectable
MB isoenzyme bands. The MB isoenzyme percentages in the
rest were: 6 with less than 5°/°i 5 with between 5 and 10°/o
and 1 with 1 5/^• The MB isoenzyme percentages here seem
to be smaller than those observed in myocardial infarction.
Class 2: Non-cardiac postoperative patients. A single
random serum sample was taken from patients in the period
after operation up to 48 hours. These patients had under¬
gone a wide range of surgical operations, ranging from
cystoscopy to oesophago-gastrectomy. Forty six of the
170 patients had raised total CK activity (200-2500 IU/l).
















































one random sample was taken from each patient, raised total
CK activity could have been missed in some patients.
Therefore, the frequency of abnormal total CK activity in
this mixed surgical group may be an underestimate of the
true incidence of this finding.
Class 3: Patients on haemodialysis with acute renal failure
Two blood samples were taken from each patient. Six of the
9 patients had raised total CK activity, ranging from 220
to 9^0HJ/1. The MB isoenzyme was not detected in any of
these patients.
Class k; Patients in coma due to barbiturate overdosage.
Three of the k patients had abnorma.l total CK activity
(205, 960, 732 IU/1), but no MB isoenzyme activity was det¬
ected in any patient.
Class 5: Miscellaneous. There were 2 such patients, one
with hypothermia and the other with the "Munchausen Syndrome"
The patient with hypothermia had a very high serum total CK
activity of 5100 IU/1 but with no MB isoenzyme present.
The patient with the "Munchausen Syndrome" was admitted to
the Coronary Care Unit with a severe chest pain, and was
found to have a serum total CK activity of 3^+00 IU/1 but
with no MB isoenzyme present. Other enzymes (AST and USLD)
were normal. His ECG gave' no evidence of a recent infarct.
The same symptoms had occurred several times in the past.
No apparent reason was known for his abnormal CK activity.
It is not clear whether the rise in CK activity was related
t-o his long walk in the cold from his previous hospital to
the Royal Infirmary, Edinburgh.
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Discussion.
The present study shows that the release of the MM
isoenzyme of creatine kinase after myocardial infarction
differs from the MB isoenzyme in two important aspects, in
its pattern of release and in its diagnostic specificity.
The pattern of release of the isoenzymes. The MB iso¬
enzyme had been shown to reach its peak value earlier and to
be cleared from blood much faster than the MM isoenzyme.
The reasons for the shorter time in reaching peak activity
for the MB isoenzyme are not clear, but it might be due to
its shorter half-life in blood and its higher myocardium/
blood concentration ratio; it cannot be explained in terms
of difference of molecular weight or subcellular distribution
pattern. The faster clearance rate of the CK isoenzyme
might be attributable to the presence of the less stable B
subunit in the enzyme molecule. If this were the case,
it would be consistent with the fact that the BB isoenzyme
is seldom detected in the serum, although the blood-brain
barrier could be a contributing factor, the BB isoenzyme being
largely present in the brain.
The diagnostic specificity of the isoenzymes. The present
study shows that the MB isoenzyme has a better diagnostic
specificity for myocardial infarction. In 90 of the 92
patients thought to have had a myocardial infarction, the MM
and MB isoenzymes of CK, AST and USLD all showed abnormal
results. In the remaining 2 cases, the MB isoenzyme was
the only enzyme with raised activity in serum. Moreover,
of the 3 cases where the MB isoenzyme was elevated without
- 106 -
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myocardial infarction, two were attributable to myocardial
damage, whereas there were 6 cases which had raised MM
isoenzyme activity with no apparent myocardial involvement
(Table ^-7).
The better specificity of the MB isoenzyme is further
supported by the study on surgical patients. All the car¬
diac bypass patients had raised total CK activity in serum,
and 12 of them had detectable MB isoenzyme bands. Although
the ECG- and clinical symptoms of these 12 patients were not
conclusive, it was thought likely that the MB isoenzyme came
»
from the myocardium as a result of physical trauma to myo¬
cardial cells at the time of the operation. However, it
was impossible to be sure that the raised enzyme levels did
not reflect enzyme release from areas of ischaemic or in-
farcted myocardium resulting from thrombi or emboli in cor¬
ollary vessels. The fact that kG of the 170 non-cardiac
postoperative patients had raised MM isoenzyme activities
showed that the use of MM isoenzyme, or total CK, in diagno¬
sing myocardial infarction could be very misleading in
patients who had undergone non-cardiac surgery. This in
general agrees with the report of Dixon e_t aT. , (1973)»
The MB isoenzyme, absent in all the non-cardiac postopera¬
tive patients, is thus the single enzyme activity measure¬
ment that is currently available xvhich is capable of suggest¬
ing a diagnosis of myocardial infarction in postoperative
patients.
The reason for the raised MM isoenzyme activity in
_serum after surgery is not clear, although it seems possible
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that it arises from surgical trauma to muscle at the site
of operation. However, no statistically significant rela¬
tionship has been found between the extent of the postoper¬
ative increase and the amount of muscle trauma (Hobson e_t
al. , 1972) or the type of operative procedure (Dixon ejt al. ,
1971)' The nature and duration of anaethesia prior to
operation has, on the other hand, been reported to be closely
related to the increase in the serum MM isoenzyme activity
(Phornphutkul e_t aT . , 1974). Renal dialysis and drug over¬
dosage also cause a rise in serum MM isoenzyme activity,
but no rise in MB isoenzyme activity has been detected.
It is worth noting that, although the MB isoenzyme is
probably the most specific diagnostic enzyme for myocardial
infarction currently available, it is not completely specific
for the myocardium. There are a number of non-cardiac
situations where the MB isoenzyme is also detected in the
serum. For example in muscular dystrophy, the skeletal
muscle CK isoenzyme pattern becomes atypical and reverts
to a foetal state, with a greater proportion of the MB iso¬
enzyme, and the MB isoenzyme is occasionally observed in
the serum of these patients (Goto et al., 1969)- Moreover,
in the present study, the MB isoenzyme activity was detected
in an apparently normal man with a serum CK activity of
400 IU/1.
Creatine kinase isoenzymes as indicators of infarct size.
Currently, there is great interest in using a "heart-
specific" enzyme to assess the size of a myocardial infarct
^and hence to predict prognosis and to evaluate therapy.
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It has been shown that there is a general parallel between
infarct size and the peak values of AST, LD, and total CK
(Nydick e_t a_l. , 1955; Kibe and Nilsson, 1967; Shell e_t aT. ,
1971). In view of the better heart-specificity of the MB
isoenzyme, it seems that the MB isoenzyme might give a better
estimate of the infarct size. However, the present find¬
ings show that the peak activity of the MB isoenzyme does
not correlate satisfactorily with the MM isoenzyme, total
CK or total AST, and the MB isoenzyme percentage of the
total CK activity was very variable at peak activities of
the isoenzyme (Tables k-3 and k-k) . Thi*s suggests that the
peak values for serum MB isoenzyme activity might not be
a good indicator of infarct size. Table k-6, on the other
hand, shows that the MB isoenzyme could be a better indicator
of post-infarct heart failure, which may be regarded as a
phenomenon related to infarct size, than the MM isoenzyme.
These two apparently contradictory findings could be explained
by the possibility that the amount of the MB isoenzyme rel¬
eased per unit time is highly variable. This seems to
suggest that peak activity measurements are not a satisf¬
actory method of assessing infarct size as small peak values
might come from a big infarct with a slow but continuous
release of the enzyme. Therefore, provided low activities
of the MB isoenzyme can be measured more sensitively and there
is little local intercellular inactivation of the isoenzyme
prior to entering the circulation, the total amount of the
Isoenzyme released into the blood after the infarct may
well be a better measurement than total CK activity for
assessing infarct size, 'as suggested by Wagner et al. (1973)-
- 109 -
It should be noted that, even if an ideal enzyme com¬
pletely specific to heart and released only when the cell
dies were to be found, assessment of infarct size by means
of serum enzyme activity measurements can at best be only
semi-quantitative, as the kinetic parameters essential to
the calculation are very difficult to obtain accurately.
Parameters for the enzyme clearance rate, the extent of inter¬
cellular inactivation and the enzyme distribution volume could
vary widely between individuals as well as with the clinical
state. A better estimate of infarct size might, however,
be obtained if the enzyme data were to be* interpreted in
conjunction with changes in haemodynamic cardiac functions
(Mathey e_t al . , 197^).
The MB isoenzyme in the diagnosis of myocardial infarction.
Measurement of the activity of the MB isoenzyme can
detect myocardial infarction earlier, is more sensitive and
more specific for the myocardium, and possibly a more precise
indicator of infarct size than measurement of the MM iso¬
enzyme or total CK activity. The facts strongly suggest
that the MB isoenzyme is a better diagnostic enzyme for the
disease. Since it is present only in very small quantities
in normal serum and is usually not detectable by electro¬
phoresis, a qualitative assessment of the isoenzyme is
sufficient if a mere confirmation of myocardial infarction
is required. However, more valuable clinical information
is likely to be obtained if the isoenzyme can be assayed
quantitatively. With a sensitive assay technique, a small
rise of the MB isoenzyme could indicate a small infarct
- 1 10 -
*
which might otherwise escape attention, although proof of
this hypothesis is still lacking. Also serial quantita¬
tive measurements of the MB isoenzyme activity give a better
chance of detecting reinfarction than MM isoenzyme measure¬
ment, as the MB isoenzyme has a faster clearance rate. It
might also allow a more accurate assessment of infarct size.
Hence, it may be important to both short-term and long-term
management of the patients.
The major disadvantage of the MB isoenzyme is its short
half-life. Patients admitted 36 hours after an infarct
may no longer have detectable amounts of the isoenzyme in
their serum. The next disadvantage is technical. So far
there is still no simple and precise method of measuring
this isoenzyme. The present electrophoretic method is
far too cumbersome to be adopted routinely. To make full
use of the potential clinical value of this isoenzyme,
this technical obstacle has to be overcome.
Conelusion.
Of all the enzymes studied, cAST, mAST, cMD, mMD, GLDH,
USLD, MB isoenzyme of CK, MM isoenzyme of CK and total CK,
the MB isoenzyne of CK has been shown to be the most■sensitive
and specific enzyme test for myocardial infarction provided
the blood specimen is taken between 12-30 hours after the
onset of symptoms. It is the only enzyme in this study
that can reliably help to diagnose myocardial infarction
after surgery and trauma.
The quantitation of the MB isoenzyme in serum might
enable detection of small infarcts and the occurrence of
reinfarction. There are, however, technical problems
relating to its accurate assay. To search for a convenient
and accurate method of assaying the isoenzyme activity, a
better understanding of the biochemical properties of the MM
and MB isoenzymes is necessary. This will be the subject
of the following sections.
SECTION 5
BIOCHEMICAL STUDIES OF THE MM AND MB
ISOENZYMES OF CREATINE KINASE
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Most of the work on creatine kinase in the past was
done with either the MM or the BB isoenzymes, assuming the
hybrid form (MB) to have properties intermediate between
its parent forms. In most of these investigations the
enzymes were extracted from rabbit, chicken or ox tissues.
The human isoenzymes have so far been relatively little
studied. With the appreciation of the clinical value of
the MB isoenzyme in the diagnosis of myocardial infarction
(Section it was considered to be of importance to invest¬
igate the properties of this isoenzyme and to compare them
with those of the other isoenzyme (MM) in* the human myo¬
cardium. The present section aims to do this.
5-1 Purification of the cytoplasmic isoenzymes from
human heart tissue.
Introduc tion. Creatine kinase was first obtained in
crystalline form from rabbit muscle (Kuby e_t aT. , 195^)*
Subsequently, pure preparations of the MM isoenzyme have
been obtained from a wide variety of animal tissues - ox,
chicken, mouse, human and monkey. Purification of the
muscle MM isoenzyme usually presents little problem. It
is readily extractable at low ionic strength and may re¬
present as much as 10 - 20% (w/v) of the soluble sarco¬
plasmic protein of the muscle (Czok and Bucher , 1960;
Gosselin-Rey and Gerday, 1970)*
The purification of the BB isoenzyme from brain tissue
came later than that of the muscle enzyme (Wood, 1963;
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Keutel e_t aT . , 1968). The method involved is more complex
as the isoenzyme usually constitutes less than "\°/o of the
brain cytoplasmic protein (Keutel et aT . , 1968). Unlike
the MM isoenzyme, the BB isoenzyme requires thiol groups to
maintain it in a stable state.
Most of the purification procedures in the past took
advantage of the unusual stability of both isoenzymes in
2 +
ethanol. In the presence of the divalent cations Mg ,
Mn^+, Zn^+, the enzyme could often be fractionated sharply
from other proteins by ethanol. This procedure was then
followed by ammonium sulphate precipitation, column fraction
ation on phosphocellulose and DEAE cellulose, and finally by
crystallisation of the enzyme.
In the present purification, the main concern was to
separate the two cytoplasmic isoenzymes (MM and MB) from
each other; so the following simplified procedure was
adopted.
Purification procedure. Unless stated otherwise the whole
procedure was carried out at ^°C.
1. Homogenisation. The fat was trimmed from normal human
heart tissue obtained at autopsy within 2k hours of death.
The tissue (18 g) was cut into small pieces with scissors,
suspended in 80 ml 0.25 mol/l sucrose solution at pH 8.0
containing 10 mmol/l KC1 , 1 mmol/l ^8-mercaptoethanol and
1 mmol/l EDTA, and homogenised in a hand-driven glass homo-
geniser. During homogenisation the pH was maintained at
8.0 with NaOH. The homogenate was filtered through four
layers of cheese cloth.
2. Centrifugation. The filtered homogenate was spun in
an ultracentrifuge (MSE Superspeed 50) for one hour at
90 000 g to remove the particulate material.
3. Ammonium sulphate precipitation. After centrifugation,
solid ammonium sulphate was added to the supernatant to give
kO°/o saturation, the pH being adjusted to 8.0. After
spinning, the precipitate was discarded and ammonium
sulphate was added to the supernatant to give 75°/° saturation.
The precipitate from this step was redissolved in 25 mmol/l
tris/HCl pH 8.0 containing 1 mmol/l EDTA and 1 mmol/l
^5-merc ap toe thano 1 .
k. Dialysis. The solution was dialysed against the above
buffer for 2k hours with two changes of buffer.
5. DEAE cellulose column fractionation. About 120 g DEAE
cellulose (Whatman microgranular, preswollen DE 52) was
suspended in 100 mmol/l tris/HCl pH 8.0 containing 1 mmol/l
^-mercaptoethanol and 1 mmol/l EDTA. Fines were removed,
the suspension was degassed and the pH was then adjusted to
8.0. The slurry was packed into a column (14 cm x 5 cm)
and then equilibrated with 25 mmol/l tris/HCl pH 8,0 (con¬
taining 1 mmol/l p-mercaptoethano1 and 1 mmol/l EDTA) by
eluting with the buffer until the conductivity and pH of the
eluate were the same as the starting buffer.
The dialysed heart extract was then fed into the column
by gravity and eluted with the starting buffer. The absorb-
ance of the eluate was monitored at 258 nm using an LKB
Uvicord (No. ^7CHA); fractions were collected on an LKB
UltroRac fraction collector (No. 7000). When no more peaks
were observed on the UV-recorder, elution by a linear ionic
gradient was started. The gradient was formed by two
cylindrical flasks, one containing 500 ml 25 mmol/l tris/HCl
pH 8.0 with 1 mmol/l ^-merc.aptoethanol and 1 mmol/l EDTA;
the other contained 500 ml of the buffer with 0.5 mol/l NaCl.
Elution was stopped when all the MB isoenzyme was eluted
(Fig. 5-1).
The protein concentration of the solution at each
purification step was determined by the biuret method (Gornall
et al., 19^9) with the exception of the column eluates which
were measured by absorbance at 280 nm (Warburg and Christian,
1941). Creatine kinase activity was assayed by the method
of Rosalki (1967)•
Figure 5-2a and b, and Table 5-1 show the results of
the purification. The specific activity of the MM isoenzyme
showed an overall increase of 94 times with a total activity
of 68 000 IU/l; that of the MB isoenzyme was increased 76
times with a total activity of 15 000 IU/l.
Figure 5-1 shows a third peak of about 1 . 6°/o of the
total creatine kinase activity, occurring mid-way between
the MM and MB isoenzyme peaks. Following electrophoresis
on a 7°/o polyacrylamide gel, this enzyme showed the same anodal
mobility as the MM isoenzyme peak. It was considered that
this small peak of creatine kinase might come either from
the small amount of the MM isoenzyme not eluted with the first
peak or from cellular particles (probably mitochondria)
ruptured during initial homogenisation.
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Purification of the MM and MB Isoenzymes of Creatine Kinase
a. Electrophoresis of Virious Stages of Purification in 7% Polyacrylamide
Gel Slab: Stained for Protein with Amido Black
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b. Electrophoresis of Various Stages of Purification in 7% Polyacrylamide
Gel Slab: Stained for CK Isoenzymes
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All the following studies were done with the iso¬
enzymes obtained from the first and the last peaks in the
column elution, identified electrophoretically as the MM
and MB isoenzymes respectively.
Tests for purity. The proportion of MB isoenzyme activity
to total activity at various stages of purification was
measured by electrophoresis on 7°/° polyacrylamide gel slabs
followed by staining and densitometric scanning (Section 6).
Undiluted samples were used for the final column eluates.
The percentages of the MB isoenzyme were found to be 30°/o,
3h°/o and 2k°/o in the original homogenate, centrifuge-super¬
natant and dialysed extract respectively. For the column
eluates containing the partially purified isoenzymes, no
activity due to the other isoenzyme was observed in the
polyacrylamide gel slab when samples of the MM and MB
extracts with activities as high as 6800 and 5500IU/1 res¬
pectively were applied. Thus, each of the two partially
purified isoenzyme preparations was practically free from
contamination by the other. The polyacrylamide gel method
was capable of demonstrating creatine kinase activity as low
as 5 IU/l (Section 6). This implied that the cross-
contamination of each isoenzyme was less than 1 in 1100.
The activities of adenylate kinase and Mg-activated
ATPase, which might have interfered with the assay technique
and gel-staining procedure, were measured in the final
extracts of both isoenzymes. The adenylate kinase activity
was measured at its optimal pH (7-5) with reagents the same
as those in the methods of Rosalki (1967)} and Hughes (1962)
but omitting creatine phosphate. The ATPase activity was
determined by the methods of Tanzer and Gilvarg (1959) and
Kuby (Kuby ejt a_l^. , 195*0 i-n the absence of creatine at pH
7.0 and 9-0. In all cases, undiluted enzyme extracts
were used. No activity of adenylate kinase or Mg-activated
ATPase was detected in either isoenzyme extract. Activities
(assayed by methods described in Section 2) of aspartate
aminotransferase (5100 IU/l) and malate dehydrogenase
(6000 IU/l) were, however, found in the MM isoenzyme pre¬
paration .
Stability of the isoenzyme preparations. The MM and MB
isoenzyme extracts were stored separately in brown bottles
at ^°C. The MM isoenzyme extract was stored in 25 mmol/l
tris/HCl at pH 8.0 containing 1 mmol/l ^-mercaptoethanol and
1 mmol/l EDTA; the MB extract was stored in an identical
solution apart from the presence of NaCl (about 0.2 mmol/l).
During the period cf study both the activity and the electro-
phoretic pattern of the extracts were checked about once
every four weeks. No significant change in activity was
observed and the electrophoretic pattern remained constant
throughout the study.
5-2 Physical properties of the isoenzymes.
Dawson e_t al_. (1967) compared the molecular weight of
the rabbit muscle (MM) and brain (BB) isoenzyme by gel-
filtration and sedimentation studies, and showed that both
forms had approximately the same molecular weight of around
80 000. Molecular weight determinations of the enzyme
subunits indicated that these were half those of the intact
molecule (Yue e_t al_. , 1968). The molecular weights of
purified creatine kinases from various species including
humans were also reported to be within the range 78 500 -
85 100 by Watts (1973). Thus, it is fairly certain that
the human MM and MB forms have similar molecular weights of
about 80 000.
5-2-1 Electrophoretic behaviour.
Since the brain type subunit (b) contains significantly
fewer basic amino acids than the muscle type (m) (Eppenberger
et al., 1967), the mb isoenzyme has, as expected, a greater
anodal electrophoretic mobility than the mm isoenzyme.
The electrophorectic pattern of the MM and MB iso¬
enzymes was studied at pH 8.0 in three different media:
a. "l°/o polyacrylamide gel slab, b. agarose gel and c.
cellulose acetate. The enzyme activity was demonstrated
by NBT staining in a and c, and NADPH fluorescence in b.
(see Section 6 for methods).
On agarose gel and cellulose acetate both the MM and
MB isoenzymes migrated as single units, the MM isoenzyme
remaining close to the origin and the MB isoenzyme being
more anodic (Figs. 5-3 and ^>-kh) . However, in 7°!° poly¬
acrylamide gel the MM isoenzyme appeared as three bands
near the origin (about the position of K-globulin) and the
„MB isoenzyme as two bands midway between the ^-globulin and
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the albumin bands. The same pattern was also seen in sera
with elevated creatine kinase activity (Fig. ^-ba).
The explanation for the MM and MB isoenzymes splitting
into sub-bands on polyacrylamide gel electrophoresis is not
certain. Several explanations are possible:
1. Partial oxidation of the isoenzymes by the ammonium
persulphate used to polymerise the gel may have occurred;
*
this is unlikely, however, as the gel has undergone a b$-
60 min pre-run during which the small amount of persulphate
in the gel would probably be removed.
»
2. The isoenzyme molecules may have been degraded into
different forms during purification. This is also unlikely
since the same sub-band pattern was found in serum creatine
kinase.
3. The sub-bands might represent different conformational
forms of the isoenzymes. If so, however, the MB isoenzyme
might have been expected to show more sub-forms than the MM
as the B subunit is less compact and hence more likely to
assume different conformations.
b. The sub-bands might represent genuine isoenzyme hetero¬
geneity. The fact that this was observed only in poly¬
acrylamide gel could be ascribed to the better resolving
power of this medium than either agarose or cellulose
acetate. The observed patterns of sub-bands (3 for the MM
and 2 for the MB isoenzyme) is compatible with the presence
of two "M" type subunits, M and M', giving rise to MM, MM',
M'M', MB and M'B.











































Electrophoresis of The MM and MB Isoenzymes of
Creatine Kinase
a. Ch 1% Polyacrylamide Gel Slab (Using Serum Samples)
Sample 1 2 3 4- 1' 2' 3'
' f" = 2*4 fold dilution respectively
b. On Celluose Acetate (Using Purified Enzyme Extracts)
OS S
<5- 2 ®
2 Ail of the mixture solution of purified MM and MB isoenzymes was
applied onto the cellulose acetate strip. Electrophoresis was performed
for 45 min in 50 mmol/1 veronal buffer pH 8.5. The isoenzyme
activities were demonstrated by incubating the strip with a layer of
substrate solution containing the necessary coupling enzymes in a
manner similar to that, in the polyacrylamide gel method (see text).
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5-2-2 Dissociation of subunits.
If the MB isoenzyme subunits are separated and
allowed to recombine, three forms of isoenzyme - MM, MB
and BB, should result, their relative proportions being
dependent on the thermodynamic stability of the different
subunit associations. If the MM isoenzyme is subjected to
the same treatment only one form of isoenzyme (MM) is to be
expected. The usual means of subunit dissociation are by
treatment with urea, guanidine hyrochloride, low pH or
repeated freezing and thawing under appropriate conditions.
*
The following procedure was carried out at k°C. 60 IU
of MM isoenzyme and 12 IU MB isoenzyme were separately
treated with i) 8 moi/i urea and ii) 6.5 mol/l guanidine
hydrochloride solutions containing 25 mmol/l tris/HCl pH
7.7 and 0.1 mol/l |9-mercaptoethanol. After mixing, the
solutions were immediately transferred to dialysis tubes
(Visking 8/32) and dialysed against 25 mmol/l tris/HCl
containing 0.1 mol/l ^-mercaptoethanol for ^8 hours.
Control experiments, in which the urea and guanidine hydro¬
chloride were omitted, were also performed. After dialysis,
agarose gel electrophoresis of the dialysed solutions was
followed by demonstration of enzyme activity by NADPH fluor¬
escence (Section 6).
The results for the guanidine hydrochloride and urea
treated enzyme preparations were the same. Four bands
were observed in the treated MB isoenzyme solutions, corres¬
ponding to the MM, MB, BB isoenzymes and a weak cationic
-"'band. This may be taken as confirmation that the isoenzyme
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isolated in this preparation is the hybrid MB type. In
the treated MM isoenzyme solutions, one strong MM and one
weak cationic band were detected. The weak cationic band
was absent in both MM and MB controls (Fig. 5-3 )•
The reactivation of the isoenzymes on dialysis after
urea or guanidine hydrochloride treatment was very dependent
on experimental conditions. Initial experiments showed
that reactivation did not occur if i) 0.1 mol/l y3-mercapto-
ethanol was absent from the dialysing buffer, ii) the incub¬
ation mixture was left standing for 30 min at 4°C before
dialysis, iii) the isoenzyme preparations were of low
activity (about 3 IU) or iv) the procedure was carried out
at room temperature (about 22°C).
The nature of the extra cationic band obtained after
treatment is uncertain. It may be a result of partial
degradation of the M subunit by the dissociating reagents
or it may be a reflection of the heterogeniety of the M
subunit.
5-2-3 Inactivation by heat.
The effect of heat on enzyme activity is two-fold.
It affects i) the structure of the enzyme molecule, and ii)
the kinetics of the enzyme reaction. The present subsection
deals with the first effect.
The inactivation of enzymes by heat is nearly always
due to the denaturation of the enzyme protein. The rate
"of the inactivation is dependent on a variety of factors
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including the temperature, pH, ionic strength and protein
(Dncentration of the solution. It may also be affected by
the presence of substrates, inhibitors or other substances
which may stabilise the enzyme molecule. In some cases
the denaturation of enzyme by heat may be partially
reversible on cooling, there being some recovery of enzyme
activity.
The stability of creatine kinase isoenzymes towards
temperature was studied by i) comparing the inactivation of
the isoenzymes at different temperatures, ii) measuring the
»
rate of inactivation at a fixed temperature, and iii)
studying the effects of substrates and other substances on
the stability of the two isoenzymes.
Procedure and Results.
Creatine kinase activity was measured by the Rosalki
(1967) method. In all cases the total volume of the enzyme
solution for heat treatment was 1.0 ml contained in plastic
cuvettes (1 cm internal diameter; 1 mm wall thickness).
The enzyme solution contained 2 g protein/ 1 (adjusted
with pure bovine albumin) in 100 mmol/l tris/HCl pH 7-9
(50°C). The precision of the temperature control in the
water bath used in these experiments was - 0.1°C.
1. Heat inactivation at different temperatures.
The isoenzyme solutions were incubated between 40°
and 70°C for 15 min. At the end of the incubation 25 ^il
aliquots were pipetted from the incubating tubes into the
assay solutions. Their activities were measured within
„„30 min after the incubation.
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Inactivation became detectable above 38°C for the MB
isoenzyme and above ^3°C for the MM isoenzyme. Above 60°C
there was complete inactivation of both isoenzymes (Fig. 5-5) •
The pH of the incubation solutions was found to vary
from pH 7.7 at 60°C to pH 8.3 at 40°C. Although both iso¬
enzymes were stable within this pH range at 37°C, the
observed differences in heat inactivation might be partly
due to this indirect effect of variation in pH.
2. Rate of inactivation at 50°C.
The rates of inactivation of four isoenzyme preparations
»
were studied:- i) 100$ MM, ii) 50$ MM + 50$ MB, iii) 25$ MM
+ 75$ MB and iv) 100$ MB. The logarithm of the percentage
of residual activity was plotted against the incubation
time and half-lives (T^) for the isoenzymes were calculated.
2
The purified isoenzymes showed a single component
logarithmic inactivation rate, whereas the isoenzyme mixtures
showed two component inactivation curves, one component
corresponding to each of the isoenzymes (Fig. 5-6). The
Tjl life was 27 min for the MM and 5 min for the MB iso-
2
enzymes.
3. Effects of substrates and other substances at 50°C.
The substrates in concentrations equal to their K
m
values (Section 5-3-2) were incubated with the isoenzyme
solutions in 100 mmol/l tris/HCl pH 7*9 at 50°C. Samples
were removed at various intervals and analysed for activity.
The Tj_ values were calculated as in 2. In addition to the
2
enzyme substrates, the effects of |?-mercaptoethanol (5 mmol/l),
Figure 5-5
Heat Inactivation of Creatine Kinase Isoenzymes
Each isoenzyme was incubated at the given temperature for 15 min„
Figure 5-6




bovine albumin (2 g/ l), magnesium ions (2 mmol/l), ABP
(0.25 mmol/l for MB; 0.5 mmol/l for MM isoenzyme) and ATP
(1.0 mmol/l) were studied.
- 2- h -
|8-mercaptoethanol , albumin, MgADP , MgATP and ATP
protected the MM isoenzyme from heat denaturation, but they
3_
were without effect on the MB isoenzyme. ADP , creatine
and creatine phosphate did not protect either isoenzyme.
2+
Free Mg ions caused both isoenzymes to be inactivated
more rapidly (Table 5-2).
Summary. In no case was reactivation of the isoenzyme on
»
cooling observed, at least in the first hour after heat
treatment. All the results in 1, 2 and 3 show that the
MB isoenzyme is more heat labile than the MM isoenzyme.
It has a shorter half-life at 50°C, is inactivated at a
lower temperature and is less protected by substrates.
5-2-k Effect of urea.
The inactivation of enzymes by urea is probably the
result of protein denaturation causedby breakage of hydrogen
bonds, although the exact mechanism is complex. It is us¬
ually impossible to define the initial and final states of
the denaturation and studies on enzyme inactivation by urea
tend to be empirical, subject to the effects of numerous
fac tors.
Procedure. The enzyme activity was measured by the Rosalki
(1967) method using a commercial reagent kit obtained from
"Boehringer Corporation, .England.
Table 5-2
Effects of Various Substances on the Heat Stability of Creatine












*ADP (0.25 mmolA for
MB; 0.5 mmolA MM)
*ATP (1.0 mmolA)
^ADP + Mg ([Mg2+]/ [ADP]
= 5)
A+ATP + Mg([ Mg2f /[ATP]
= 2)





















3- 4-* At pH 7.9 ADP and ATP existed mainly as ADP and ATP respectively.
+ At pH 9 the main ionic species for ADP and ATP were MgADP and
MgATP" respectively.
k
The concentrations of all the enzyme substrates were equal to their
respective K values,
m
The incubation mixture contained 20 mmol/l tris/HCl
pH 7.5 100 mmol/l ^-mercaptoethanol, 0.8 g protein/ 1
(adjusted with bovine albumin) and urea at various con¬
centrations (2 mol/l, 5 mol/l and 8 mol/l). Suitable
amounts of pux^ified extracts of the MM and MB isoenzymes
were mixed with the incubation solution to a final activity
in the absence of inhibitor of about J00 IU/l. The incuba¬
tions were at ^°C, incubation in 8 mol/l urea was also at
25°C. 25 ^11 samples were removed at timed intervals and
creatine kinase activity measured immediately.
The possible effect of reactivation Sue to dilution
in the assay medium was also investigated. After the
enzyme had been incubated with urea for 90 min, 25 Al
samples of the mixture were delivered into the assay solut¬
ions and left standing at 37°C for various intervals. At
the end of each interval, substrate was added and the enzyme
activity measured.
The effect of urea in the assay solution on the iso¬
enzyme activities was also studied between 0-1 .6 mol/l urea.
The assay solution was pre-incubated for 2 hours at 25°C
and 15 min at 37°C before the activity was measured.
Results. The results are shown in Fig. 5-7• There was
little inactivation in 2 mol/l and 5 mol/l urea although the
MB seemed to be more affected than the MM isoenzyme in
both cases. In 8 mol/l urea both isoenzymes were inactive
ated, the MB isoenzyme (T-j = 2 min) much more rapidly than
2"









































The rate of inac tivat ion was temperature dependent
(Fig. 5-8). The Tjl life values of both isoenzymes at 25°C
2
were too short to be measured accurately. The logarithmic
plot (F ig. 5-8) shows that.the decay curves of both iso¬
enzymes are non-linear suggesting a complex non-first-
order inactivation.
For all three concentrations of urea, no reactivation
of either isoenzyme was found within 2 hours after urea
incubation. This suggests that urea in the stated experi¬
mental conditions not only dissociates the subunits of the
»
isoenzyme (which might be expected to re-associate when the
urea is greatly diluted - Section 5-2-2), but also affects
the tertiary (and possibly secondary) structures of the
protein subunits.
Urea in the assay solution inhibited both isoenzymes
to a similar extent; half-activity concentrations were
0.63 mol/l for the MM and O.69 mol/l for the MB isoenzymes .
5-2-5 Inactivation by thiol-reacting reagents.
Earlier inhibition studies showed that creatine kinase
contains thiol groups (Bailey and Perry, 19^7). By
studying the reaction with iodoacetate and 2-^-dinitro-1-
flourobenzene Mahowald _e_t aT. (1962) identified two active
cysteine thiol groups in the molecule. Of these two thiol
groups, one was found to be present in each of the catalytic
sites on the enzyme (Watts e_t aT . , 1962). The amino acid
-ffequence associated with.-these "essential" thiol groups was
Figure 5-8
Urea Inactivation of the Isoenzymes of Creatine Kinase at
Different Temperatures
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found to be very similar in both the muscle type and the
brain type subunits.
1. Xodoacetamide.
Iodoacetamide is thought to inactivate thio1-containing
enzymes by alkylating the thiol groups. However, the in-
activation is often complicated by side reactions and sec¬
ondary effects of alkylation.
E-SH + ICH2C0NH2 . E-CH2C0NH2 + HI
In studies on the alkylation of creatine kinase, iodoa-
cetamide is usually preferred to iodoacetp.te because, while
inactivation by both reagents is unaffected by pH variations
from 6-9 (Rabin and Watts, 1960), inactivation by iodoa-
cetamide (but not iodoacetate) is unaffected by changes in
the ionic strength of the medium (Watts and Rabin, 1962).
2. Oxidised glutathione (GSSG).
This disulphide may serve as an oxidant of the enzyme's
thiol groups. The extent of the reaction depends on the
redox potential difference between glutathione (E^ at pH 7.0
= -0.23 volts) and the enzyme's thiol group involved.
SH SH
/ /








E + GSSG fi E =2 GSH oxidation
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For enzymes with more than one reactive thiol group, both
inter- and intra-moiecular oxidations are theoretically
possible. In practice, however, intra-molecular oxidation
is less common, as its occurrence depends on the mutual
accessibility of the two thiol groups and their steric
orientation.
Disulphide oxidation usually occurs slowly but the
rate may be increased by raising the temperature and con¬
centration of GSSG (Hopkins et al. 1938). Increase in pH
to about 9.0 favours the oxidation of the enzyme's thiol
_ »
groups, presumably the -S form reacts more readily.
3. p-Hydroxymercuribenzoate (pHMB).
This is a very reactive thiol reagent. The pHMB
OOC-^ ^-Hg+ ion reacts with thiol groups forming
mercaptides:-
E-SH + OOC^Hg* ;± E-S-Hg-^ Vc00~
Procedure and Results.
1. In all experiments creatine kinase activity was measured
by the Rosalki method (1967). A sample of the isoenzyme
preparation, equivalent to 700 IU/l in the incubation
mixture, was incubated with the respective thiol-reacting
reagent solution which contained a total protein concentra¬
tion of 0.8 g/l obtained by adding bovine albumin. The
activity of this incubation mixture was assayed at timed
intervals by removing 25 /ul portions. Controls were per¬
formed omitting the thiol-reacting reagents.
The incubation mixture in each case contained i) 1 mmol/l
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iodoacetamide in 2.0 mmol/l tris/HCl buffer pH 7.0 at
O - 1°C, ii) 10 mmol/l oxidised glutathione in 2.0 mmol/l
tris/HCl pH 9.0 at 20°C, and iii) 1 mmol/l pHMB in 30
mmol/l tris/HCl pH 8.0 at 2 - 3°C.
The logarithm of the percentage residual activity was
plotted against the incubation time. The MM and MB iso¬
enzymes were each affected by iodoacetamide to a similar
extent (Fig. 5~9a). Oxidised glutathione did not cause
significant inactivation of either isoenzyme (Fig. 5~9b)
over a period of 100 min. Both the MM and MB isoenzymes
were inactivated by pHMB, the MM (T_l 8 min) more rapidly
2
than the MB isoenzyme (Tj_ 60 min) (Fig. 5~9c). The half-
2
lives of the two isoenzymes in the presence of these thiol
reagents are listed in Table 5-3.
1. The inhibitory effects of the thiol reagents in the
reaction mixture were also studied. The concentrations
used were 0-^00 mmol/l iodoacetamide, 0-8.0 mmol/l GSSG and
0-6.0 mmol/l pHMB. They were separately pre-incubated in
the reaction mixture for 2 hours at 25°C and 15 min at 37°C
before activity was measured using the method of Tanzer and
Gilvarg (1959)•
Iodoacetamide, GSSG and pHMB were all found to be
inhibitory (Table 5-^)« There were no significant differ¬
ences between the isoenzymes.
3. Since the greatest difference between the two isoenzymes
was found in the inactivation by pHMB, the action of pHMB
was chosen for study in more detail. The Rosalki method
-*(1967) was used for all activity measurements.
Figure 5-9
Inactivation of Creatine Kinase Isoenzymes by Thiol-reacting
Reagents
a. Iodoacetamide ( 1 mmol/1)
Inhibition by 4roM-lodoacetamide at CT-fC
* Figure 5-9
Inactivation of Creatine Kinase Isoenzymes by Thiol-reacting
Reagents









Inactivation of Creatine Kinase Isoenzymes by Thiol-reacting
Reagents
c. p-hydroxymercuribenzoate (pHMB) ( 14 mmol/1)
Inactivation by 14mm HMB at 2°-3°C
Table 5-3
Inactivation of the MM and MB Isoenzymes by Thiol-reacting Reagents




(1 mmol/1) 7.0 0°- 1° 22 17
Oxidised
• Glutathione
(10 mmol/1) 9.0 25 Very Slow Inactivation
p-hydroxy-
mercuri-
benzoate (14mmol/l) 8.0 2°- 3° 60 8
The enzyme activity was measured in the backward reaction by the Rosalki
method (1967).
Table 5-4
Inhibition of Activity of Creatine Kinase Isoenzymes
Inhibit ors Concentration for Half-activity Inhibition
MM Isoenzyme MB Isoenzyme
Oxidised
Glutathione 3.25 mmol/1 4.85 mmol/1
Iodoacetamide 148 /imol/1 133 jimol/l
p-hydroxy-
mercuri-
benzoate 2.4 mmol/1 2.6 mmol/1
The enzyme activity was measured in the ofrward reaction by the method
of Tanzer and Gilvarg (1959) with inhibitors in the assay solution containing
5" ihmol/1 /3-mercaptoethanol. *
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i) Effect of pHMB concentration. The inactivation was
carried out over a range of pHMB concentrations (0-20 mmol/l)
under the same conditions as in 1. Activity was determined
after 90 min incubation.
The MM isoenzyme was more readily inactivated by pHMB
than was the MB isoenzyme. The maximal difference occurred
in 14-15 mmol/l pHMB (Fig. 5-10a).
ii) Effect of pH. The isoenzymes were incubated in the
range pH 7^4 to pH 9-0 with 14 mmol/l pHMB for 90 min, all
other experimental conditions being the same as above.
»
Variation of pH did not affect the pattern of inactiva¬
tion of the MM isoenzyme; in contrast the MB isoenzyme
showed least inactivation at pH 8.0-8.5 (Fig. 5-^0b).
iii) Effect of tris/HCl concentration. Keeping the pH
at 8.0, pHMB at 14 mmol/l and the incubation period at
90 min, the concentration of tris (added as tris/HCl buffer)
was varied from 20 mmol/l to 100 mmol/l. A control experi¬
ment was performed with a similar increase of chloride
concentration, added as sodium chloride.
The difference between the rates of inactivation of the
two isoenzymes was critically dependent on the concentration
of tris/HCl (Fig. 5-1Oc). The control experiment with
chloride ion showed that the effect observed was due to
variation in tris concentration.
iv) Buffer types. The isoenzymes were incubated for 90
min with three other types of buffer, 30 mmol/l potassium
^phosphate, 30 mmol/l triethanolamine and 30 mmol/l veronal,
Figure 5-10
Inactivation of the MM and MB Isoenzymes of Creatine Kinase
by p-hydroxymercuribenzoaie
Effect of Hydroxymercuribenzoate concentration on
inactivation of CK isoenzymes





















Inactivation of the MM and MB Isoenzymes of Creatine Kinase
by p-hydroxymercuribenzoate
c.
Effect of Tris/HGl concentration on inactivation of CK by HMB
(35mmol/l)





















all at pH 8.0, in the presence of 1U mmol/l pHMB.
The rate of inactivation of both isoenzymes was found
to vary with the nature of the buffer. In veronal buffer
little inactivation of either isoenzyme was observed, but
in phosphate and triethanolamine buffers both isoenzymes
were inactivated (Table 5-5)•
v) Effect of albumin. The total protein concentration in
the incubation mixture was varied from 0-k g/l, with 1k mmol/l
pHMB in 30 mmol/l tris/HCl pH 8.0. Activity was determined
after 90 min incubation at 2°- 3°C.
»
Bovine albumin had no significant protective effect on
either isoenzyme up to k g/l.
vi) Reactivation in the assay solution. Since the assay
solution contained 9 mmol/l GSH and the pHMB was diluted
kk times in it, reactivation of the isoenzymes in the assay
solution was likely. It was studied by delivering aliquots
of the incubation mixture after 90 min incubation into a
series of assay solutions which were then incubated at 37°C.
The activity was measured at regular intervals.
Both isoenzymes were rapidly reactivated in the assay
solution. They recovered 65°/° of their original activity
in about 15 min (Fig 5-1Od).
Discussion.
The inactivation and inhibition of enzymes by thiol-
reacting reagents are known to be complex. The rate of
inactivation depends on a large number of variables which






























































concentrations of protein, enzyme and the thiol-reacting
reagent, side reactions and the presence of protective
reagents (e.g. enzyme substrates, cofactors and thiols).
It is, therefore, unlikely.that any simple conclusions can
be drawn concerning the mode of action of the thiol-reacting
reagents from these studies on the isoenzymes. Moreover,
only partially purified enzymes were used. The value of
the present results, therefore, is essentially comparative.
The more detailed study of the pHMB inactivation reveals
the complexity of the above effects since the rate and extent
ft
of inactivation are influenced by the nature and concentra¬
tion of the buffer as well as the concentration of pHMB.
This, together with the high concentration of pHMB needed,
makes it likely that side reactions other than with the
enzyme thiol groups might have been involved. The rever¬
sible nature of the pHMB inactivation suggests that the
mercaptide complex (if this is the complex formed) is not
a tight one, and no permanent change in the enzyme site has
occurred. The extent of the reactivation is determined by
the duration and concentration of the thiol compounds in
the enzyme assay solution.
Figure 5-9 and Table 5-^ show that a much higher
concentration of pHMB than iodoacetamide was needed to
produce the same degree of inhibition and inactivation, yet
pHMB is known to be one of the most reactive thiol-reacting
reagents. This might be due to the smaller size and the
electric neutrality of the iodoacetamide molecule.
-<—!•>* In the inhibition studies, 5 mmol/l ^-mercaptoethanol
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*
was present in the assay solution for the activation of the
creatine kinase isoenzymes. It reacted with the thiol
reagents and reduced their effective concentrations. So
the observed concentration causing inhibition to half the
original activity are suitable only for comparing the two
isoenzymes.
Conelusion.
In the same experimental conditions, the MM and MB
isoenzymes behave similarly towards iodoacetamide and oxid-
»
ised glutathione, but differently towards pHMB. Their
greatest difference in inactivation by pHMB was achieved at
14 mmol/l pHMB in 30 mmol/l .tris/HCl pH 8.0 after 60 - 70
min incubation at 2 - 3°C.
5-3 Enzymatic properties of the isoenzymes.
5-3-1 Effect of magnesium ions.
2+ 2+ 2 +
Many bivalent cations, for example Mg , Mn , Ca
2+
and Co , have been found to activate muscle creatine kinase
(MM), while others like Ba^+, Sr~+, Ni^+, Cr^+, Cd""+ and
2 +
Zn are either inactive or inhibitory (o1Sullivan and
2 +
Morrison, 1963). Only Mg has been studied in this
investigation.
Magnesium ions are the "natural" activators of the
~-*great majority of enzymes that act on phosphorylated
- 13^ -
substrates, the kinases and synthetases. A plot of reaction
velocity against concentration of the added cation is comm¬
only a rectangular hyperbola similar to the curve of sub¬
strate concentration plotted against velocity, from which
the "K " of the cation can be obtained. The interpretation
m
of such curves is not simple. The cation may activate by
combining with the enzyme, with either of the substrates,
or by a number of indirect means such as changing the
equilibrium position of the reaction and removing inhibitors
present in the reaction mixture. For creatine kinase it
2+
has been confirmed that Mg activates by* combining with
the adenine nucleotide substrates. It has also been shown
2-
that only the ionic species MgADP and MgATP are the real
nucleotide substrates (Nihei e_t al. , 1961 ; Noda ejt a_l. ,
1960).
2+
The reaction of Mg with the adenine nucleotides can















PKal " PKa2 = 6-9



























PKal = 3 pKa2 =6.65





K = acid dissociation constants
an
2+
= stability constants of Mg -nucleotide complexes
From these equilibria it can be seen that the concen¬
trations of the real substrates are dependent on 1) the rel¬
ative magnitudes of the K and K values, 2) the amount ofn7
2+
Mg present and 3) the pH of the medium.
For ATP at pH 9*0 at which the forward reaction of
k-
creatine kinase was measured, the concentration of ATP is
10 + 3 = 102*1 times greater than HATP3 . H2ATP is
negligible at this pH. This ratio is made even smaller
2+
when Mg is present in excess as K » K . Under these
J
3-
conditions the existence of MgHATP and HATP is negligible,
2-
and MgATP concentration can be taken as that of the total
ATP.
For ADP at pH J.O about 70 - 85^0 of total ADP exists
3- 2- -
as ADP , and the rest as HADP , H2ADP being negligible
at this pH. The value of K2 at pH 7-0 is less well
documented than , but it is thought to be much smaller
than (Nihei e_t al. , (1961) neglected K2 in their
- 136 -
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calculation of MgADP concentration). Thus, the equili¬
brium can still be made to shift overwhelmingly in favour
2+
of MgADP formation by adding sufficient Mg , and in this
circumstance the MgADP concentration approaches that of
the total ADP.
2-
The calculation,of concentrations of MgATP and
MgADP from equilibrium constants is difficult because the
accuracy of such calculations depends entirely on the pre¬
cision of these constants. Unfortunately the values for
the constants vary considerably with experimental conditions
(O1Sullivan and Perry, 196^). Moreover,the kinetics of
2+ 2+
Mg binding is further complicated by the facts that Mg
also, to a smaller extent, combines with OH and creatine
phosphate (Morrison and James, 1965)> and that Na+ and K+
with the adenine nucleotides (Melchion 195^)*
Proc edure.
Activity in the forward reaction was measured by the
method of Tanzer and Gilvarg (1959)> and the backward by
the colorimetric method of Hughes (1962).
2+
The effect of a range of Mg concentrations (0-9
mmol/l), added as magnesium acetate, on the reaction
velocity was studied at a fixed concentration of the
nucleotide substrate. A family of curves was obtained at
different concentrations of the nucleotide. The concentra¬
tions of creatine in the forward reaction and creatine
phosphate in the backward reaction were kept constant
throughout at 20 mmol/l and 10 mmol/l respectively.
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2+
The effect of Mg on the activity of the backward
reaction was also studied in the presence of varying con¬
centrations of creatine phosphate with the ADP concentra¬
tion kept at 2 mmol/l.
Re su11 s .
In all studies similar results were obtained for the
MM and MB isoenzymes.
2+
All the Mg concentration-velocity curves with
varying concentrations of either nucleotide substrate
(ATP or ADP) crossed each other, showing ^that at a fixed
2+
concentration of Mg the reaction velocity was not directly
proportional to the nucleotide concentration (Figs. 5-1 1&
2+
and b). This suggests that the Mg binds with the nuc¬
leotide to form a real substrate complex rather than binding
directly with the enzyme (Gutfreund, 1972). Inhibition
2+
by excess Mg was evident in the forward reaction in the
2+
range of Mg concentrations studied (Fig. 5-11a).
2+
The Mg coneentration-velocity curves with varying
concentrations of creatine phosphate did not, however,
2+
cross each other, suggesting that Mg did not react with
creatine phosphate to bind with the enzyme (Fig. 5-11c),
2+
although an inactive complex of Mg with creatine
phosphate has been shown to exist.
By replotting the velocity data with nucleotide
2-f-
substrates the optimal Mg /nucleotide ratio was found to
be 2 for the forward reaction and to lie between 5 and 10
for the backward reactions (Fig. 5~l2a and b).
Figure 5-11
2+
Effect of Mg on the Activity of Creatine Kinase with Varying
Concentrations of Adenine Nucleotide




b. Backward Reaction with MM Isoenzyme
700f
6 8 10
I Mg * ] mmol /1
[Creatine phosphate] was kept constant at 10 mmol/l;
o [ADP] 0.5 mmol/l; □ [ADP] 1.0 mmol/l;
A [ADP] 2.0 mmol/l.
[Creatine] was kept











c. Effect of Mg on the Activity of Creatine Kinase with
Varying Concentrations of Creatine Phosphate
0 2 A 6 8 10
[ Mg * ] mmot / I
[ADP] was kept at 2 mmol/1; a [Creatine phosphate] 1.25 mmol/1;
O [Creatine phosphate] 2.50 mmol/1; □ [Creatine phosphate]
10 mmol/1.
Figure 5-12
Effect of [Mg^j/ [Adenine Nucleotide] on the Activity of
. .. ..... . . Creatine Kinase.
Activity IU/l
a. Forward Reaction with MM
Isoenzyme
12. ? 14 16
[Mg ] / [ATP]
b [ATP] 0.5 mmol/I; o [ATP] 0.75 mmol/1; A [ATP] 1.5 mmol/1





b. Backward Reaction with MB
Isoenzyme
A [ADP] 0.5 mmol/1;
• [ADP] 2.0 mmol/1.
[Mg^] / [ADP]
□ [ADP] 1.0 mmol/1;
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Therefore, in all kinetic studies on creatine kinase
described in this thesis, Mg^+ was present in the experi-
2+
mentally determined optimal Mg /nucleotide ratio, and
2
the assumption was made that the coneentration of the Mg
2— —
-nucleotide substrates (MgATP and MgADP ) equalled that
of the total nucleotide.
5-3-2 Substrate affinities of the isoenzymes.
Based on an earlier suggestion of Henri (1902),
Michaelis and Menton (1913) proposed that enzymic action
could be explained by the formation of an enzyme-substrate
complex which subsequently broke down into free enzyme and
products. Their treatment was later generalised by Brigg
and Haldane (1925) who assumed that the enzyme-substrate
complex existed in a steady state during the reaction.
Single-substrate system. This system can be written as
k1 k2
E + S t ES * E + P
k-l
According to the Steady-state theory,
v = V/(1 + Km/S) 1)
where v = initial velocity of the reaction
V = maximum velocity in a fixed concentration of
enzyme P = products
K = Michaelis constant k = rate constant
m
S = substrate concentration
E = enzyme concentration
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The meaning of* the (which equals the substrate concen¬
tration at half maximum velocity) varies with the reaction
mechanism and is represented by k^ +- k^/k ^.
To obtain the kinetic parameters, various ways of
plotting the data derived from equation 1) can be used:-
1. v against S. A rectangular hyberbola is obtained
where V can theoretically be estimated as the asymptotic
value of v as S becomes very large (approaches infinity).
K is obtained as the value of S at which v = V/2.
m
2. 1/v against l/S (Lineweaver and Burk, 193^)-
ft
This double reciprical plot is based on the linear equation
l/v = K /V . J + l/Vm S
V and K can be worked out from the slope and intercept of
m
the plot.
3- v against V/S (Eadie, 19^2; Hofstee, 1952).
This is from the equation
v = V - K V/S
m
S/v against S (Hanes, 1932).
S/v = K + S/V
5. v against pS (-log S) (Dixon and Webb, 196^).
pS = pKm + l0g (V-v)/v
Because of their better precision, the linear plots (2, 3
and k) are usually preferred to the non-linear ones (1 and
5). Of the three linear plots the Lineweaver-Burk method
has been used most extensively although, when the line is
drawn "by eye" or from simple "least squares" calculations,
- 1^0 -
■*
it is the least satisfactory, since most points tend to
group at one end of the line, if rate measurements are
made at regular intervals of S, tending to cause impreci¬
sion in the estimation of V and K . The other two methods
m
are better on this respect. The disadvantage of the
Lineweaver-Burk plot can, however, be removed by using
weighted non-linear regression analysis (W ilkinson, 19 61).
Cleland (1967) has provided computer programs for such
statistical corrections.
Two-substrate systems. When two substrates are involved
»
in an enzyme reaction the steady-state treatment does not
necessarily give the "Michaelis-type" equation. There
are, however, three conditions which give linear reciprical
plots in a two-substrate system.
1. The rapid-equilibrium-random-order mechanism.
In this mechanism the enzyme (E) can form a binary
complex with either substrate (S or S, ) and also thev a b'
ternary complex, ES^S^, with no restriction to the order in
which and become attached to the enzyme. The break¬
down of the ternary complex into products (Px and P ) is
rate-determining and is so slow that it is in equilibrium
with S , S, , ES and ES,. Using Cleland's shorthandaba b 0
notation the whole mechanism can be described as follows:
-1^1 -
2. The ordered-ternary-complex mechanism.
In this mechanism one of the substrates (S ) combinesv a7
with the enzyme so much more readily than the other sub¬
strate (S^) that hardly exists at all and the ternary
complex ES S is formed virtually only from the ES
sl b sl






ES EP P P EP P
a x y x y y
»
3. The substituted-enzyme mechanism (ping-pong mechanism)
No ternary complex is fornjed in this mechanism. The
enzyme reacts with one substrate to give one product and a
substituted enzyme which further binds with the other
substrate to yield another product and the free enzyme.
s SKa b
E ±^ i j e
ES P E' P
ax y
All these three mechanism yield the "Michaelis-type"
rate equation. Using the usual notations,
V/v = 1 + K /S + K./S. + K ./S S. 2)' af a b' b ab' a b '
K , K, = Michaelis constants for S and S,a' b a b
K , = constant whose meaning varies with the
ab
reaction mechanism.
The values of these constants can be obtained by
plotting l/v against at a constant value of S^. A
■series of values of the,.l/v intercept are obtainable using
- Ik2 -
different values of S, . These are plotted against S, .b b
The l/S intercept then gives l/K . The original plotb ♦ b
of l/v against l/S for various values of intersect at
a point, giving -K /K . A corresponding procedure ofab a
plotting l/v against l/S, at various concentrations of Sb a
yields K and K ,/K (Florini and Vestling, 1957)* Sucha ab b.
study can give information concerning the reaction mech¬
anism. If is zero, as in the substituted enzyme
mechanism, a series of parallel lines will be obtained in
the double reciprical plot. If is not zero, the lines
in the double reciprical plot converge to' a point, sugg¬
esting the presence of a ternary complex. Unfortunately,
such plots cannot distinguish the random from the ordered
ternary complex mechanisms. Other investigations, such
as product inhibition studies, are needed to discriminate
between these two mechanisms.
Procedure and Results.
The substrate affinities of the isoenzymes were
studied in both the forward and backward reactions.
In the forward reaction, initial velocities were
measured at pH 9-0 at 37°C by the method of Tanzer and
Gilvarg (1959). The range of substrate concentrations
was i) creatine 2.5 mmol/l to 20 mmol/l, ii) ATP 0.25 mmol/l
2-t-
to 3-0 mmol/l with Mg /ATP ratio kept constant at 2.
In the backward reaction, the method of Hughes (1962)
was used to measure initial velocity at pH 7*0 at 37°0.
The range of substrate concentrations was i) creatine
- 1 h3 -
4
phosphate 0.33 mmol/l to 10 mmol/l, ii) ADP 25 /unol/l to
2+
750 jU.mol/l. The Mg /ADP ratio was held at 10 throughout.
The results were analysed by the double reciprical
plot using the method of Florini and Vestling as des¬
cribed above. A computer program (Wilkinson, 1961; Hoy
and Goldberg, 1971) was used to help analyse the data.
Some of the reciprical plots are shown in Figs. 5~13a
and b; 5-1^a, b, c and d.
For both isoenzymes, in both forward and backward
reactions, the lines in the primary plots( intersect
giving the constants K ,/K and K ,/K . The Michaelis
clD D clU cl
constants for various substrates were derived from the
secondary plots.
The values of all these kinetic parameters are listed
in Table 5-6.
Discussion.
The present results suggest the presence of enzyme-
substrate ternary complexes for both the MM and MB iso¬
enzymes. It has already been confirmed by many investi¬
gators (Morrison and James, 1965; Jacobs and Kuby, 1970)
for the MM and BB isoenzymes that the reaction is of the
random-rapid-equilibrium type. Since MB isoenzyme is a
hybrid of the MM and BB isoenzymes, it seems reasonable to
propose the same reaction mechanism for the MB isoenzyme.
(This is further supported by the product inhibition study
described in a later subsection). On this assumption,
the kinetic parameters obtained will have the physical
. f
Figure 5-13
Double Reciprical Plot for the Creatine Kinase Isoenzymes
a. Forward Reaction; MB Isoenzyme with Variation in Creatine
Concentration at Different ATP Concentrations
[ATP]:
A 3.0 mmolA; B 1.5 mmol/1; © 1.0 mmol/1; o 0.75 mmol/1;
A 0.5 mmol/1.
Figure 5-13
Double Reciprical Plot for the Creatine Kinase Isoenzymes
b. Backward Reaction: MM Isoenzyme with Variation in Creatine
Phosphate Concentration at Different ADP
Concentrations
/ [Creatine Phosphate] mmot /1 x1°
[ADP]:
• 500/umol/1; o 250 /amol/1; ■ 125 yumol/1; A 87.5/umol/l;









'/[ATP] mmol/l * 10
Figure 5-14





















Forward Reaction (pH 9)
MM Isoenzyme
ab b Ki E*Cr«±E + Cr 1 9«2 mmol/1 14-2 mmol/1
K / Kab a K2 E • MgATP ^E + MgATP 1-75 mmol/1 2-8 mmol/1
K
a K3 E* MgATP Cr^E - MgATP
+ Cr
20-S mmol/1
(S. D.= 3-6 )
10-0 mmol/1
(S.D. = 2.2)
Kb K4 E- MgATP-Cr^E-Cr
+ MgATP





Kcd/ Kd KS E-CrP^E + CrP 0*77 mmol/1 2*08 mmol/1
Kc K6 E • MgADP ^E + MgADP 0*11 mmol/1 0*24 mmol/1
K
c K7 E* MgADP- CrP —















K = Michaelis constant for creatine (Cr)
a
K = Michaelis constant for MgATP
K^= Michaelis constant for creatine phosphate (CrP)
K^= Michaelis constant for MgADP
K
, ,K = Kinetic constantsab cd
- m -
*
meanings described in Table 5-6.
It has been assumed that the effective concentrations
2+
of Mg -nucleotide complexes approach those of the total
nucleotides (as described in the last sub section). So far
as this is valid, the kinetic parameters calculated for
the total nucleotide may be taken as good approximations
2+
of those of the corresponding Mg -nucleotide substrates.
5-3-3 Effect of pH.
pH may affect enzyme activity by i) irreversibly in¬
activating the enzyme at extreme pH values, ii) altering
the reaction rate (^max) and iii) changing the enzyme
substrates affinities (K ). The second and third effectsx
s
are usually reversible.
The effect of irreversible inactivation can be studied
by exposing the enzyme to a range of pH values and then
assaying the activity at a pH at which the enzyme is stable.
This effect can be distinguished from those on K and V
s max
by comparing such a pH-stability curve with the pH-activity
curve (enzyme activity being determined at various pH
values) which shows the overall effect of pH.
In order to investigate the effects of varying pH
upon V and K independently of each other, the kinetics
m3.x s
of the ionisation of the enzyme, substrates and enzyme-
substrate complexes have been studied (Michaelis and
Davidsohn, 1911; von Euler ejt al. , 192^1; Dixon, 1953;
- -\h5 -
Laidler, 1955)* The following is a summary of the
findings:
pH affects the enzyme activity by changing the ionic
forms of enzymes (e), substrates (s) and enzyme-substrate
complexes (es).
The effective concentrations of E, S and ES at any
particular pH are inversely proportional to their res¬
pective "pH functions" (f), f^, fg and f^g. Hence
V = k(ES) = k(ES)/fEg 1)
•
k = e • s/ (es) = x -f»§_
s (es)* fE fg
- k 2)
3 fe fs j
It can also be proved that in steady state kinetics
k = k fes „ x
m m - —- 3)
e s
k = that part of the rate constant, k, which is
independent of pH
K = that part of the dissociation constant of substrate,
s '
Kg, independent of pH
K = that part of Michaelis constant, K , independent
m r m ^
of pH
* = active ionic form
V = maximum velocity at a given concentration of enzyme
A plot of negative log f (pf) against pH yeilds straight





1 s pK for ES 2 s pK forEor S
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of the dissociation constants (pK) of various ionic forms
at the intersections.
A plot of log V against pH is equivalent to plotting
pf against pH and hence it gives the pK values of thell/O
ES complex (Equation 1). Similarly, plots of pKm against
pH are equivalent to plotting (pf„ + pf- - pf„„) againsthj o Jj/O
pH and hence yielding pK values for E, S and ES (Equation
3). Therefore, with this method of plotting the dissocia¬
tion constants of the chemical groups essential for activity
in E, S and ES can be found.
Procedure and Results.
1. The overall effect of pH on enzyme activity was
studied by measuring the activity of the two isoenzymes
at various pH values ranging from 4.5 to 10.5- The
forward reaction was measured by the method of Tanzer and
Gilvarg (1959) and the backward reaction by the method of
Hughes (1962). The buffers used were i) 50 mmol/l sodium
succinate pH 4.5 - 6.5> ii) 50 mmol/l tris/HCl pH 6.5 -
9.0 and iii) 50 mmol/l glycine/NaOH pH 9.0 - 10.5.
In the forward reaction the two isoenzymes had
slightly different pH optima, with the substrate concentra¬
tions used, pH 9.0 for the MM isoenzyme and pH 8.0 - 9.0
for the MB. The MB isoenzyme had a higher activity (about
20%) in glycine buffer than in tris but the MM isoenzyme
did not show this difference. In the backward reaction
both isoenzymes showed peak activities at pH 6.5 - 7-0
(Fig. 5-15).
Figure 5-15
jdH -activity Curves for Creatine Kinase Isoenzymes
o—o Backward reaction MM isoenzyme;
A—A Backward reaction MB isoenzyme;
©—• Forward reaction MM isoenzyme;
k—k Forward reaction MB isoenzyme.
Buffers used were:
50 mmol/1 succinate buffer pH 4.5-6.5;
50 mmol/1 tris/HCl buffer pH 6.5-9.0;
50 mmol/1 glycine/NaOH pH 9.0-10.5.
- 1^7 -
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2. The stability of the isoenzymes in the pH range k.5
- 10.5 was studied by incubating the isoenzymes at 37°C
for 15 min in 50 mtnol/l buffers at different pH values,
the buffer types used being the same as in the previous
experiment. The protein concentration of the incubation
mixtures for both isoenzymes was adjusted to 0.8 g/l with
pure bovine albumin. At the end of the incubation 50 yul
portions were removed and assayed immediately by the method
of Rosalki (1967) using an automated reagent kit (Boeh-
ringer, England).
The MB isoenzyme was found to be less stable to
extreme pH than the MM isoenzyme having a stable range of
G.k - 9-0 pH units as opposed to pH 6.0 - 10.0 for the MM
isoenzyme (Fig. 5_16).
3. Since the K values in the backward reaction differ
m
widely between the isoenzymes, the pB[ effect on V and
in this reaction was selected for study. The Rosalki (1967)
method was used to measure the initial velocity. The V
and K values were obtained at different pH values from
m r
6.2 - 8.2 with the same procedure as before (5-3-2).
The pKm and log V values were plotted against pH (D ixon
1953).
Over the range pH 6.5 - 7«5j "the of the MB iso¬
enzyme for MgADP decreased by a factor of two, while that
of the MM increased two fold. In the same range, the K& '
m
of the MB isoenzyme for creatine showed little change
while that of the MM isoenzyme showed a three fold increase.
-"The change of V was similar for both isoenzymes. It
Figure 5-16
Stability of the Activity of Creatine Kinase Isoenzymes at
Different pH Values
pH
The isoenzymes were incubated in buffers at different pH values ( Succinate
pH 4.5-6.5; tris/HCl pH 6.5-9.0; glycine/NaOH pH 9.0-10.5 all at 50
mmol/1) for 15 min at 37 C. Their activites were measured by the





showed little change from pH 6.2 - 7«0, but there was a
sharp drop at pH values above 7•0•
When the results were plotted according to the method
of Dixon (1953)) all the piots, except that for the pK^
for creatine phosphate for the MM isoenzyme and log V for
the MB isoenzyme, could be fitted into straight lines of
zero and unit slopes, showing intersections at the following
pH values (Fig. 5-17a and b):
MM Isoenzyme MB Isoenzyme
Change of slope +1 -1 +1 -1
Log V - pH 7 • ^
pKmMgADP~ pH 7.k pH 7.0 pH 6.9 pH 7 • 2
pK creatine
m
phosphate - - - pH 7-55
Discus sion.
The two isoenzymes have been shown under the experi¬
mental conditions used in this investigation to have
similar pH optima in both forward and backward reactions.
These values, however, may change with substrate concentra¬
tion and temperature. Similarly, the pH stability profiles
are also not absolute, being dependent on incubation tempera¬
ture, incubation time and exact composition of the incubation
mixture.
It can be seen from the results of 3 above that the
greatest difference between the two isoenzymes in the
values for both MgADP and creatine phosphate are found at
pH 7-5' This may be important for the selective analysis
Figure 5-17
Variation of Kinetic Parameters with pH for the MM and MB
Isoenzymes for the Backward Reacti on







A MgADP MB isoenzyme; ©MgADP MM isoenzyme;













G-5 7-0 7-5 8-0
pH
85
• MM isoenzyme; A MB isoenzyme.





of the MB isoenzyme. However, the sensitivity of the
assay, for both isoenzymes, is less at pH 7«5 than pH 7*0>
as V is much lower at pH 7»5 than at pH 7«0-
It is difficult to interpret the changes of slope in
the log V and pKm plots especially in the two-substrate-
ternary-complex system postulated for creatine kinase.
According to the rules of Dixon (1953)> "the change at pH
7.^ may be attributable to the pK value of the enzyme-
substrate complex (probably the ternary complex) of the
MM isoenzyme; likewise the change at pH 6.9 may be
attibutable to a pK„e of the MB isoenzyme. The changes inJj/O
slope at pH 7«2 and pH 7*55 for the MB isoenzyme and at
pH 7-0 for the MM might be ascribed to the pK values of
free substrates, free enzyme or, in a two-substrate system,
the binary complex between enzyme and complementary sub¬
strate. Since the two dissociation constants of creatine
phosphate are pK^ = 2.7 and pKg = ^ • 58 , it seems unlikely
that these changes of slope refer to its ionisation.
However, MgADP, which has a pK value of 6.6, might be
responsible for the change at pH 7.0 for the MM isoenzyme.
The assignment of these apparent pK values to a particular
ionising group is, however, very hazardous as the dissocia¬
tion of the ionising groups in free and protein bound forms
can be very different. Moreover, the whole procedure will
be invalidated if changes in pH cause a change in the rate-
determining step of the enzyme reaction.
- 150 -
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5-3-^ Effect of ionic strength.
This was studied by measuring the activities of the
isoenzymes in the forward reaction (Tanzer and Gilvarg,
1959) in the presence of increasing glycine/NaOH buffer
concentration and increasing concentration of NaCl.
It was found that while both isoenzymes were inhibited
■at high NaCl concentrations, only the MB isoenzyme was
progressively inhibited by increasing strength of glycine/
NaOH buffer (Fig. 5-18),
It is not certain how much the inhibitory effect at
high concentrations of NaCl is due to increase of ionic
strength and how much to specific inhibition by CI
(see 5-3-7).
5~3~5 Temperature effect.
This subsection deals with the effect of assay temp¬
erature on reaction velocity. Heat inactivation of the
isoenzymes has already been discussed in 5-2-3.
In most chemical reactions, an increase in tempera¬
ture is accompanied by an increase in reaction rate, as
is described in the Arrhenius equation,
2.303 log k = -E R i + C
£1 1
k = kinetic rate constant
E^ = Arrhenius energy
R = gas constant
T = temperature °K
* v . •' /•.















If log k is plotted against 1/T, E can be obtained from
cl
the slope of the plot. E& is related to the heat of
activation (^H ) by the equation, A® = + RT.
ci cl ci
Ih an enzyme reaction; the maximum velocity (v) can
be used to replace k in the Arrhenius plot as V = kE^., E^_,
the total enzyme concentration, being a constant value.
The Arrhenius plot is linear over only a limited
range of temperature and only if a single observed reaction
step is being changed by changing temperature. Temperature-
dependent equilibria between different forms of the enzyme
or substrate exist in many enzyme systems, and in these
cases, non-linear Arrhenius plots will be obtained.
Proc edure.
The temperature-dependence of the enzyme reaction
rates was studied in the temperature range 20° - kO°C in
both the forward (Tanzer and Gilvarg, 1959) a^id. backward
(Rosalki, 1967) reactions. The pH of the buffer was
adjusted at each temperature to pH 9.0 in the forward
reaction and pH 7*0 in the backward reaction.
The substrate concentrations used were: creatine
2'
20 mtnol/l, ATP 1.0 mmol/l and Mg """ ions 2 mmol/i in the
forward reaction; and creatine phosphate 35 mmol/l, ADP
2+
1.5 mmol/l and Mg ions 10 mmol/l in the backward reaction.
Results.
The temperature-dependence of both forward and back¬
ward reactions of the two isoenzymes is shown in Fig. 5—19•























Arrhenius Plots for the MM and MB Isoenzymes
Forward Reaction
1-7J , .




The Effect of Temperature on the Reaction of Creatine Kinase
Isoenzymes
MB Is oenzyme MM Isoenzyme
Forward Reaction
Q10(25°- 35°C) 1.6 1.7
"E " 3.2 Kcal 9.3 Kcal
a (21°- 30° C) (21°- 30°C)
Transition
0
Temperature 30 C 30 C
Backward Reaction
Q10(25°- 35°C) 1.9 1.6
"E " 10.1 Kcal 10.7 Kcal
a
« JL lvUlx V/ • i vu.
(20 - 28°C) (20°- 28°C)
Transition
0
Temperature 28°C 28 C
"E " = apparent Arrhenius Energy
a
The forward reaction was measured by the method of Tanzer and Gilvarg
(1959); the backward reaction by the Rosalki Method (1967).
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with a change of slope at a transition temperature (Fig.
5-20a and b).
The apparent E^ and (i.e. change of reaction rate
per 10°c) values of the two isoenzymes are listed in
Table 5-?.
Discussion.
In both forward and backward reactions, with the
substrate concentrations used, the reaction velocity does
not increase as much in the 30° - ^0°C range as in the
20° - 30°C range, especially for the MM isoenzyme. The
slight decrease in activity in the forward reaction of the
MM isoenzyme beyond 39°C is likely to be due to substrate
depletion as the enzyme is stable between 39° - ^3°C.
Since the enzyme activities at all temperatures were meas¬
ured at fixed substrate concentrations the temperature
effects on the ionisation of substrates, and hence on the
K values for the substrates, were also measured. Thus,
m ' '
the log v against l/T plots, obtained in this study, give
only apparent values of E&.
5-3-6 Thiol activation.
It has been known for a long time that the inclusion
of thiol compounds in the assay mixture for creatine kinase
enhances the enzyme activity and increases accuracy and
reproducibility (Hughes, 1962; Kar and Peargon, 196^).
If the thiol compounds act by keeping the "essential"
thiol groups of the enzyme in reduced form, different
degrees of activation by thiols with different redox
potentials would be expected. Among the common low
molecular weight thiols, the order of redox potentials
at pH 7*0 is dithiothreitol< reduced glutathione (cysteine
thioglycollic acid. Dithiothreitol, having the lowest
redox potential, should be the most potent activator of
the four. This agrees with a recent report of Rao e_t al.
(197*0, but is at variance with an earlier report (Kar
and Pearson, ~\96k) which suggested that all the common low
molecular weight thiols had a similar activation effect on
creatine kinase.
The aim of the present experiment was to study the
activation effect of five common thiol compounds (reduced
glutathione, dithiothreitol, L-cysteine, thioglycollic
acid and jl-mercaptoethanol) on both the forward and back¬
ward reactions of the MM and MB isoenzymes.
Procedure and Results.
The enzyme activity was measured in the presence of
0-10 mmol/l thiol compounds by the method of Tanzer and
Gilvarg (1959) at pH 9.0 at 37°C for the forward reaction
and by the method of Rosalki (1967) at pH 7.0 at 37°C for
the backward reaction. The activity was then plotted
against the thiol concentration for both isoenzymes.
The pattern of activation by the thiol compounds for
the MB isoenzyme was found to be similar to the pattern
observed for the MM in both forward and backward reactions.
- 15k -
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In the forward reaction, all thiol compounds, except
cysteine, showed maximum activation from 2.5 mmol/l upwards.
At low concentrations, cysteine inhibited both isoenzymes
(Fig. 5-21 a). In the backward reaction, the thiol
compounds activated the isoenzymes to different extents:
dithiothreitol> y3-mercaptoethanol > reduced glutathione
L-cysteine >thioglycolic acid. Cysteine and thioglycolic
acid at low concentrations inhibited the MM and to a smaller
extent the MB isoenzymes (Fig. 5-21b).
Rao e_t al. (1975) reported that, in a mixture of the
»
MM and MB isoenzymes, reduced glutathione only activated
the MM isoenzyme while dithiothreitol activated both iso¬
enzymes, this suggested that an assay solution using
reduced glutathione as activator would underestimate serum
creatine kinase activity. To determine whether or not
reduced glutathione activates the MB isoenzyme in the
presence of the MM isoenzyme, serum samples from patients
with severe myocardial infarction and various mixtures of
the purified MM and MB isoenzymes were assayed in the
presence of i) 9 mmol/l reduced glutathione and ii) 9 mmol/l
reduced glutathione + 10 mmol/l dithiothreitol. The
backward reaction (Rosalki, 1967) was used for this study.
The results are shown in Table 5-8. In the present
experimental conditions, dithiothreitol did not further
activate the creatine kinase in serum samples which were
shown by electrophoresis to contain the MB isoenzyme as
well as the MM isoenzyme, nor did it further activate








Activation of Creatine Kinase Isoenzymes by Thiol Compounds
b. Backward Reaction (MM Isoenzyme)
Table 5-8
Activiation Effect on the Activity of the MM and MB Isoenzyme















■264 (257) 2371 (2000) 1240 (1057) 1230 (1150) 1070 (921)
Purified MM
Isoenzyme 285 (251) 596 (583) 1118 (1124)
224 (217) 515 (535) 1003 (1057)
MM MB MM MB MM MB MM MB MM
976 + 114 833 + 224 596 + 515 285 + 779 142
MB
891
1070 (1043) 1057 (1084) 1003 (989) 1030 (1084) 1016 (1000)
All serum samples were shown by electrophoresis on agarose film to contain
MB as well as MM isoenzyme activities.
* Activity data without brackets were determined in the presence of 9 mmol/1
GSH; those with brackets were determined in the presence of both 9 mmol/1
GSH and 10 mmol/1 DTT.
All enzyme activities were measured by the Rosalki method (1967).
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presence of dithiothreitol neither enhanced nor inhibited
the activity of the MM or MB isoenzymes when assayed
separately with 9 mmol/l reduced glutathione.
Discussion.
From the above experiments with individual isoenzymes
the activation effect of the thiol compounds seems to be
related to their respective redox potentials. This is
more evident in the backward than in the forward reactions.
The difference in activation between dithiothreitol,
p-mercaptoethanol and reduced glutathione is, however,
small and any one of the three thiols at a concentration
in the range 3 to 10 mmol/l is suitable as activating
reagent. Extrapolation of the present results with
individual purified isoenzymes to conditions in serum may
be misleading as serum contains many substances that react
with thiols.
The assay conditions under which Rao e_t al. (1975)
obtained differential activation of the MM and MB isoenzymes
by glutathione and dithiothreitol must be critical, since
the findings have not been reproduced in the present study
using similar, but not identical, assay conditions.
5-3-7 Product inhibition.
Enzyme inhibition. Enzyme inhibition may be reversible
or irreversible. The present study is concerned only
with reversible inhibition where there is an equilibrium
— 156 -
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between the inhibitor and the free enzyme or the enzyme-
substrate complex.
In a simple one-substrate-one-intermediate system,
K.
l
I + E EI
KS It
K • .







v. = initial velocity
i
V = maximum velocity
K. = dissociation constant of EI
x
K'. = dissociation constant of ESI
x
Kg = dissociation constant of ES
k = rate constant of rate determxning step
V = initial velocity in absence of inhibitor
o




If K. = K« . 1 = VS
v. (Kq + S) (1 + i/K . ) ... non-competi-x
tive inhibition
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If K" . = oo 1 V S
x
Kg (1 +■ I/K±) + S competitivev .l
inhibition
If K. oo 1 V S
x
KQ + ( 1 +I/K' . ) So x unc ompe titivev .x
inhibition
If K' .> K . or K > K' . mixed inhibition
xx xx
(Laidler and Bunting, 1973)
From the above equations it can be seen that 1. in
non-competitive inhibition the presence of S has no effect
on the binding of the enzyme with the inhibitor; 2. in
competitive inhibition the presence of S reduces the
enzyme binding with the inhibitor; and 3« in uncompetitive
inhibition the inhibitor only binds with the enzyme-sub¬
strate complex.
Various graphical procedures have been proposed to
discriminate between these types of inhibition. Some of
these are
i) l/v. against l/S
ii) -*-/vi against I
iii) S/v_^ against S
iv) v_^ against v^/S
v) l/i against 1/i, i being (vq - v^)/v0
vi) (l)(l-i)/i against S
The graphical patterns of the various forms of
inhibition of the first two kinds of plots are as follows:-
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In the plot of against I the inhibition constant
(K_^) can be read directly from the graph; whereas in the
plot of l/v^ against l/S, K_ can be obtained by further
plotting the slopes against l/l.
In a two substrate system the values may be found
in a similar manner by holding one substrate concentration
(S^) constant while varying that of the other (S^). The
K_ for obtained in this way might vary with the sub¬




Inhibition by reaction products.
Reaction products may inhibit enzyme reactions by
enhancing the backward reaction so as to compete with the
forward reaction, or by combining with the enzyme to form
inactive complexes. The former effect can usually be
neglected as initial reaction velocities are usually
measured. Also, in many enzyme reactions, the reaction
equilibrium lies far to one side, the reverse reaction
being insignificant. In these conditions, reaction pro¬
ducts inhibit the enzyme reaction mainly by binding to
the enzyme.
Since reaction products usually have structures similar
to their substrate predecessors, they may compete with
substrate for binding sites on the enzyme thus showing
competitive inhibition.
The study of product inhibition patterns may help to
clarify reaction mechanisms. In a rapid-equilibrium-
- 160 -




E EAxB ► E 4- A +• Bx
B:::::::^EB f^Ax
E = enzyme
Ax, B = substrates
A, Bx = products
Product A is a competitive inhibitor with respect to sub¬
strate Ax and product Bx to substrate B. . The inhibition
pattern of product A in relation to substrate B (or Bx
to Ax) is, however, complicated. It will be non-competi¬
tive if the binding of substrate B to the enzyme does not
affect the subsequent binding to A; on the other hand, if
the presence of B affects the binding of A to E, the
inhibition will be of the mixed-type.
Since the substrate Ax binds to both E and EB, the
product A being similar in structure to Ax can bind not
only to E but also to EB as well. Therefore the
obtained for A is dependent on the concentration of B.
Similarly K_ for Bx varies with the concentration 'of Ax.
In this reaction mechanism there are, therefore, two
possible enzyme-substrate-product complexes, E.A.B. and
E.Ax.Bx which are incapable of reacting any further.
Proc edure.
The product inhibition of creatine, creatine phosphate,
2-
MgATP and MgADP for both isoenzymes was studied in
relation to the substrates. The conditions for the
assay were:
Product inhibitor Substrate concentration Methods of
Assay (37°C)
1. Forward reaction
Creatine phosphate Creatine (2.5 - 15mmol/1 Tanzer and
(0 - 15 mmol/1) ATP (1.0 mmol/l) Gilvarg
Mg2+/ATP = 2 (1959) PH 9.0
ADP i) ATP (0.5 -
(0 - 1.5 mmol/l)
1 .5 mmol/1) _ Kuby (195^)
Mg2+/ATP = 2 pH 9-0
Creatine (20 mmol/l)
ii)Creatine (7.5 - 25
mmol/1)




(0-15 mmol/l) Creatine phosphate Rosalki (1967
(0.67-5.0 mmol/l) pH 7.0
ADP (1.0 mmol/l)
Mg2+/ADP = 10
ATP (0-2.0 mmol/l) i) creatine phosphate Hughes (1962)
(20 mmol/l) pH 7-0
ADP (0.2-2 mmol/l)




Both i) and ii)
- Mg2VADP = 10
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Results.
The types of inhibition (as confirned by both Line-
weaver-Burk and Dixon plots) and the apparent K_^ values
(obtained from the Dixon plots) are listed in Table 5-9 •
Examples of the graphs obtained are shown in Fig. 22a(b,c
and d.
Discussion.
The patterns of product inhibition of both isoenzymes
conform to the random-order-rapid-equilibrium type of
mechanism. There were no qualitative differences between
the isoenzymes although the "K." values so obtained for MB
isoenzyme were generally lower than the corresponding
values of MM isoenzyme. The "K_" values are only apparent
being dependent on the concentration of the fixed substrate
The inhibition of the forward reaction by ADP can be
assumed to be due entirely to the species MgADP under the
present assay conditions (see Section 5-3-1).
Little inhibition of the backward reaction by ATP
(0-2 mmol/l) at pH 7.0 was observed although inhibition of
^
the MM isoenzyme by MgATP (0-3 mmol/l) has been reported
at pH 8.0 (Morrison and James, 1965)- In an early experi¬
ment, some inhibition of both isoenzymes by ATP was
observed, giving non-linear Lineweaver-burk plots. Later
it was found that the ATP solution used had hydrolysed,
however, so the observed inhibition might have been due to
the presence of inorganic phosphate present in the ATP
solution. On repeating the experiments with a fresh
*
Table 5-9


















("K "= 0.35 mmol/1)
Non -competitive











("K." =9.6 mmol/1) ("K." = 13.3 mmol/1)
"K." = apparent inhibition constant.
Figure 5-22
Product Inhibition of Creatine Kinase Isoenzymes
[Creatine]: □ 2.5 mmol/1; • 5.0 mmol/1; m 7.5 mmol/1;
A 10 mmol/1; o 15 mmol/1.
[Creatine phosphate]:
e 0.67 mmol/1; □ 1.25, mmol/1; A 2.5 mmol/1; o 5.0 mmol/1.
Figure 5-22
Product Inhibition of the Creatine Kinase Isoenzymes
[ATP]: ■ 0.5 mmol/1; A 0.75 mmol/1; a 1.0 mmol/1; o 1.5 mmol/1.
[Creatine]:
O 7.5 mmol/1; □ 10 mmol/1; A 20 mmol/1; • 25 mmol/1.
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sample of ATP, little inhibition of either isoenzyme was
detected. Under the experimental conditions, nearly all
2-
the ATP existed as MgATP , possibly \vith a very small
amount of MgHATP-. Since the affinity of the isoenzymes
for MgATP is much lower than that for MgADP (one tenth
as low for the MB isoenzyme and one fifth as low for the
MM isoenzyme; Table 5-6), it would be expected that a
2-
relatively high concentration of MgATP was necessary to
compete with MgADP . However, a concentration range 0-2
2 —
mmol/l MgATP was considered sufficient, as other studies had
shown considerable inhibition in this range (Morrison and
James, 1965). The cause for this apparent discrepancy is
not clear.
5-3-8 Effect of anions.
Anions affect enzyme activities either by non¬
specific action by increasing the ionic strength or by
specific individual effects. The specific effects of
anions include i) changing the ionisation constants of
enzymes or substrates, ii) altering enzyme structure,
iii) binding with enzyme or enzyme-substrate complex as
ligands, iv) affecting the charge-distribution of the
active sit.es of enzymes, or v) functioning as competitive
inhibitors to substrates. Thus they can, directly or
indirectly, alter the kinetics of enzyme reactions. . The
effects of ten different anions on the activities of the




1. 50 mmol/l solutions of nitrate, chloride,
flouride, borate, acetate, benzoate, sulphate, phosphate,
succinate and maleate as sodium salts were incubated sep¬
arately with the isoenzymes in the assay solutions. The
pH of the salt solution was preadjusted to that of the
assay mixture, pH 9-0 for the forward reaction measured by
the method of Tanzer and Gilvarg (1959) and pH 7«0 for the
backward reaction (Rosalki, 1967). Two concentrations
of enzymes were used in each case to eliminate the possib-
ility of the observed effect being due to the coupling
enzymes involved in the assay. The inhibition was expre¬
ssed as a percentage of the activity in the absence of the
anion.
There were few differences between the isoenzymes for
all the anions studied. With the exception of borate,
which only inhibited the forward reaction, all other anions
affected both the forward and backward reactions to a
similar extent. Three types of anionic effect were found
i) strong inhibition ( < 70°/° residual activity) by benzoate,
sulphate, phosphate, maleate and borate (forward reaction),
ii) mild inhibition {70B/°-95°/° residual activity) by chloride,
nitrate, fluoride and succinate, iii) no inhibition by
acetate (Table 5-10)«
2. The effect of phosphate ions was chosen to study
in more detail, as the enzyme reaction is concerned with
phosphate transfer, and inorganic phosphate is most likely
—to be present as an impurity in the adenine nucleotide
Table 5-10













Water 100 100 100 100
Nitrate 69 78 86 84
Chloride 83 83 91 99
Fluoride 86 94 86 85
Borate 28 34 91 101
*Acetate 99 112 95 103
Benzoate 44 38 65 66
Sulphate 43 53 54 69
Phosphate 37 50 42 54
Succinate 80 100 88 96
Maleate 58 70 60 75
* The total concentration of acetate was 53 mrnol/1 because of the presence of
magnesium acetate in the assay solution.
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substrates. The inhibition by phosphate ions was
studied in the concentration range 0-62 mmol/l in the
presence of varying concentrations of both substrates,
creatine phosphate and MgADP , in the backward reaction.
The results were analysed by the Lineweaver-Burk and
Dixon plots.
The type of inhibition by inorganic phosphate (as
shown by both Lineweaver-Burk and Dixon plots) with respect
to the substrates are listed in Table 5-1 1 • Some of the
results are shown in Fig. 5~23a and b.
Discussion.
Comparison of the effects.of different anions at a
fixed concentration can only give an approximate estimate
of the relative inhibitory action of the anion, as the
degree of inhibition may not be linearly proportional to
the concentration of the anion.
The finding that CI , NO^ and F are mild inhibitors
is slightly misleading, for they are only so in the absence
of either creatine or MgADP. In the presence of both
creatine and MgADP, these anions can greatly stabilise the
complex creatine-enzyme-MgADP by occupying the gap between
creatine and MgADP in the complex (Milner-White and Watts,
1971).
The acetate ion hardly inhibited either the forward
or the backward reactions, although values varying from
350-^00 mmol/l have been reported (Heyde and Morrison,
1970; Nihei _ejt aT. , 1961). Acetate has also been reported
*
Table 5-11
Inorganic Phosphate Inhibition on the Backward Reaction of
Creatine Kinase Isoenzymes
Reference Substrate Types of Inhibition
MM Isoenzyme MB Isoenzyme
Creatine Phosphate Non - competi tive Non-competitive
("K." = 30 mmol/1)
1
("K." = 48 mmol/1)
MgADP Non -competitive Competitive (?)
("K " = 45 mmol/1)
l
("K " = 20 mmol/1)
l
"K " = apparent inhibition constant.
Figure 5-23
Inorganic Phosphate Inhibition of the Activity of Creatine Kinase





A 0.5 mmol/l; ■ 1.0 mmol/l;
Figure 5-23
Inorganic Phosphate Inhibition of the Activity of Creatine Kinase
Isoenzyme in the Backward Reaction
[Phosphate] mmol/l
[Creatine phosphate]:
■ 0.625 mmol/l; o 12.5 mmol/l; a 2.5 mmol/l; A 10 mmol/l.
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to activate creatine kinase by 10-30^ (Milner-White and
Watts, 1971)» It *ias been proposed that acetate binds
to the enzyme at an allosteric si te (Watts, 1973).
Nihei e_t a_l. (1961 ) suggested that the strong inhibi¬
tion by sulphate and phosphate was due to their binding
with the enzyme at the site occupied by the transferable
organic phosphoryl group. Thus, these anions would be
expected to act as competitive inhibitors in relation to
the phosphorylated substrate (Creatine phosphate in the
backward reaction). For phosphate ions, however, a non¬
competitive (or mixed) inhibition was found with both MB
and MM isoenzymes. This may be attributable to the con¬
formational changes occurring after the binding of the phosphate
ion (Watts, 1973)•
5-4 Discussion.
The present survey has shown that the two isoenzymes
are qualitatively very similar. Most of the substrate-
affinity and product inhibition studies suggest that the
MB isoenzyme has the same reaction mechanism as the MM
isoenzyme. Both isoenzymes had similar pH optima, and
both were similarly inhibited by .different types of anions,
reaction products, iodoacetamide, oxidised glutathione and
2 +
excess Mg . Under suitable conditions both could be
reactivated on dilution after treatment with urea,
guanidine/HCl and p-hydroxymercuribenzoate and both were
activated by thiols. These similarities might have been
forecast, for half of the MB molecule is of the muscle
type.
However, despite the similarities there were many
quantitative differences between the isoenzymes. Apart
from the difference in electrophoretic mobility the MB
isoenzyme had a higher affinity for both MgADP and creatine
phosphate. Furthermore, the isoenzymes differ in the way
which the value for MgADP and for creatine phosphate
varied with pH. The activity of the MB isoenzyme was
enhanced by glycine/NaOH buffer relative to tris/HCl
»
whereas the MM isoenzyme was not. Thirdly, in many
circumstances, including i) stability at extreme pH values
ii) heat inac tivation and iii) urea, inac tivation, the MB
isoenzyme has been shown to be less stable than the MM
isoenzyme. The only occasion in this study where MB
isoenzyme was apparently more stable than MM isoenzyme was
during the pHMB inactivation.
Because of the relatively unstable character of the
MB isoenzyme and its similarity to the MM isoenzyme in
many other properties, the differential measurement of the
MB isoenzyme in the presence of the MM isoenzyme, as in
clinical diagnosis, is difficult. Using the differences
in kinetic parameters noted above it is possible by using
low and high substrate concentrations at suitable pH
values to enhance the activity of the MB and MM isoenzymes
relative to one another. By determining the ratio of
creatine kinase activity at low to high substrate concentra¬
tions, the proportion of MB isoenzyme present in a mixture
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of MM and MB isoenzymes may be calculated (Witteveen e_t al. ,
197^)• However, there are difficulties in measuring
creatine kinase activity at low substrate concentrations
and it is difficult to measure creatine kinase activity
sufficiently precisely to detect the relatively low
proportions of the MB isoenzyme present in most normal and
pathological sera.
In those instances where quantitation of isoenzyme
mixtures has been possible, the most successful techniques
have employed differential inhibition or denaturation of
the different isoenzymes, e.g. the effect of heat and
urea denaturation on lactate dehydrogenase. For creatine
kinase, however, these are less likely to be successful
with the MB isoenzyme since this is usually present in
much smaller quantity than the MM isoenzyme in serum.
Anionic inhibitors had similar effects on both isoenzymes
and the differences in product inhibition were not great
enough to form the basis of any practical method. Heat
inactivation at 50°C affected the MB much more than the MM
isoenzyme and in view of the small quantity of the MB
isoenzyme present in serum, it is doubtful whether its
selective destruction by heat could be made a practical
method of measuring the MB isoenzyme.
Inactivation by pHMB, which affected the MM more than
the MB isoenzyme, might be of value in the selective
measurement of the MB isoenzyme. However, the rate of
inactivation by pHMB was found to be critically dependent
_^,pn the type and concentration of buffer. Moreover, the
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inactivated enzymes were readily reactivated on dilution
in the assay mixture which contained a thiol compound.
Therefore, although it is possible to devise conditions
capable of measuring the MB isoenzyme in mixtures of
partially purified MB and MM isoenzymes, these conditions
might not apply to the analysis of mixtures of creatine
kinase isoenzymes in serum.
No differences between the isoenzymes in their act¬
ivation by different thiol compounds have been found, but
this aspect requires further study as serum creatine kinase
»
isoenzymes might behave differently from their purified
forms from tissue. A method has been recently reported
(Rao e_t al, 1975) describing the selective assay of the
MB isoenzyme based on the differential activation of two
thiol compounds.
On the basis of the present findings, it seems un¬
likely that any of the differences observed between the
isoenzymes, in kinetic behaviour, inactivation and inhibi¬
tion by various substances, is great enough to warrant
attempts at its development as a routine test for determ¬
ining the MB isoenzyme in serum. Currently, it seems that
techniques based on differences in charge, such as electro¬
phoresis or ion-exchange chromatography, are more likely
to provide simple and reliable techniques for the accurate
determination of MB isoenzyme activity in serum. This will be
further discussed in the following section.
SECTION 6
DETERMINATION OF THE MB ISOENZYME
CREATINE KINASE IN SERUM
- 170 -
*
This section is concerned with the search for a
convenient and simple method of measuring the MB isoenzyme
in serum.
6-1 Introduc tion.
The measurement of clinically useful isoenzymes has
been of importance in clinical chemistry for a long time.
The methods used can, in general, be classified into two
groups:
1. Methods involving the removal of interfering iso¬
enzymes by either i) separation techniques or ii) differ¬
ential inactivation.
2. Methods using the original untreated isoenzyme
mixture in conditions that suppress the activities of the
interfering isoenzyme(s) without affecting the activity of
the isoenzyme to be measured. Methods in categories 1 ii)
and 2 may be difficult to develop and depend on the physical
and enzymatic properties of the isoenzymes concerned.
Methods in category 1 i) are more common and many isoenzymes
were discovered by methods of this type, particularly
elec trophoresis.
The following is a brief summary of the efforts made,
mostly.in the past 10-20 years, to develop methods for the
differential measurement of isoenzymes, especially those of
lactate dehydrogenase. Xt seemed possible that similar
methods might be used to assay the MB isoenzyme.
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Method 1; Removal of interfering isoenzymes.
i) Separation techniques. Ion-exchange chromato¬
graphy and electrophoresis, techniques based on differences
in charge, are the most commonly employed methods in this
category. The physical forces involved are summarised in
Table 6-1. Electrophoresis is often the technique first
used to demonstrate the heterogeneity of an enzyme.
Vieme, in 1959? used agar gel electrophoresis to assay the
lactate dehydrogenase isoenzymes. Electrophoretic methods
using other media, such as cellulose acetate and starch,
were soon used for serum isoenzyme analysis. Hess and
Walter (1961) were among the earliest to introduce an ion-
exchange method using DEAE cellulose to separate lactate
dehydrogenase isoenzymes.
ii) Destruction of interfering isoenzymes.
a) Selective precipitation of isoenzymes. This is based
on the different solubilities of the isoenzymes and has been
used as a routine procedure e.g. the precipitation of the
slower forms of lactate dehydrogenase by acetone (Latner
and Turner, 1963) and of liver alkaline phosphatase by
ethanol (Peacock e_t ail., 1963).
b) Heat inactivation. Herbert (19^^) found that prostatic
acid phosphatase was inactivated after one hour at 37°C
while erythrocyte acid phosphatase was little affected by
this treatment. She was probably the first to use heat
stability as a means of differentiating enzyme species.
Since then, heat treatment has been used to measure LD^ and
LD (LD1 = isoenzymes of lactate dehydrogenase in descend-£ I ~~ J
ing order of mobility towards the anode on electrophoresis)
Table 6-1





































which are more heat resistant than LD^ and LDj,. Alkaline
phosphatases from bone and liver have also been differenti¬
ated in this way (Whitby and Moss, 1975)•
c) Immunological methods. Because isoenzymes have
different protein structures, antisera can, in principle,
be raised specifically against each isoenzyme. By selec¬
tively inactivating a particular species, the activity of
the other species can therefore be measured e.g. the MM and
BB isoenzymes of creatine kinase (Jockers-Vretou and Pflei-
derer, 1975)•
Method 2: Suppression of interfering isoenzyme activities.
i) Differences in substrate affinity. This method is
well exemplified by the lactate dehydrogenase isoenzymes.
The fast-moving forms (LD^ and LD^) have a higher substrate
affinity for pyruvate than the slower forms (LD^ and LD^).
Plagemann e_t al. (i960) calculated the ratio of the velocity
at high substrate concentration to the velocity at low
substrate concentration, and plotted the logarithm of this
ratio against the percentages of LD, and LD_ in a mixture1 5
of the two isoenzymes. A direct relationship was found
and there was excellent agreement between observed and
calculated values. Differences in pH optima between iso¬
enzymes have also been used, in combination with the diff¬
erence in substrate affinity, e.g. in the measurement of
the relative percentages of the isoenzymes of aspartate
aminotransferase (Fleisher e_t aT. , i960).
ii) Use of substrate analogues. An isoenzyme may
have a characteristic ratio of activity with substrate to
- 173 -
its activity with a substrate analogue. For example,
lactate dehydrogenase isoenzymes have characteristic ratios
of activity with pyruvate to their activity with 2-oxobuty-
rate (Wilkinson and Rosalki, 1960). These ratios have
been used to indicate the relative proportions of the diff¬
erent isoenzymes present.
iii) Use of inhibitors. Abul-Fadl and King (19^+9)
showed that L(+) tartrate inhibited the acid phosphatase of
the prostrate gland, while formaldehyde and copper inhibited
other acid phosphatases. Urea and oxalate, which inhibit
the slow and fast moving forms of lactate dehydrogenase
respectively, have also found a number of applications in
selective measurements of lactate dehydrogenase isoenzymes.
Difficulties in measuring the MB isoenzyme.
The chief difficulty is that only small amounts of the
MB isoenzyme are present even in the serum of patients with
acute myocardial infarction - usually less than 30% of the
total creatine kinase activity. In normal serum the diff¬
iculties are much greater, since less than 3% of the total
serum creatine kinase is present as the MB isoenzyme.
Moreover, the MB isoenzyme has been shown, under a variety
of conditions, to be less stable than the more abundant MM
form (see Section 5)* Thus, many conventional means of
inhibition or inactivation often affect the MB more than
the MM isoenzyme. Methods based on the difference between
total activity and that of MM isoenzyme after the destruction
of the MB isoenzyme are not practicable because of the small
amount of the MB isoenzyme present and the serum dilution
• ••
effect (see Section 2)."
- 174 -
«*
Existing methods of measuring the MB isoenzyme.
In view of the difficulties mentioned above it is
hardly surprising that most of the existing methods are
based on the separation by charge differences between the
MM and MB isoenzymes.
Electrophoresis in a variety of media has been widely
used in many laboratories - cellulose acetate (Roberts e_t al. ,
1974), agarose (Sherwin, 1967)5 agar (Van der Veen and
Willebrands, 1966), starch gel (Sjovall and Voigt, 1964)
and polyacrylamide gel (Smith, 1972), followed by various
methods of demonstrating and quantitating the separated
isoenzymes. Simple methods using column chromatography
on DEAE Sephadex (Mercer, 1974) and DEAE cellulose (Nealon
and Henderson, 1975) have been described.
A method using the difference in substrate affinity
between the MM and MB isoenzymes has been reported (Witte-
veen e_t al. , 1973) • An immunological method designed mainly
to differentiate the MM and BB isoenzymes has also been
used to measure the MB isoenzyme (Jockers-Wretou, 1975)-
More recently, it has been reported (Rao e_t al. , 1975)
that differential activation by thiol compounds may be used
to measure the amount of the MM and MB isoenzymes in serum.
In 1974 when this work was started the MB isoenzyme was
most commonly measured by electrophoretic separation.
None of the electrophoretic methods was altogether satis¬
factory. They were either too cumbersome or too imprecise
for the routine quantitative analysis of the isoenzyme. It
..«.*as hoped that a simple ^batch ion-exchange method might
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help solve this problem.
6-2 Methods.
All creatine kinase activities were determined by the
method of Rosalki (1967) using reagents supplied by the
Boehringer Corporation, Lewes, England. Enzyme activity
was determined at 37°C at 3^0 nm using an LKB reaction rat
analyser; the total assay volume was 1.1 ml and the sampl
volume (for serum) was 25 >ul (see Section 2).
Partially purified preparations of the MM and MB
isoenzymes from heart tissue (see Section 5) were used for
assessment of the methods.
6-2-1 lon-exchange chromatography.
Jon-exchange chromatography separates the components
in a mixture on the basis of the number of charged groups
available on each molecule for interaction with the ion-
exchanger. Since the two isoenzymes of creatine kinase
differ widely in electric charge, the simple procedure of
stepwise elution may be used instead of the more elaborate
gradient elution. For simplicity a batch method was
chosen in preference to a column method. In this study
Sephadex (cross-linking dextran) was used rather than
cellulose, mainly because of the higher exchange capacity
of Sephadex, due to the presence of more ionisable groups
within the matrix of the, gel beads. Another advantage
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that Sephadex gives is that its bead form enables it to be
sedimented readily, which makes it convenient for a batch
technique involving washing and packing. The main dis¬
advantage in using Sephadex is the large changes in volume
which result from changes in salt concentrations or pH.
It is possible that large molecules, which have gained
access to the gel matrix during the initial stages of
elution when the salt concentration is low, might be trapped
when the gel shrinks as the salt concentration rises during
the process of elution.
Since the MB isoenzyme is more negatively charged than
the MM isoenzyme, a cationic exchanger which binds the MM
isoenzyme in preference to the MB isoenzyme should, in
principle, be used so as to yield the MB isoenzyme on a
single elution with buffer of appropriate pH and ionic
strength. This was tried with carboxymethyl Sephadex (CM-
50, Pharmacia, Uppsala, Sweden). No satisfactory separa¬
tion was achieved, due to difficulty in finding a suitable
pH value for the eluting buffer. The isoelectric point
of the MM isoenzyme is around pH 5-6, but lowering of the
buffer pH to below 6.0 is not feasible because both iso¬
enzymes are unstable at pH values below 6.0 (Section 5)
and the CM Saphadex is not fully effective below pH 6.0.
Therefore, a less direct two-step elution technique using
the anion exchanger, DEAE Sephadex, was used.
Reagent s.




2. Buffer 2: Tris/HCl, 50 mmol/l, pH 8.0 in NaCl
0.25 mol/l
3. DEAE Sephadex A-50 (Pharmacia Fine Chemicals,
Uppsala, Sweden)
About 10g DEAE Sephadex was equilibrated with Buffer 1
with three changes of buffer within 2k hours. Excess
buffer was poured off and the slurry distributed in 2.5 ml
portions, equivalent to about 100 mg dry Sephadex, into
10 ml plastic tubes which were stored at ^°C.
Procedure.
1 ml of serum or diluted serum (active samples were
diluted to give a creatine kinase activity of 600 TU/1)
was added with 5 ml Buffer 1 to a 2.5 ml portion of DEAE
Sephadex. Preliminary dialysis of serum samples was not
found to be necessary as the ionic strength of serum is
roughly equal to that of Buffer 1. The tube was mixed by
inversion and allowed to stand for 15 min. After spinning
the supernatant was decanted and the sediment washed twice
(four times in certain experiments) with 6 ml portions of
Buffer 1. The washings were pooled to give eluate 1 which
contained the MM isoenzyme (see results).
The Sephadex sediment was then washed three times with
Buffer 2, using k ml, 3 ml and 3 ml volumes and pooling the
washings to give eluate 2 (containing the MB isoenzyme).
The creatine kinase activity of eluate 2 was determined
spec trophotometrically using 25O/1I sample in place of the
usual 25 /il •
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6-2-2 Separation on polyacrylamide gel slabs (Smith, 1972) .
Polyacrylamide gel offers a stable and satisfactory
medium for protein separations. The gel is formed by the
polymerisation of acrylamide monomer and bisacrylamide in
the presence of free radicles. The polymerisation is nor¬
mally catalysed by either the photodecomposition of ribo¬
flavin or ammonium persulphate in the presence of tetra-
methylethylenediamine (TEMED) in the absence of excess
oxygen.
The polyacrylamide gel consists of long chain molecules
with cross linkages, the pore size in the gel being depend¬
ent on the concentration of theacrylamide and bisacrylamide.
With a range of total acrylamide concentration between 6.5
and 20 °/o, the average pore diameter varies from 0.6 to k nm
(Fawcett and Morris, 1966). This enables the gel to exert
a sieving effect on most proteins whose diameters vary from
1.6 to 8 nm, and thereby give sharp and well resolved bands.
The polyacrylamide gel does not contain any ionisable groups
and hence endosmosis is negligible. It is transparent and
so provides a good medium for staining. However, polyacryl¬
amide absorbs light in the uv region, so the detection of
LTV absorbing substances in the gel is often not practicable.
The tight matrix of the gel allows little diffusion of
protein macromolecules into and out of the gel. Thus, for
demonstration of enzyme activity in the gel by coupled
enzyme reactions, the coupling enzymes have to be introduced
into the gel by electrophoresis.
Creatine kinase (ck). activity can be demonstrated in
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the gel by the following coupled enzyme reactions:
CK
ADP + Creatine phosphate v ATP +- Creatine
HK
ATP + Glucose *■ ADP 4- Glucose-6-phosphate
Glucose-6-phosphate + NADP —— ~—NADPH + 6 Phosphoglu-
c onate
NADPH + Phenazine methosulphate -i- Nitroblue tetrozolium
»■ Purple formazan
G-6-PD = Glucose-6-phosphate dehydrogenase
HK = hexokinase
The formazan is insoluble in water but soluble in organic
solvents, stable to oxygen, but can be decomposed in strong
light. It has a higher extinction coefficient at 560 nm
than NADPH has at 3^+0 nm and so increases the sensitivity
of the method. The intensity of the formazan band is
determined by a number of factors - the enzyme concentration,
the substrate concentration, the incubation temperature,
the incubation period and the diffusion coefficients of the
reacting components.
The method to be described is that originally reported
by Smith (1972). Some modifications were made to optimise
the method for quantitative measurements. This method was
used throughout the clinical study on the release of creatine
kinase isoenzymes and details of its performance have already
been described in Section k.
6-2-3 Separation on agarose film.
Agarose film (1 °/o agarose) is a medium with a large
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pore size ( 120nm in diameter), offering little steric
hindrance. Therefore, it requires only a short time and
a low voltage for the electrophoretic separation of iso¬
enzymes. The procedure can be carried out at room tempera¬
ture with little danger of overheating. Since the gel is
porous it allows entry of coupling enzymes into the gel by
diffusion. Also, since the agarose gel has no charged
groups, endosmosis is minimal. For these reasons a much
simpler procedure is possible with this medium than with
polyacrylamide gel slabs. However because of the softness
and thinness of the gel, the film is much more delicate to
handle than the tough polyacrylamide gel slab.
Unlike polyacrylamide gel, agarose gel does not absorb
UV light. Therefore demonstration of creatine kinase
activity by NABPH fluorescence is possible. Fluorescence
measurements are often much more sensitive than equivalent
spectrophotometric measurements and the intensity of emitted
light is directly proportional to the total number of
fluorescent molecules present, provided the number of
molecules is small, and so, unlike transmission measurement
of the stained bands, a homogeneous distribution of fluores¬
cent molecules in the band is not essential for a valid
reading of fluorescence intensity. Despite these advant¬
ages, fluorescence measurements are easily affected by the
impurities in the gel, the physical state of the fluorescing
NADPH, the intensity of the exciting beam, the thickness of




A commercially available electrophoresis system was
used (Corning Eel, Evans Electroselenium Ltd., Halstead,
Essex, England).
1. A cassette electrophoretic cell and power supply (90V - 5/0 «
The cell consisted of a base and cover. The cell
base was divided into two chambers each with a carbon elec¬
trode. The cell cover had a U-shaped cassette holder to
secure the agarose film during electrophoresis.
2. Plastic-bached pre-prepared agarose-film.
»
This consisted of a thin layer of agarose gel (^81 yum)
adherent to a transparent plastic backing. Sample wells
capable of holding 2.3 P-1 solution were imprinted in the gel
surface.
3. An incubator-drier.
An incubator section was maintained at 39°C + 2°C;
the drier section at 60°C +■ 5°C with a draught of filtered
air.
Reagents.
1. Sodium barbital buffer 50 mmol/l, pH 8.6.
2. Agarose gel consisting of 1 °/o W/V agarose and 59^ W/V
sucrose in 30 mmol/l 2-amino-2-methyl-1-propanol buffer,
pH 8.6.
3. Creatine substrate mixture
a) 50 mmol/l 2-(N-morpholino) ethane sulphonic acid
pH 6.2.
b) bottles of lyophilised reagent-mixtures; ADP, MgClg,
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L-cysteine, AMP, glucose, hexokinase, NAD, G-6-PD
and creatine phosphate
k. Substrate solution, formed by dissolving one bottle of
Reagent 3b) with 1 ml of Reagent 3a)•
Proc edure.
The procedure advised by the manufacturers was followed.
2 yul sample was introduced into each sample well and
allowed to absorb into the gel before the film was mounted
onto the cell cover. After a 20 rnin elec trophoretic run,
the gel was removed from the cell and a layer of substrate
ft
solution was spread evenly on the gel surface with the help
of a 5 ml serological pipette. The same coupled reaction
sequence was used to demonstrate the isoenzymes as in the
polyacrylamide method except that NADPH fluorescence was
used for visualisation. The gel was incubated at 39°C
for 20 min and then dried at 60°C for 20 min.
When viewed under UV light, fluorescent bands indicated
the position of creatine kinase isoenzymes (Fig. 6-1).
These bands were scanned for NADPH fluorescence with the
Vitatron TLD 100 densitometer using a mercury source with
an ultraviolet filter in the primary position and a ^58 nm
filter in the secondary position. The MB isoenzyme content
of the sample was calculated as in the polyacrylamide method
above.
The optimal activity of serum samples for this method
was found to be 300 XU/1 and any samples with activity
higher than 300 IU/1 were diluted accordingly.
Figure 6-1





6-2-4 An attempt to assay the isoenzyme by differential
inactivation.
In Section 5> the MB isoenzyme was shown to be more
stable than the MM isoenzyme to inactivation by p-hydroxy-
mercuribenzoate (pHMB). It was, therefore, considered that
this reagent might be of value in the analysis of the MB
isoenzyme. If this inactivation effect was coupled with
the differences between the isoenzymes in substrate affinity,
the activity of MM isoenzyme might be almost completely
suppressed, thereby allowing the MB isoenzyme be determined
independently.
Various amounts of the MM and MB isoenzyme preparations
were separately incubated for 60 min at 4°C in a mixture
containing 14 mmol/l pHMB and 30 mmol/l tris/HCl, pH 7-0.
The activity of the isoenzymes was measured immediately
after the incubation, the reaction being started by intro¬
ducing 25 /tL of the incubation mixture. The creatine phos¬
phate concentration in the substrate solution was reduced
from the usual 35 mmol/l to 10 mmol/l. The latter con¬
centration was optimal for the MB isoenzyme, but suboptimal
for the MM isoenzyme. The results are shown in Table 6-2.
It can be seen that the activity of the MM isoenzyme was
suppressed to 2°fo while 48^ of the MB isoenzyme still remained.
Normal serum samples were fortified with various amounts
of both isoenzyme preparations and were incubated and
assayed in exactly the same way as above, the serum samples
being diluted five times on mixing with the incubation
•^mixture. Table 6-3 shows that between 37% and 45^ of the
Table 6-2
Inactivation of the Partially Purified Creatine Kinase Isoenzymes
by 14 mmol/1 pHMB at 4 C for 60 min
MM Isoenzyme MB Isoenzyme
Original 2500 1500 500 560 490 542 550 540
Activity IU/1
Activity after 50 20 10 7 261 254 250 254
Incubation
% Residual 2% 1.4% 2% 1.5% 53.3% 47% 46% 47%
Activity
Table 6-3
Inactivation of the Creatine Kinase Isoenzymes in Serum by
















1 37 43 0 1332 35.6 -
2 2455 0 1016 41.4 -
3 1255 0 559 44.5 -
4 531 0 231 43.5 -
5 98 736 446 - 55.3
6 52 490 282 - 53.2
7 25 245 147 - 55.9
8 30 98 99 - 68.4
* calculated on the assumption that the MM component activity had
KTv- * *
»
decreased to 40%. " •
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MM isoenzyme activity remained; there was a recovery of
53°/° to 68°/ of MB isoenzyme activity. Thus, the differen¬
tial inactivation of the MM isoenzyme seen with purified
isoenzyme preparations was not observed in serum.
6-3 Assessment of methods.
6-3-1 Batch ion-exchange method.
Accuracy.
Varying amounts of the partially purified MM and MB
isoenzymes were added to normal sera whose MB isoenzyme
activity was assumed to be negligible. About 95°/° (Table
6-k) of added MM isoenzyme was present in eluate 1, and eluat
2 contained no creatine kinase activity providing the origina
specimen (after dilution) showed less than 600 IU/1 (two
washes to obtain eluate 1) or 1500 XU/1 (four washes to
obtain eluate 1 ).
Addition of MB isoenzyme to normal sera with low
creatine kinase activity (Table 6-5) showed that an average
of 75c/° of the applied MB activity was recovered in eluate
2. Increase of NaCl concentration to 0.3 mol/l in Buffer
2, increase in the number of washings and the presence of
2 mmol/l yS-mercaptoethanol in the eluting buffers did not
alter the recovery. In some of these experiments, eluate
1 contained more creatine kinase activity than was present
in the original sample. Presumably this was partly due
Table 6 -4
DEAE Sephadex Ion-exchange Method - Effect of Addition of Varying
Amounts of MM Isoenzyme to Serum Samples of Low Total CK Activity
Serum Total MM Total MB Total Activity Total Activity MM Re
Sample Activity Activity of 1st Eluate of 2nd Eluate covery
IU/1 IU/1 IU/1 IU/1 in 1st
Eluate
*1 2500 0 2200 20 89%
2 2500 0 2300 14 91%
3 2500 0 2500 0 100%
4 1750 0 1740 4 99%
5 1740 0 1620 5 93%
6 1830 0 1780 0 97%
7 1240 0 1300 0 105% '
8 1260 0 1170 0 92%
9 1290 0 1060 0 82%
'10 890 0 830 12 93%
11 720 0 690 6 96%
12 480 0 460 0 96%
13 390 0 420 0 108%
14 250 0 240 0 96%
15 220 0 200 0 91%
* For samples 1-9: eluate 1 obtained from 4 washes and for samples
10-15 : eluate 1 obtained from 2 washes.
Table 6-5
DEAE Sephadex Ion-exchange Method - Effect of Addition of MB
Isoenzyme to Serum Samples of Low Total CK Activity (Assumed
to be due to MM Isoenzyme Only)
Serum Total MM Total MB Total Activity Total Activity MB Re-
Sample Activity Activity of 1st Eluate of 2nd Eluate covery
IU/1 IU/1 IU/1 IU/1 %
16 44 736 138 519 70.5
17 22 736 55 533 72.4
18 44 736 110 523 71.1
19 27 491 90 344
•
70.1
20 39 491 62 356 72.5
21 61 491 96 378 77.0
22 37 245 52 184 75.0
23 7 245 31 164 67.0
24 54 245 74 197 80.4
25 98 98 106 74 75.5
26 58 98 68 76 77.6
27 41 98 53 75 76.5
28 41 49 48 35 71.4
29 44 49 42 37 75.5
30 32 49 28 39 79.6
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to the presence of MB isoenzyme in eluate 1 (although not
detected by electrophoresis) but may also have been due to
activation of creatine kinase by dilution.
When mixtures of the MM and MB isoenzyme of varying
composition were analysed, it was found that there was a
linear relationship between the amount of MB isoenzyme in
the mixture and that determined by the method (Fig. 6-2).
As before, however, MB isoenzyme concentration was under¬
estimated by about 25°/°-
Specificity.
The ability of the ion-exchange method to separate the
MB from the MM isoenzyme in pathological sera was investi¬
gated by analysing eluates 1 and 2 obtained from four sera
from patients with acute myocardial infarction. Both
eluates (after concentration by pressure dialysis when
necessary) after electrophoresis were stained for creatine
kinase activity using the agarose film technique. In all
cases only the MM isoenzyme was demonstrable in eluate 1
and only the MB isoenzyme in eluate 2.
Precision and sensitivity.
The precision of the ion-exchange method was determined
by between-batch repeat analysis of samples from patients,
using the formula S.D. = d /(2N-1)
d = difference between duplicate
determinations
N = number of pairs of data
Figure 6-2
Analysis of Isoenzyme Composition of Mixtures of Partially
Purified MM and MB Isoenzymes
10 20 30
Percentage MB isoenzyme in mixture
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The results (Table 6-6) indicate that at low activities
the method has relatively poor precision and this limits the
useful range within which the method is of value. In
practice, activities of less than 10 IU/1 cannot with confi¬
dence be distinguished from zero and this figure is, there¬
fore, the practical lower limit of sensitivity of the method.
It would be possible with more washing steps and concentration
of eluates to increase the sensitivity. At activities over
20 IU/1 the precis ion was considered satisfactory.
The method is relatively simple to perform and results
can be available within about two hours oT receipt of the
s amp 1 e .
6-3-2 Electrophoretic methods.
Unlike the ion-excliange method these techniques do not
yield a direct measurement of MB isoenzyme activity. They
measure the proportion of creatine kinase activity present
as the MB isoenzyme; their precision and accuracy are,
therefore, partly dependent on the measurement of total
creatine kinase activity of the specimens.
With both electrophoretic techniques, MB and MM iso¬
enzymes were mixed in varying proportions and the mixtures
analysed. The results (Fig. 6-2) indicate that, at least
when partially purified enzymes are used, both techniques
give a fairly accurate measure of the amount of each iso¬
enzyme present in the mixture.
- 18? -
The precision of the two methods was calculated
using between-batch analysis of patients' samples (Table 6-6).
The agarose film technique was more precise than the
polyacrylamide gel method although both methods, in common
with the ion-exchange technique, are imprecise at low MB
isoenzyme activities.
The sensitivity of both techniques seemed to be depend¬
ent on the extent of serum dilution. For active samples
where the serum had to be diluted before application, the
sensitivity, when the MB isoenzyme result was reported as
a percentage, was higher than for the undiluted sera,
presumably due to dilution of interfering substances in the
serum.
Sera from patients with myocardial infarction were
examined by both electrophoretic methods and by the ion-
exchange method whereas the polyacrylamide gel method
appeared less satisfactory (Fig. 6-3, Table 6-7).
In terms of technical performance the agarose film
method was rapid, taking about 1\ hours to analyse a batch
of 8 samples. The polyacrylamide gel method, on the
other hand, was more time consuming, taking about 6 hours
for a batch of 18 samples before a result was available.
This method also required considerable technical skill if
satisfactory results were to be obtained.
G-k Discussion.
The kinetic assay- <?f the MB isoenzyme by differential
Table 6-6
Precision Obtained from Between-batch Analysis of Patients' Specimens













































In parentheses is the number of samples analysed.
Figure 6-3
Correlation between the Agarose Film and Ion-exchange Methods
of Determining Serum MB Isoenzyme Activity
Table 6-7
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Agarose Film 36 1.01 (0.03) -1.4 (3.5) 0.98
Method




inactivation by pHMB seems to work well in purified extracts
but is not applicable to serum, presumably due to the high
concentration of protein and other substances present in
serum. Further dilution of serum in the incubation mixture
is not practicable as the amount of MB isoenzyme present,
already small, might be diluted below the limit of sensit¬
ivity of the method. This, together with the rapid re¬
activation of both isoenzymes in the assay mixture has made
it impracticable to develop a method based on this differ¬
ential inactivation.
Methods based on differences in substrate affinity
alone are often unsuitable for routine use since large
differences in substrate affinity are required; such diff¬
erences may be affected by the presence of various serum
constituents. Moreover, substrate affinities of enzymes
present in organ extracts and serum are not always identical
In some cases, e.g. malate dehydrogenase, the substrate
affinity is not even a constant value and it may fall after
the release of the enzyme into plasma (Schmidt and Schmidt,
1960). Nevertheless, one such method had been reported
for the MB isoenzyme (Witteveen ejt al. , 197^)*
It seems likely that many Clinical Chemistry labora¬
tories may be requested to provide measurements of the
activity of the MB isoenzyme of creatine kinase, since in
certain circumstances, this enzyme test has unique advantage
over other currently available "cardiac enzymes" (Section k)
Unfortunately, at present, no one method of measurement
appears altogether satisfactory. Any test considered for
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routine use should be accurate and precise but should also
be cheap and relatively simple to perform.
Most existing methods for measuring the MB isoenzyme
are insufficiently sensitive to detect the amounts normally
present in human serum, although it has recently been
reported that a chromatographic technique using DEAE
cellulose is suitable for this purpose provided the serum
samples are concentrated prior to analysis (Nealon and
Henderson, 1975)None of the methods described in this
thesis is sensitive enough to detect MB isoenzyme levels of
*
0-6 IU/1 , the reference values suggested by Nealon and
Henderson. It is not at present apparent how important
this lack of sensitivity may be, since the main advantage
of MB isoenzyme measurement seems to be its specificity for
cardiac tissue rather than its ability to detect minor degree
of myocardial damage. MB isoenzyme measurements offer
a rapid, effective method of distinguishing patients with
serum enzyme elevation due to myocardial infarction from
those with enzyme elevation due to other causes. For these
purposes, a semi-quantitative result may be all that is
required.
The polyacrylamide gel technique has been used as a
semi-quantitative method for some years, mainly for res¬
earch purposes. However, it is rather tedious and the
present quantitiative method developed from it is signif¬
icantly less precise than the other methods we have tested.
Most of the difficulties relate either to the difficulty
of introducing the coupling enzymes, glucose-6-phosphate
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dehydrogenase and hexokinase, into the separating gel in a
sufficiently uniform manner, or to non-specific reduction
of the phenazine methosulphate/nitroblue tetrazolium
mixture by the thiol agents included in the solution in
order to activate creatine kinase. The major advantage
of the polyacrylamide gel technique is that high resolution
of the isoenzyme bands is readily obtainable, but it seems
unlikely that this could be a useful feature in routine
diagnostic work.
The commercial agarose film method, on the other hand,
has proved simple, reliable and rapid. Although the method
is not claimed to be quantitative it has been possible to
obtain reasonable quantitation by scanning the fluorescent
bands obtained.
The results with partially purified isoenzymes suggest
that the ion-exchange method should give low results for
serum MB isoenzyme activity, since only 75°/> of added MB
isoenzyme was "recovered" from serum. In fact, the ion-
exchange method correlated well with both electrophoretic
methods, yielding results of the same magnitude. It seems
unlikely that the electrophoretic methods underestimate MB
isoenzyme activity since accurate results were obtained
when mixtures of purified isoenzymes were analysed. It
is more probable that the MB isoenzyme preparations added
to the serum did not behave in the same manner as endogenous
creatine kinase isoenzymes. However, it is difficult to
be certain about the accuracy of all these procedures since
loss or denaturation of one or both isoenzymes during
separation may be completely or partially compensated by
the effects of serum dilution on creatine kinase activity.
Apart from problems of lack of sensitivity all three
methods are able to detect and quantitate the MB isoenzyme
of creatine kinase. Experience with MB isoenzyme determin¬
ation in a fairly large series of patients with myocardial
infarction suggests that all such patients will attain serum
activities of the MB isoenzyme readily quantifiable by these
techniques.
The practical problems of selecting a suitable technique
for routine use will depend on a number of factors, such as
cost, convenience, analytical performance and the patient
population to be studied. The presently available evidence
suggests that column chromatography on DEAE cellulose or
Sephadex may be the most accurate method of determination.
However, even if the simplified techniques described (Mercer,
197^5 Nealon and Henderson, 1975) are used, the method may
be rather time consuming and require creatine kinase analysis
on several eluate tubes. Of the methods compared in the
present study, the polyacrylamide gel technique is less acc¬
urate, less precise and requires greater technical skill
than the other two methods. The agarose film technique
(and possibly other similar commercial techniques) is fairly
rapid and appears reasonably precise and accurate. The
batch method using DEAE Sephadex, can be performed in about
the same time, is cheaper and requires a minimum of special
apparatus, but may need 1 ml of serum. It is felt that
either of these methods would be suitable for use in a routine
- 192 -
laboratory and would provide clinical information not








The study of the tissue specificity of isoenzymes has
found many useful applications in clinical enzymology since
tissue specific isoenzymes often indicate the site of a
disease process. The use of different isoenzymes of lactate
dehydrogenase in the diagnosis of diseases affecting diff¬
erent tissues illustrates the success of such studies.
However, it is extremely rare to find an isoenzyme which is
completely specific to one tissue: it is necessary for the
clinical enzymologist to investigate the distribution of
isoenzymes in different tissues and their release in various
disease states. In this way the practioal advantages to
be gained from isoenzyme studies on serum may be assessed.
It is with this aspect of tissue specificity that the present
studies on the MB isoenzyme of creatine kinase have been
cone erned.
Most of the clinical studies on the tissue specificity
of isoenzymes have been concerned with enzymes which are
present in the cytoplasm of the cell. However, it is
known that mitochondrial and membrane-bound enzymes may be
released under certain pathological circumstances (Schmidt
et al., 1967a; Boyde, 1968a). Much of the evidence
suggests that mitochondrial isoenzymes are released only
when cellular damage is more severe than that necessary to
cause the release of soluble cytoplasmic enzymes. Thus
another aspect of the present study has been to measure the
release of mitochondrial isoenzymes into the blood of
patients with myocardial infarction.
The investigations into the release of the MB isoenzyme
- -\ 9b -
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have shown that measurement of the activity of this enzyme
in serum provides a more specific and sensitive test for
myocardial infarction than any of the other enzymes
studies (mAST, cAST, mMD, cMD, CK-MM, USLD and GLDH).
Furthermore, it was the only enzyme that could reliably
help to diagnose myocaAal infarction after surgical oper¬
ation. The activity of the MB isoenzyme in serum reached
a peak value earlier and returned to normal earlier than
any of the other enzymes studied. Consequently MB isoenzyme
measurement is particularly valuable in detecting the occur¬
rence of reinfarction. On the other hand, the test is of
less value than other enzyme tests in patients in whom it
is not possible to obtain blood specimens within 36 hours
of suspected infarction.
The results of the clinical study on patients with
suspected myocardial infarction indicate that the mitochon¬
drial isoenzymes of aspartate aminotransferase (mAST) and
malate dehydrogenase (mMD) were of less value in establishing
a diagnosis of infarction than the corresponding cytoplasmic
isoenzymes (cAST and cMD). The serum activity of the
mitochond1ial isoenzymes rose more slowly and reached a peak
later than the cytoplasmic isoenzymes. Furthermore, the
peak activity did not correlate well with the corresponding
peak activity of the cytoplasmic isoenzymes. Xt is possible
that this poor correlation was due to release of cytoplasmic,
but not mitochondrial, isoenzymes from cells which suffered
reversible damage in the early stages of the disorder.
However, the peak value of mitochondiral isoenzyme activity
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was found to correlate better with post-infarct heart
failure than the cytoplasmic isoenzymes. Therefore, it
is possible that the mitochondrial isoenzymes may be
better indices of the severity of the infarction than the
cytoplasmic isoenzymes. In the absence of reliable data
about blood half-life of all the enzymes being studied, it
was not possible to determine definitively whether the re¬
lease of mitochondrial enzymes continued after the release
of cytoplasmic enzymes had ceased.
The biochemical studies on the partially purified iso¬
enzymes from human heart tissue show that'the MB isoenzyme
is less stable to heat, to denaturation by urea and to
extreme pH values than the MM isoenzyme. The MB isoenzyme
had a lower Km value for both creatine phosphate and MgADP
than the MM isoenzyme. Also the Km values of the two iso¬
enzymes behaved differently when the pH of the reaction
mixture was varied. Apart from these quantitative differ¬
ences, in many other respects the two isoenzymes showed
similar properties, for example in the type of reaction
mechanism, behaviour with many inhibitors and with thiol
compounds. In most respects, as stated above, the MM
isoenzyme was more stable than the MB isoenzyme, but, under
suitable experimental conditions, the MM isoenzyme was almos
completely inhibited by p-hydroxymercuribenzoate while
about 50°l° of the activity of the MB isoenzyme remained.
It was impossible to reproduce this differential inhibition
of the MM isoenzyme when the isoenzymes were present in
serum rather than in purified extracts, so the method could
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not be used as the basis for a test of clinical value.
From the study of the more conventional separative
methods, a batch ion-exchange method was developed and
found to compare favourably with the polyacrylamide gel
method used in this study and with a commericial electro-
phoretic method using agrose film. In certain circum¬
stances, depending on the equipment, staff and finance avail¬
able, the batch ion-exchange method could prove to be the
method of choice for the routine measurement of the activity
in serum of the MB isoenzyme of creatine kinase.
ft
Although the MB isoenzyme has proved the most sensitive
and specific test at present available for the diagnosis of
myocardial infarction, it is not certain how long this will
remain true. Clinical enzymology, in common with other
disciplines, continues to develop new methods which add to
the value of those which have previously been found useful.
In this way, the original descriptions of the value of AST
and ID in the diagnosis of myocardial infarction (LaDue
et al. , 195^5 Wroblewski and LaDue, 1955) were later
supplemented by the use of LD isoenzyme studies (Wroblewski
et al., i960) and the introduction of serum creatine kinase
measurements (Dreyfus et al., i960). Since then, few new
enzymes of diagnostic value for myocardial infarction have
been discovered. Instead much effort has been spent on
improving the precision, sensitivity and tissue specificity
of the existing enzyme assays.
There has been a less obvious but equally important
--^process of consolidation, during the past ten years -
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techniques of enzyme assay have been improved, reference
ranges have been measured more accurately, and possible
pitfalls in interpretation have been clarified. The
process is not yet complete, even for aspartate aminotrans¬
ferase, since clinical enzymologists are only now reaching
agreement on the experimental conditions suitable for a
reference method. Xt is apparent that much more informa¬
tion about the use of the MB isoenzyme will be required,
both in terms of methodology and in terms of evaluation of
its place in clinical diagnosis.
One area currently of great clinical'interest is the
use of serum enzymes to estimate infarct size (Shell e_t al. ,
1973). These workers have used serial serum enzyme measure¬
ments obtained in the first few hours after infarction to
predict the rest of the serum enzyme time curve. In the
absence of therapeutic intervention, these workers found
that the "predicted" and "observed" curves were similar,
and were therefore able to predic.t likely infarct size
within about 12 hours of infarction. Shell ejt al. ( 1 973 )
also found that they were able to reduce the "observed"
infarct size to less than the "predicted" value by appropr¬
iate measures such as hypotensive therapy. The enzyme
selected for such evaluations should be specific for the
myocardium, but the other necessary characteristics are less
easy to assess and may depend on the purpose for which the
evaluation of infarct size is required.
If a retrospective assessment of infarct size is to be
carried out for prognostic or other reasons, it would seem
- 198 -
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desirable that an enzyme liberated only from irreversibly
damaged or dead cells should be used. Possibly one of the
mitochondrial enzymes would be most suitable for this pur¬
pose, at least on theoretical grounds. If, on the other
hand, serum enzyme activities are to be used to assess the
effectiveness of therapeutic measures designed to reduce
infarct size (Shell and Sobel, 197^)> then an enzyme which
is released into the plasma early in the disease, and which
is released from reversibly as well as irreversibly damaged
cells, is required. The MB isoenzyme of creatine kinase
seems to fulfil this second set of requirements fairly well.
In practice it seems likely that there will be many diffi¬
culties, partly because of biological variation in the rate
of release and inactivation of enzymes, and partly due to
difficulties in obtaining sufficiently precise and accurate
measurements of enzyme activity.
Present knowledge about the biochemical factors con¬
tributing to the release of enzymes from damaged myocardium
is very limited. Since many of the enzyme tests have been
established on an empirical basis, it is possible that un¬
expected problems might arise with further improvements
in the sensitivity and specificity of methods of enzyme
assay. It has been pointed out that improvements in methods
of assay could, in some cases, remove chemical "artefacts"
in the assay system that contribute to the clinical signi¬
ficance of the result. For example, renin when assayed
after separation from serum correlates less well with the
presence of hypertension than when assayed in untreated
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serum, although the latter method of assay is less precise
and accurate (Goodfriend, 1970)* It is possible that in
some diseases it is of more diagnostic value to measure
enzyme activity than enzyme concentration because of the
presence of at present unknown activating or inhibiting
factors in serum. A more accurate method of measurement
of enzyme concentration might no longer be affected by such
a factor and hence the test would be of less diagnostic
value.
It is not certain whether these reservations are
relevant to the present studies on enzyme* release in myo¬
cardial infarction. However, it seems unlikely that the
maximum diagnostic value will be obtained until more is
understood about those factors which control the release of
enzymes from damaged cells and about other metabolic and
adaptive changes which may occur in such cells. Some
studies of this nature have already been carried out.
Niles and Barnhouse (1967) studied myocardial cells in
heart tissue slices and observed that prolonged anoxia
caused disruption of the bonds between lipid and protein.
Gudbjarnasson and co-workers (1967) studied the activity
of myocardial enzymes from various sites in the cell after
myocardial infarction. They found a sharp decrease in the
activity of glycolytic and oxidative enzymes in mitochondria
but a large increase in the activity of the hexose monoph¬
osphate shunt enzymes. More recently, it has been suggeste
that the ATP content of the cell and the presence of
phospholipases in the surrounding inflammatory fluid were
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important factors controlling the release of enzymes
from injured cells (Wilkinson and Robinson, 1973;
Robinson and Wilkinson, 197^)*
It is clear that the metabolic events which occur close
to and within an area of ischaemic or infarcted myocardium
are of great importance to doctors wishing to improve the
prevention, diagnosis and management of the condition. The
release of enzymes is only one biochemical event among many,
but it seems likely that there is a close inter-relationship
between all the factors involved. In addition to their
purely diagnostic role, studies on enzyme* release may play
their part in unravelling other problems associated with
the metabolism of ischaemic tissue. For this purpose it
might be profitable for future work to study the mitochon¬
drial isoenzyme of creatine kinase as it is closely linked
with the energy metabolism of the cell. These studies
would include the investigation of its biochemical properties,
its functions in mitochondria during normal and anoxic
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The foLI owing abbreviations have been used in the text:-
a. Enzymes
Trivial name Systematic name Code
number
Acid phosphatase Orthophophoric monoester hydrolase 3.1.3.2
Adenylate kinase ATPiAMP phosphotransferase 2.7.4.3
Alanine aminotransferase L-alanine:2 oxoglutarate amino- 2.6.1.2
(ALT) transferase
Aldolase Ketose-1 -phosphate aldehyde lyase 4.1.2.7
Alkaline phosphatase Orthophosphoric monoester hydrolase 3.1.3.1
Aspartate aminotransfer- L-aspartate: 2 oxoglutarate 2.6.1.1
ase (AST) aminotransferase
ATPase ATP phosphohydrolase 3.6.1.4
Creatine kinase (CK) ATP:creatine phosphotransferase 2.7.3.2
Glucose-6-phosphate D-glucose-6-phosphate: NADP 1.1.1.49
dehydrogenase (G6PD) oxidoreductase
Glutamate dehydrogenase L-glutamate:NAD oxidoreductase 1.4.1.2
(GLDH)
Glyceraldehyde 3-phosphate D-glyceraldehyde-3-phosphate: 1.2.1.12
dehydrogenase NAD Qxidoreductase
Hexokinase (HK) ATP: D-hexose-6-phosphotransferase 2.7.1.1
Isocitrate dehydrogenase L-isocitrate: NADP oxidoreductase 1.1.1.42
(de ca rboxyla ting)
Lactate dehydrogenase L-lactate:NAD oxidoreductase 1.1.1.28
(LD)
Malate dehydrogenase L-malate:NAD oxidoreductase 1.1.1.37
' (MD)
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